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ABSTRACT 
Previous research has demonstrated the effectiveness of the supplement d-aspartic acid 
to increase testosterone levels in infertile men. With this supplement readily available 
on the market, supplement companies are capitalising on the purported benefits to 
improve the resistance training goals of strength and hypertrophy. There is a 
requirement for more research to fully elucidate these claims within the context of a 
resistance trained population, and investigate the proposed mechanisms of action. 
Thus the effectiveness of the supplement d-aspartic acid to improve resistance training 
gains in resistance-trained men was studied throughout this thesis. This was achieved 
by 1) observing changes in testosterone over a 2-week dosing study and 2) investigate 
any testosterone-mediated improvements in strength, power, hypertrophy and neural 
adaptation over a three-month training study. A secondary objective was to clarify if 
any relationship exists between gonadal hormones and training related outcomes. 
Study 1 investigated three dosages: placebo, three grams and six grams of d-aspartic 
acid, taken daily throughout a two-week combined supplementation and training 
protocol. No changes in hormones were detected in the three-gram group. Participants 
within the six-gram group experienced significant reductions in both total testosterone 
and free testosterone. This reduction suggested that the higher dosage of d-aspartic 
acid was affecting negative feedback mechanisms within the hypothalamic-pituitary-
gonadal axis or potentially over accumulating within the testes, causing disruption to 
testosterone production. As this was the first study to implement a higher dose of six 
grams per day, it was unknown what may occur if this dosage was consumed over a 
longer timeframe. It was important to explore the effects of this dosage further within 
the context of a long-term training study. Study 2 implemented a 12-week periodised 
training protocol combined with six grams daily d-aspartic acid supplementation. The 
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d-aspartic group experienced a reduction in estradiol, with no observed change in 
testosterone. Additionally, supplementation caused an increase in the early rate of 
force development within the quadriceps muscle. Peripheral neural adaptation of the 
gastrocnemius muscle was observed in the placebo group, but not in the d-aspartic 
group. Both groups increased hypertrophy and, strength within the quadriceps and calf 
muscles to a similar extent. No relationships were observed between testosterone 
change and hypertrophy or isometric strength change. A positive relationship was 
observed in change scores between estradiol and h-reflex recruitment gain of the soleus 
and gastrocnemius muscles. A negative relationship was observed between estradiol 
and the neural excitability of the soleus muscle, at the level of the motoneuron. Both 
relationships suggested that reduced levels of estradiol may be negatively impacting 
spinal plasticity within the calf muscles. The long-term supplementation of d-aspartic, 
even at the higher dosage of six grams, had no positive influence on testosterone levels 
in resistance trained men. The reduction observed in estradiol, while not affecting 
strength or hypertrophy, may have disrupted improvement in calf spinal excitability 
within this population. 
This thesis supports and expands upon the current d-aspartic acid literature in 
resistance trained men. Results suggest that supplementation is ineffective at 
increasing testosterone levels, and has no ability to yield greater improvements in 
strength or hypertrophy from 12 weeks of resistance training. D-aspartic acid appears 
to have some interesting effects on neural adaptation and rate of force development 
that warrant further investigation to determine if it is a viable supplement for the 
improvement of quadriceps power.  
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CHAPTER 1 – INTRODUCTION 
Thesis Statement 
In the strength and conditioning community a key determinant, with regards to training 
gains, is the anabolic hormone testosterone. Circulating testosterone both directly 
imparts anabolic action, by interaction with androgen receptors (Heemers & Tindall, 
2007) and indirectly, via increases in other growth factors, such as insulin-like-growth-
factor 1 (Wu et al., 2007). Interaction with androgen receptors increases satellite cell 
activity and proliferation, causing a cascade of events leading to protein synthesis and 
muscle growth (Heemers & Tindall, 2007). Positive correlations between testosterone 
levels and training related strength gains have been observed in resistance trained 
populations (Häkkinen, Pakarinen, Alen, Kauhanen, & Komi, 1988b; Häkkinen, 
Pakarinen, Alen, & Komi, 1985). Resistance trained populations also tend to have 
higher basal testosterone levels (Häkkinen et al., 1988b; Häkkinen, Pakarinen, et al., 
1985; Willoughby & Leutholtz, 2013; Willoughby, Spillane, & Schwarz, 2014), which 
may be an adaptive mechanism to improve strength and hypertrophy gains within this 
population. The importance of testosterone is also highlighted in anabolic steroid 
research, whereby the exogenous elevation of testosterone to supraphysiologic levels 
clearly has the ability to improve strength and hypertrophy, with and without a training 
stimulus (Bhasin et al., 1996). Due to these factors, the supplement industry has 
endeavoured to monetize various testosterone boosters. One recent testosterone 
booster which has entered the market is d-aspartic acid (DAA). 
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Aspartic acid (C4H7NO4) is a α-amino acid which is known to exist in two isoforms, 
l-aspartic acid and d-aspartic acid. (2R)-2-aminobutanedioic acid or d-aspartic acid 
(DAA), previously believed to be exclusive to brain tissue in octopus, squid and 
cuttlefish, has also been shown to exist in mammals (A. D'Aniello et al., 1996). Free 
DAA is found in tissues and cells related to the central nervous and endocrine systems 
(A. D'Aniello, 2007; Furuchi & Homma, 2005). DAA is believed to stimulate the 
production and release of testosterone through multiple pathways of the hypothalamic-
pituitary-gonadal (HPG) axis. It has been shown to increase steroidogenic acute 
regulatory protein (StAR) gene expression, in rat Leydig cells (Nagata, Homma, 
Matsumoto, & Imai, 1999). StAR is a key regulator for enhancing the transport of 
cholesterol, from the outer to the inner mitochondrial membrane (Furuchi & Homma, 
2005). This transportation of cholesterol is believed to be the rate-limiting step in the 
production of steroid hormones, therefore by increasing levels of StAR, DAA may 
indirectly increase testosterone (Stocco, 1998). In vitro rat studies have demonstrated 
that DAA increases levels of testosterone, luteinizing hormone, progesterone (A. 
D'Aniello et al., 1996) and growth hormone (A. D'Aniello et al., 2000). This is believed 
to occur due to the accumulation of DAA in the anterior pituitary and testes (A. 
D'Aniello et al., 2000). Additional in vitro studies – on isolated rat testes (A. D'Aniello 
et al., 1996) and Leydig cells (Nagata, Homma, Lee, & Imai, 1999) – indicate that 
DAA increases the rate of testosterone synthesis in a dose-dependent manner. In these 
animals, the maximal-effective-dose of DAA, which elicited the greatest hormonal 
response (LH, testosterone and progesterone), was 1 µmol/g (A. D'Aniello et al., 
1996). In humans, data partially supports the efficacy of DAA to increase testosterone, 
with positive improvements observed in infertile men consuming a 3 g/d dosage 
(D’Aniello et al., 2012; Topo, Soricelli, D'Aniello, Ronsini, & D'Aniello, 2009). 
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Currently, there is no information about the effect of different doses of d-aspartic acid 
in humans. Furthermore, the longest period this supplement has been researched in 
resistance trained men was over a period of one month, and in this study, three grams 
of d-aspartic acid did not increase basal testosterone (Willoughby & Leutholtz, 2013). 
It is possible that a larger dose is required in this population to increase basal 
testosterone. Elevated testosterone over the course of a training program could increase 
the chance of interaction with androgen receptor sites (Heemers & Tindall, 2007), 
upregulate satellite cell activity and increase levels of other anabolic hormones (Wu et 
al., 2007), leading to greater strength gains via hypertrophic adaptation. DAA may also 
work directly on mechanisms of neural adaptation, via its proposed role as a 
neurotransmitter (S. D'Aniello, Somorjai, Garcia-Fernàndez, Topo, & D'Aniello, 
2011; Spinelli et al., 2006), leading to increased strength or power gains.  
D-aspartic acid in resistance trained men 
To date, three studies on pure d-aspartic acid supplementation (D’Aniello et al., 2012; 
Topo et al., 2009; Willoughby & Leutholtz, 2013), and two studies on DAA 
proprietary blends have been conducted in humans (Rodgers, Schriefer, Gunnels, & 
Bloomer, 2016; Willoughby et al., 2014). One proprietary blend study involved the 
methylated form of DAA (NMDA) (Willoughby et al., 2014). NMDA is believed to 
have similar hormonal effects as DAA (Arias et al., 1996; A. D'Aniello et al., 2000; 
Estienne, Hurlock, & Barb, 1998; Ondo, Wheeler, & Dom, 1988) and can also be 
synthesised from DAA (G. D'Aniello et al., 2000). Early research in humans showed 
promising increases in testosterone levels after short (Topo et al., 2009) and long term 
(D’Aniello et al., 2012) supplementation protocols in participants with fertility issues. 
After 12 days of supplementation (3.12 g/d), in a population of healthy males (27–37 
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years), levels of testosterone were significantly increased by 42% (4.5–6.4 ng/ml) 
(Topo et al., 2009). Recently it was reported that after 29 days of supplementation (3 
g/d) and resistance training, levels of total testosterone and free testosterone were not 
significantly altered (Willoughby & Leutholtz, 2013). Training status and the 
accompanying basal testosterone levels may, in part explain the difference in outcome 
between these two studies. Topo et al. recruited sedentary male in vitro fertilisation 
(IVF) patients with low basal testosterone levels (~4.55 ng/ml) (Topo et al., 2009). In 
contrast, Willoughby & Leutholtz recruited resistance trained men who exhibited a 
higher average baseline testosterone count (~7.96 ng/ml) (Willoughby & Leutholtz, 
2013). Resistance trained (RT) men tend to demonstrate higher levels of basal 
testosterone ranges than novice trainers. Basal testosterone levels of RT men range 
from approximately 5.1–12.0 ng/ml , (Häkkinen, Pakarinen, Alen, Kauhanen, & Komi, 
1988a; Häkkinen, Pakarinen, et al., 1985; Willoughby et al., 2014) and novices range 
from about 3.7–8.5 ng/ml (Craig, Brown, & Everhart, 1989; Häkkinen et al., 2002; 
McCall, Byrnes, Fleck, Dickinson, & Kraemer, 1999; Reaburn, Logan, & Mackinnon, 
1997; Staron et al., 1994). A larger dose for RT men may be needed to raise 
testosterone levels beyond this apparent adaptation to chronic resistance training. 
Current research has only explored the effectiveness of one dosage of DAA – 3 g/d 
(Topo et al., 2009; Willoughby & Leutholtz, 2013) – hence the maximum effective 
dose for humans is yet to be determined. Supplement companies are currently 
recommending three grams of DAA once to twice a day, with these recommendations 
drawn from the 3 g/d literature. It is reasonable to believe that in RT males, a higher 
dose may be required to upregulate mechanisms of testosterone production such as 
enhanced cholesterol transport; an increase in testosterone regulatory hormones; and 
the accumulation of DAA within various glands along the HPG axis. This boost in 
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testosterone over time may equate to greater hypertrophy and neural adaptation, via an 
increased exposure of testosterone to androgen receptors located within muscle and 
nerve cells. These improvements may be further expressed by a gross increase in 
strength. 
Hypertrophic adaptation 
Resistance exercise training is well-known to lead to hypertrophy of skeletal muscle. 
However, the relative effect that basal testosterone change has on hypertrophy (within 
normal physiological ranges) is not abundantly clear. Hypertrophy is a result of an 
increase in the cross-sectional area (CSA) and the total volume of the muscle (Bruce, 
Phillips, & Woledge, 1997; Flann, Lastayo, McClain, Hazel, & Lindstedt, 2011). An 
important mechanism that attributes to hypertrophy is signalling pathways which 
initiate muscle protein synthesis (MPS). Testosterone is believed to be a major driver 
for the initiation of these signalling responses. Testosterone interacts with androgen 
receptors located on the muscle cell. Testosterone binds to the androgen receptor to 
up-regulate transcription rates and results in an increase in muscle protein synthesis 
(Heemers & Tindall, 2007). The importance of the testosterone-androgen receptor 
complex is supported by research where AR activity was blocked in rats. The rats that 
were exposed to an AR antagonist experienced significantly lower levels of muscle 
hypertrophy in comparison to control (Inoue, Yamasaki, Fushiki, Okada, & Sugimoto, 
1994). Testosterone also stimulates the proliferation and differentiation of satellite 
cells (SC), which has been demonstrated in young (Sinha-Hikim, Roth, Lee, & Bhasin, 
2003) and old (Sinha-Hikim, Cornford, Gaytan, Lee, & Bhasin, 2006) people, as well 
as increasing IGF-1 (Wu et al., 2007). Thus, an increase in testosterone levels, 
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mediated by DAA supplementation, could improve hypertrophy via the 
aforementioned mechanisms. 
Neural adaptation 
A fundamental mechanism for strength development is adaptation within the 
peripheral or central nervous systems. Androgen receptors have been found in a 
number of mammal nervous tissues including rat (Jordan, Price Jr, & Handa, 2002), 
gerbils (Mansouri, Siegford, & Ulibarri, 2003) and human fetal brain tissue (Hammond 
et al., 2001). It is believed that the AR may help grow and maintain the relative size of 
these motor neurons throughout normal life. In vitro experiments on human fetal brain 
tissue suggests that testosterone provides neuroprotective benefits (Hammond et al., 
2001). It stands to reason that AR may exist within human motor neurons and that 
testosterone interaction could be beneficial to neuromuscular adaptation. Thus a boost 
in testosterone from DAA supplementation could increase strength via neural 
adaptation mechanisms.  
One study to date has explored transitory increases in testosterone and changes with 
the corticospinal pathway in humans (Bonifazi, Ginanneschi, Della Volpe, & Rossi, 
2004). Researchers injected 5000 IU of human chorionic gonadotropin (hCG) directly 
into participant’s muscles, causing gonadal stimulation. This artificially increased 
testosterone levels, within normal clinical ranges (4.95 to 8.73 ng/ml). These increases 
were concurrent with reduced threshold of the evoked potentials from transcranial 
magnetic stimulation (TMS), indicating that testosterone can positively increase the 
output from a given input, within the corticospinal pathway. This suggests that 
artificially increasing testosterone levels, via supplementation may improve strength 
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or power, by increasing the efficiency of the corticospinal pathway. Adaptation of this 
pathway can be investigated by observing EMG responses to electrical nerve 
stimulation. 
Spinal adaptation mechanisms can be investigated by observing changes in the 
Hoffman reflex (H-wave) (Aagaard, Simonsen, Andersen, Magnusson, & Dyhre-
Poulsen, 2002b). Increases in H-waves have been noted as a result of resistance 
training (Aagaard et al., 2002b; Holtermann, Roeleveld, Engstrøm, & Sand, 2007; 
Lagerquist, Zehr, & Docherty, 2006), indicating adaptation of the Ia spinal reflex 
pathway. These papers collected H-wave data at a single stimulus intensity, however 
by collecting data along the entire ascending limb of the H-reflex curve, the change in 
excitability of motor units with various recruitment thresholds can be investigated 
(Vila-Cha, Falla, Correia, & Farina, 2012). The resistance training group experienced 
reductions in the stimulus intensity for H-wave threshold, suggesting excitability of 
lower threshold motor units. Conversely, the endurance training group observed 
reductions at high and low stimulus intensities, indicating increased excitability across 
the threshold spectrum (Vila-Cha et al., 2012). Supraspinal adaptation can be explored 
by observing changes in volitional waves (V-waves). V-waves are recorded during a 
maximal voluntary contraction (MVC) while simultaneously stimulating at a 
supramaximal intensity (130% of the maximal motor response - Mmax). The Vmax/Mmax 
ratio is believed to be an indication of increased supraspinal drive (Aagaard et al., 
2002b). Augmented supraspinal activation from the motor cortex increases 
transmission efficiency to the motor units and firing rate of the motor units, resulting 
in an increased force output (Aagaard et al., 2002b; Van Cutsem, Duchateau, & 
Hainaut, 1998). Research has previously demonstrated increased V-waves after 
strength training within novice populations (Aagaard et al., 2002b; Vila-Cha et al., 
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2012). Currently within the literature, there is a lack of data exploring the changes in 
V-wave and H-reflex data in a resistance trained population. Furthermore, there is 
scarce data on the relationship between basal testosterone and neural adaptation. If d-
aspartic acid mediated increases in testosterone effect strength via neural mechanisms, 
the combination of H-wave and V-wave data would help clarify if the adaptation is 
originating from supraspinal centres or along the reflex arc of the Ia afferents (Aagaard 
et al., 2002b; Vila-Cha et al., 2012). 
Overview 
The current literature indicates that supplementation of d-aspartic acid (3 g/d), has the 
potential to increase resting levels of testosterone in clinical populations, but not in 
resistance trained men. The first study of this thesis will measure testosterone levels 
within a resistance trained population, after 14 days of combined d-aspartic acid 
supplementation and resistance training. This research will examine whether 6 g/d of 
d-aspartic acid is more effective than 3 g/d and if so, by how much. The second study 
of this thesis will examine the long-term effects of d-aspartic acid on hormonal change, 
investigating any hormonally mediated effects on training outcomes, following a 12-
week resistance training program. Training outcomes measured will include, changes 
in strength, hypertrophy and adaptation of nervous system. Consequently, this thesis 
will be based on original research that strives to study the effectiveness of d-aspartic 
acid, both for its potential to raise testosterone levels and the effect on training 
outcomes in resistance trained populations.  
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Aims objectives and hypotheses 
 
Thesis aim 
The primary aim of this thesis was to explore the effectiveness of the proposed 
testosterone boosting supplement: d-aspartic acid, in resistance trained men. This aim 
was achieved by 1) observing changes in testosterone over a 14-day dosing study and 
2) implementing a three-month training study, noting changes in testosterone from 
supplementation, over a longer timeframe, as well as any testosterone-mediated 
improvements in strength, power and hypertrophy.  
Objectives study 1 
The objective of the first study was to evaluate the effects of two doses of d-aspartic 
acid (3g and 6g) on basal testosterone levels in resistance trained men. A secondary 
objective was to establish if a relationship exists between basal testosterone levels and 
responsiveness to DAA.  
Hypotheses study 1 
H1: Testosterone levels will be unchanged in the three-gram group. 
H2:  Testosterone levels will be increased in the six-gram group. 
H3: Lower initial testosterone levels would correspond with increased 
responsiveness to d-aspartic acid. 
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Objectives study 2 
The primary objective of study two was to evaluate the long-term effectiveness of d-
aspartic acid at a 6 g/d dosage, on basal testosterone levels during three months of 
resistance training. A secondary objective of this study was to reveal potential 
mechanisms of any training-related gains in strength, hypertrophy and power. The 
final objective was to clarify if any relationship exists between hormonal change and 
training-related improvements, in a resistance trained population.  
Hypotheses study 2 
H1: Six grams of daily supplementation of d-aspartic acid during three months of 
training will result in increased basal testosterone as compared to placebo. 
H2: Six grams of daily supplementation of d-aspartic acid during three months of 
training will result in larger gains in isometric strength in the seated leg 
extension and calf raise as compared to placebo. 
H3: Six grams of daily supplementation of d-aspartic acid during three months of 
training will result in greater hypertrophy of the quadriceps and calf muscles 
as compared to placebo. 
H4: A positive relationship will be observed between testosterone levels and 
quadriceps hypertrophy. 
H5: A positive relationship will be observed between testosterone levels and 
isometric strength of the calf and quadriceps muscles. 
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CHAPTER 2 – LITERATURE REVIEW 
The conceptual and empirical aspects of the research 
 
The figure below depicts the conceptual framework for the study. 
 
 
 
 
 
 
 
The conceptual model investigated in this thesis is that the relationship between d-
aspartic acid supplementation (independent variable) and improvements in dynamic 
strength (dependent variable) will be moderated by elevated basal testosterone, with 
proposed mechanisms of action for the strength increase related to neural and 
hypertrophic adaptation.  
Figure 1  Conceptual Model 
NEURAL CHANGE 
D-ASPARTIC ACID 
HYPERTROPHY 
STRENGTH 
& POWER 
TESTOSTERONE 
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D-Aspartic Acid 
Aspartic acid is a α-amino acid which is known to exist 
in two isoforms, l-aspartic acid and d-aspartic acid. 
(2R)-2-aminobutanedioic acid or d-aspartic acid 
(DAA), previously believed to be exclusive to brain 
tissue in octopus, squid and cuttlefish, has also been 
shown to exist in mammals (A. D'Aniello et al., 1996).  Free DAA is found in tissues 
and cells related to the central nervous and endocrine systems (A. D'Aniello, 2007; 
Furuchi & Homma, 2005).  
In rat’s maximal levels of DAA production occur during the embryonic stage at the 
same time when testosterone production is greatest (A. D'Aniello et al., 1996). D-
aspartic acid appears to stimulate testosterone production through multiple pathways. 
When rats are given DAA, it is shown to accumulate in the anterior pituitary and testes, 
which occurs in parallel with an increase in blood levels of luteinizing hormone, 
testosterone and progesterone (A. D'Aniello et al., 1996). In vitro studies on isolated 
testes indicate that DAA increases the rate of testosterone synthesis (A. D'Aniello et 
al., 1996). Research on purified rat Leydig cells demonstrates that cells cultured in 
DAA for 3+ hours increased production of testosterone in a dose-dependent manner 
(Nagata, Homma, Lee, et al., 1999). Additional in vivo rat studies has shown that 5 
hours after injection DAA has a high affinity for accumulating in the anterior pituitary 
and moderate affinity for the testes, adrenals and hypothalamus (A. D'Aniello et al., 
2000). The authors also reported that DAA supplementation caused an observed 
increase in growth hormone (GH), luteinizing hormone (LH), testosterone and 
progesterone. The combination of these experiments suggests DAA acts on the 
Figure 2  D-Aspartic Acid 
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aforementioned tissues to release the hormones, either directly or indirectly at various 
points on the hypothalamic–pituitary–gonadal axis (see Figure 4 on page 16). 
Alternatively, DAA may be synthesised into N-methyl-D-aspartic acid, which has 
similar properties to DAA.  
N-methyl-D-aspartic acid (NMDA) or N-methyl-D,L-Aspartate (NMA), is the 
methylated forms of DAA and is believed to contribute to the mechanisms that 
underlie various hormone release in animal models. Evidence suggests that NMDA 
indirectly induces increased secretion of pituitary hormones, LH (Arias et al., 1996; 
Arslan, Pohl, & Plant, 1988; Bourguignon, Gerard, & Franchimont, 1989; A. 
D'Aniello et al., 2000; Estienne et al., 1998; Gay & Plant, 1987; Ondo et al., 1988; 
Pohl, Lee, & Smith, 1989; Price, Olney, Mitchell, Fuller, & Cicero, 1978; Schainker 
& Cicero, 1980; Wilson & Knobil, 1982), GH (Gay & Plant, 1987; Wilson & Knobil, 
1982), (Chang, Barb, Kraeling, Rampacek, & Asanovich, 1993; A. D'Aniello et al., 
2000; Downing, Joss, & Scaramuzzi, 1996; Estienne et al., 1996; Estienne et al., 1998; 
Estienne, Schillo, Green, Hileman, & Boling, 1989; Holloway & Leatherland, 1997; 
Pinilla, Gonzalez, Tena-Sempere, Dieguez, & Aguilar, 1999) and Prolactin (PRL) 
(Chang et al., 1993; Pohl et al., 1989). NMDA is believed to stimulate the release of 
these hormones via action at the hypothalamus – specifically the medial preoptic 
nucleus (Ondo et al., 1988) – releasing Gonadotropin-releasing hormone (GnRH) 
(Arias et al., 1996; Bourguignon et al., 1989; Zanisi & Messi, 1991). One study has 
shown that NMDA can also directly stimulate the rat pituitary gland (in vitro evidence 
of LH released from anterior pituitary) (Zanisi & Messi, 1991). It is understood that 
NMDA can be synthesised from DAA. With administration of DAA to Wistar male 
rats there is a significant increase in the concentration of NMDA (2h post injection) 
occurring in the hypothalamus (3.26-fold increase), anterior pituitary, hippocampus 
14 
 
(both ~2.8-3.0-fold increase), and to a lesser extent “total brain” and liver (G. 
D'Aniello et al., 2000). Additional experiments confirmed similar findings in vitro (G. 
D'Aniello et al., 2000). Tissue samples were incubated with DAA and S-adenosyl-L-
methionine (SAMe) – again with the hypothalamus demonstrating to be the tissue 
where NMDA biosynthesis occurred at the highest rate – followed by the 
hippocampus, anterior pituitary, brain and liver (G. D'Aniello et al., 2000). When 
incubated with DAA and NMDA (A. D'Aniello et al., 2000), the hormonal release of 
GH was increased, which was enhanced in the anterior pituitary + hypothalamus 
model, as opposed to the anterior pituitary alone, suggesting NMDA and DAA may 
work in synergy to stimulate the release of various hormones. 
Anabolic hormones 
Anabolic hormones that can contribute to hypertrophy or strength gains include 
testosterone, IGF and human growth hormone. The response of IGF-1 to resistance 
training have been observed in the literature to increase (Borst, Vincent, Lowenthal, 
& Braith, 2002; Marx et al., 2001), or not change at all (Kraemer et al., 1999; Petrella, 
Kim, Cross, Kosek, & Bamman, 2006; Walker, Kambadur, Sharma, & Smith, 2004). 
Basal levels of growth hormone tend not to change from resistance training (Craig et 
al., 1989; Kraemer et al., 1999; Kraemer et al., 1998; Marx et al., 2001). This may be 
attributed to the large variety in isoforms of GH produced in the body and the limited 
availability to detect them with current technology. Of all the hormones in the body, 
testosterone is considered to be one of the most powerful androgenic-anabolic 
hormones secreted by the body.  
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Testosterone ((17β)-17-Hydroxyandrost-4-en-3-one) is a 
0.288 kD 19 carbon steroid hormone of the androgen 
class. It is primarily produced in the Leydig cells of the 
testes or in smaller quantities in the ovaries and the 
adrenal cortex. Testosterone is of interest to the strength 
and conditioning community for direct action on androgen receptors and up-regulation 
of insulin-like growth factor 1 (IGF-1) (Wu et al., 2007). Interaction of testosterone 
with the AR causes the AR to activate and bind to the testosterone molecule. 
Subsequently the AR-testosterone complex cause an upregulation of the rate of 
transcription, by joining together with selective genes (Kadi, 2008). Besides genomic 
pathways via AR interaction, research has also identified mechanisms of signal 
transduction. Through a series of rat experiments using inhibitors of 
phosphatidylinositol 3-kinase / protein kinase B (PI3K/Akt) pathway and AR 
inhibition (Basualto-Alarcón, Jorquera, Altamirano, Jaimovich, & Estrada, 2013) it 
was shown that testosterone initiates Akt phosphorylation via PI3K, which in turn 
activates the mechanistic target of rapamycin / ribosomal protein S6 kinase 1 
(mTOR/S6K1) axis (Basualto-Alarcón et al., 2013). Both signalling pathways (AR 
and Akt/mTOR/S6K1) play a role together in skeletal muscle hypertrophy. 
Additionally, the results of this study suggest the likelihood of crosstalk occurring 
between the two pathways, which would assure an organised response pattern 
(Basualto-Alarcón et al., 2013).  
Testosterone secretion is controlled by a negative feedback loop, as shown in Figure 
4. In the healthy young adult, gonadotropin releasing hormone stimulates the release 
of luteinizing hormone, which stimulates testosterone secretion. As more testosterone 
becomes available, it will feed back through the negative feedback loop, inhibiting 
Figure 3  Testosterone 
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production to maintain normal testosterone levels. Evidence from small mammal 
studies suggests exogenous supplementation of DAA accumulates within various 
tissues along the HPG axis, causing upregulation of testosterone production through 
various mechanisms. 
 
Gonadotropin-releasing hormone (GnRH) 
 
Luteinizing hormone (LH) 
 
Testosterone 
 
When DAA accumulates in the testes, the increase in production of testosterone is 
believed to occur via hCG-induced synthesis. This increase in output occurs from 
upregulation of the transportation of cholesterol from outside the mitochondrial 
membrane to the inner membrane (Furuchi & Homma, 2005). The overall rate of 
testosterone production is limited by cholesterol availability and DAA has been shown 
to increase the mRNA and protein levels of steroidogenic acute regulatory protein 
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Anterior Pituitary 
 
Gonads 
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- 
- 
Figure 4  Testosterone Negative Feedback Loop 
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(StAR), which is a key regulator of the transport of cholesterol from the outer to inner 
membrane (Nagata, Homma, Matsumoto, et al., 1999). This mechanism first 
demonstrated in rats has also been identified in humans (Miller & Bose, 2011). Since 
accumulation of DAA occurs within the rat hypothalamus and anterior pituitary gland 
causing increased production of luteinizing hormone (A. D'Aniello et al., 1996). 
Theoretically, testosterone would be indirectly increased (Figure 4). These 
mechanisms suggest that it is reasonable to believe that testosterone levels could be 
manipulated, via the supplementation of DAA. The chronic manipulation of basal 
testosterone could provide a plausible mechanism of hypertrophic and strength 
improvement. 
Mechanisms of hypertrophy 
Skeletal hypertrophy is largely a result of the accretion of the myofibril proteins, actin 
and myosin. The addition of new muscle sarcomeres in parallel increases the cross-
sectional size of the myofibril and thus the muscle fibres (Goldspink, 1985). Exercise-
induced muscle hypertrophy arises from the accrual of multiple increases in the rate of 
myofibrillar synthesis rate that occur after each exercise bout across a training protocol 
(Brook et al., 2015; Damas et al., 2016). Multiple mechanisms have been discovered 
that help to explain muscular hypertrophy. These are broadly categorised into intrinsic 
factors within the muscle (e.g. muscle protein synthesis) and systemic factors (e.g. 
basal hormonal levels). 
Intrinsic factors 
Hypertrophic mechanisms pertaining to within the muscle are known as intrinsic 
factors. Intrinsic factors include activation of various signalling pathways (Akt/mTOR, 
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PA/mTOR, mechanoreceptor), phosphorylation of intramuscular signalling proteins, 
regulation of messenger RNA (translation initiation), increases in AR content, satellite 
cell activity and expression of muscle-specific microRNA. 
 mTOR 
One of the most important pathways in the regulation of muscle protein synthesis is 
the mammalian/mechanistic target of rapamycin complex 1 (mTOR). mTOR and 
downstream proteins are important regulators of the initiation of mRNA translation 
(Burnett, Barrow, Cohen, Snyder, & Sabatini, 1998). The process of translation 
initiation involves the binding of a ribosome to the mRNA (Sonenberg & Hinnebusch, 
2009). The stages of translation can be separated into initiation, elongation, 
termination and ribosome recycling (Sonenberg & Hinnebusch, 2009). Protein 
synthesis data in rats portrays increased polypeptide initiation, but not elongation 
suggesting that the initiation of mRNA translation is the rate-limiting step in protein 
synthesis (Monier & Le Marchand-Brustel, 1982). mTOR is initiated by the 
phosphorylation of upstream targets including insulin receptor substrate 1 (IRS1), Akt, 
tuberous sclerosis complex 2 (TSC2). Downstream targets of mTOR include 
ribosomal S6 kinase 1 (p70S6k), 4E-BP and ribosomal protein S6 (RPS6) (Sonenberg 
& Hinnebusch, 2009). 4E-BP regulates translation by binding with the eIF4E (cap-
binding factor). Activation of mTOR disassociates 4E-BP from eIF4E via 
phosphorylation, along with the phosphorylation of other cap-binding factors – eIF4G 
and eIF4A. The freedom of these cap-binding factors allows for them to bind with the 
capped 5’ end of mRNA enabling them to form the translation initiation complex 
eIF4F. mTOR also phosphorylates p70S6k, which in turn phosphorylates RPS6, which 
is believed to help with translation initiation (A. M. Gonzalez, Hoffman, Stout, 
Fukuda, & Willoughby, 2016).  
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Figure 5  Signalling pathways involved in muscle protein synthesis.
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It has been proposed that muscle lysosomes contain an abundance of Rheb and TSC2 
at rest. However, the presence of TSC2 keeps Rheb in its inactive, GDP-bound state 
(Sato, Nakashima, Guo, & Tamanoi, 2009), which also causes mTOR to be inactive 
(Jacobs et al., 2013). Thus, TSC2 is considered an upstream inhibitor of mTOR. The 
phosphorylation of TSC2 (Figure 5, A  B) causes it to disassociate from the 
lysosome and allows Rheb to change to a GTP-bound state. Amino acid availability is 
thought to help to activate mTOR (Mackenzie, Hamilton, Murray, Taylor, & Baar, 
2009). The localisation of mTOR to the lysosome allows for the interaction with GTP-
bound Rheb, causes mTOR to activate (Jacobs et al., 2013). Activation of mTOR 
phosphorylates p70S6k, which upregulates the initiation of translation, increasing 
MPS rates. 
Traditionally mTOR has been explored with respect to activation by the growth 
factors, insulin and IGF-1. These growth factors bind to their respective receptors 
causing insulin receptor substrate 1 to recruit PIK3 (Shepherd, Withers, & Siddle, 
1998) to phosphorylate PIP2 into PIP3 (Alessi & Cohen, 1998). Phosphorylation of 
PIP3 then results in the phosphorylation of Akt and Akt phosphorylates TSC2 (Alessi 
et al., 1997), causing TSC2 to relocate and eventuate in the aforementioned activation 
of mTOR and subsequent increase in MPS. However, studies have shown that 
resistance exercise causes either a decrease (Deldicque et al., 2008) or no change in 
Akt phosphorylation (Adam M Gonzalez et al., 2015), despite phosphorylation of 
p70S6K, suggesting resistance exercise can activate mTOR independently of the 
growth factor pathway. Data indicates that post strength training T2C2 is 
phosphorylated by an unknown kinase, which is theorised to be detected by a 
mechanoreceptor when the muscle is under load (Figure 5A). Additionally, another 
recently discovered pathway is related to the production of phosphatidic acid, which 
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was upregulated in the stretched muscle (Hornberger et al., 2006) and during eccentric 
exercise (O'Neil, Duffy, Frey, & Hornberger, 2009). PA has been shown to activate 
mTOR directly by binding to the FRB domain of mTOR (Chen & Fang, 2002). 
Additionally, an upstream enzyme responsible for the production of PA (PLD1) was 
suggested to be an effector of Rheb (Sun et al., 2008) (Figure 5A). 
Significant downstream targets of mTOR include the kinase p70S6k and the ribosomal 
protein S6. Rats subjected to electrical stimulation demonstrated a high correlation 
between the percent increase in muscle mass and the percent change in p70S6k 
phosphorylation (r=0.998) (Barr & Esser, 1999). Since then this has also been 
demonstrated in untrained males, whereby increase in Thr389 phosphorylation p70 
was significantly correlated with percentage change in 1RM squat strength (r=0.84), 
whole body FFM (r=0.89), FFM of the leg (r=0.81) and type IIA fibre CSA (r=0.82) 
(Terzis et al., 2008). Furthermore, this appears to be volume dependent, with a 3x6RM 
protocol elevating phosphorylation of p70S6k three-fold and a 5x6RM protocol 
elevating it six-fold (Terzis et al., 2010). The combination of this data suggests that 
these downstream effectors are important indicative markers of MPS.  
Muscle protein synthesis has long been believed to be a driver of muscle hypertrophy. 
However, there is a lack of correlation between the initial acute rise in MPS and 
chronic muscle hypertrophy (Mitchell et al., 2014). Recently a close connection 
between MPS and resistance training-induced muscle hypertrophy has been 
demonstrated in healthy males (Damas et al., 2016). After ten weeks of resistance 
training, the integrated muscle protein fractional synthetic rate (0–48 hour, obtained at 
the 10-week time point) was observed to be highly correlated (r = 0.91) with fibre CSA 
(Damas et al., 2016) and with vastus lateralis CSA (r = 0.94) (Damas et al., 2016). The 
greatest absolute response of MPS in this study occurred in the 48 hours after the initial 
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resistance training bout and also corresponded with the largest observation of muscle 
damage (as indicated by Z-line streaming) (Damas et al., 2016). Both the response of 
MPS and the direct marker of muscle damage, after this initial training bout, were not 
significantly correlated with muscle hypertrophy. Normalisation of MPS to the 
percentage area containing Z-band streaming (direct damage), resulted in similar 
observations between the acute response to the initial training bout, the three-week 
bout and the ten-week bout of resistance training. The data from this study suggests 
that a novel training stimulus increases absolute MPS to a great extent. However, this 
increase may be more indicative of repair to damaged proteins, rather than the accrual 
of additional myofibrils in parallel, which explains the lack of correlation with markers 
of hypertrophy. By three weeks of resistance training, there are significant correlations 
between hypertrophy and MPS, and these are augmented further after ten weeks of 
training (Damas et al., 2016). 
Satellite Cells 
Skeletal muscle stem cells, more commonly known as satellite cells because they were 
revealed to be located above the myofiber, beneath the basal lamina. First discovered 
over 50 years ago within frogs (Mauro, 1961), only in the last decade or two has 
research begun to better understand the function and role of SC within skeletal muscle. 
The myocyte is a cell or muscle cell is a multinucleated cell containing many hundreds 
of nuclei (Dumont, Bentzinger, Sincennes, & Rudnicki, 2015). Each nucleus regulates 
gene production for a given volume of cytoplasm, within the domain of the nucleus 
(Allen, Roy, & Reggie Edgerton, 1999). The myonuclear domain hypothesis is a 
prevailing theory, which describes that the ratio of nuclei to cytoplasm remains 
relatively constant. As previously outlined the acute exercise bout increases signalling 
mechanisms that increase protein synthesis, via an enhancement of translational 
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efficacy (Sonenberg & Hinnebusch, 2009). The net accretion of protein increases the 
myofiber volume. Satellite cells become relevant in the later phase of myofiber growth, 
once the myofiber volume increases to a point whereby the current nuclei population 
cannot support the volume of cytoplasm. At this point, new nuclei are believed to be 
integrated to support continual growth (O'Connor, Pavlath, McCarthy, & Esser, 2007). 
This is achieved by proliferation and differentiation of satellite cells (Collins et al., 
2005). Through injury (Zammit et al., 2004), growth stimuli (Zammit et al., 2004) and 
permissive testosterone levels (Kvorning et al., 2015), the cells are activated from their 
quiescent state, express various transcription factors, Pax7 and MyoD (Zammit et al., 
2004), to re-enter the cell cycle, causing the cells to multiply (Siegel, Kuhlmann, & 
Cornelison, 2011). A unique property of satellite cells is the ability to migrate to the 
damaged area, a process known as chemotaxis (Bischoff, 1997). Some cells will 
differentiate into myoblasts and fuse with the damaged myofiber to become available 
as nuclear donors, thus balancing the myonuclear domain ratio. Others regain a 
quiescent phenotype to support the satellite cell pool (Zammit et al., 2004).  
In mice where SC can be reduced, the abolishment SC has demonstrated conflicting 
results. One paper demonstrated the same increases in muscle mass and fibre cross-
sectional area between normal mice and gene-altered mice (SC 90% depleted) 
(McCarthy et al., 2011). Contrastingly the data from a more recent study that used an 
almost identical study design demonstrates that satellite cell ablation prevents overload 
hypertrophy (Egner, Bruusgaard, & Gundersen, 2016). Egner and colleagues’ 
highlights that the discrepancies between the papers were likely due to the 
methodology for the determination of hypertrophy. Specifically, the reliance of 
relative muscle mass as a proxy for fibre hypertrophy and inclusion of regenerating 
fibres that was used in the 2011 paper, may have resulted in the lack of significant 
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differences between the groups. SC undeniably play a role in skeletal muscle 
hypertrophy, despite the debate of if they are essential or not. In humans, studies have 
shown that change in the myonuclear number correlate with increases in myofiber size 
(Bellamy et al., 2014; Leenders et al., 2013; Petrella et al., 2006). Conversely, others 
have demonstrated increases in myofiber size independent of myonuclear addition 
(Kadi et al., 2004; Mackey et al., 2007; Petrella et al., 2006). This has led to the theory 
of a myonuclear domain ceiling, which suggests that an absolute or relative threshold 
for myonuclear addition exists before there is a requirement for subsequent 
myonuclear addition (Petrella et al., 2006; Petrella, Kim, Mayhew, Cross, & Bamman, 
2008). In humans, research also demonstrates that normal testosterone levels are 
required for the differentiation of satellite cells (Kvorning et al., 2015). Testosterone 
also has a direct effect on other intrinsic mechanisms. 
Androgen Receptor 
The anabolic action of testosterone is facilitated by the androgen receptor. Both 
concentric and eccentric exercise increases concentrations of mRNA for androgen 
receptors, suggesting increased turnover from resistance training (Bamman et al., 
2001). Data indicates that AR fold change is correlated with mean fibre change, despite 
no significant change in AR protein content pre to post resistance training (Mitchell et 
al., 2013). Similar results have been observed in young and old men (Ahtiainen et al., 
2011). Related to these intrinsic factors are the various conditions and stressors that 
resistance exercise exposes the muscle to.  
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Exercise muscle stress 
Resistance training exposes the muscle to mechanical tension, metabolic stress, 
damage to the muscle fibres and surrounding structures. It is not yet clear as to the 
specific mechanosensor that detects muscle tension and activates intrinsic factors to 
up-regulate MPS. Plausible locations of the mechanosensor include the myosin 
filaments, extracellular matrix, the myotendinous junction and the costamere (West, 
Burd, Staples, & Phillips, 2010). This mechanism is likely linked with muscle damage 
as it is believed that deformation of proteins within one or more of these structures 
directly activates mTOR via release of a phospholipid called phosphatidic acid (PA), 
(You, Frey, & Hornberger, 2012) or via an mTOR-independent pathway involving 
focal adhesion kinase (FAK) (Klossner, Durieux, Freyssenet, & Flueck, 2009). Muscle 
damage is believed to be an important driver of muscle hypertrophy. However, the 
extent of damage that is experienced in some protocols may be unnecessary as the dose 
response of muscular damage has yet to be determined. Surrounding the muscle cell is 
the membrane called the sarcolemma. Performing resistance training can cause 
deformation of the sarcolemma (West, Burd, Staples, et al., 2010), which is also known 
to release a phospholipid called phosphatidic acid (PA) (O'Neil et al., 2009), which as 
previously discussed can upregulate mTOR. Furthermore, damage to the myofibres 
will cause activation of satellite cells to up-regulate hypertrophy via these mechanisms 
(Zammit et al., 2004). 
Metabolite accumulation during resistance training may be a potential up-regulator of 
downstream growth mechanisms. Isometric training has demonstrated superior 
hypertrophy in long continuous contractions in comparison to short, intermittent 
contractions (Schott, McCully, & Rutherford, 1995). The group with longer 
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contractions also experienced a greater drop in pH, phosphocreatine (PCr) and a 
greater rise in inorganic phosphate (Pi) and the Pi : PCr ratio. Time under tension 
volume was matched, suggesting that the group that experienced the greater metabolic 
stress also experienced greater hypertrophy (Schott et al., 1995). Further evidence of 
the role of metabolites is seen in blood flow restriction studies. Typically, low load 
training (<60% 1RM) appears to attenuate the hypertrophic response (Schoenfeld, 
Wilson, Lowery, & Krieger, 2016), however, the introduction of metabolic stress via 
blood flow restriction has been demonstrated to create a hypertrophic response in 
untrained or recreational subjects (Loenneke, Wilson, Marín, Zourdos, & Bemben, 
2012) in comparison to low load training. Despite this data, research is not yet clear as 
to the specific mechanisms that metabolic stress affects to upregulate MPS. Theoretical 
mechanisms include increased fibre recruitment, elevated hormonal release, altered 
myokine production, production of reactive oxygen species and cellular swelling 
(Schoenfeld, 2013). It is plausible that metabolic stress could also play a role in the 
upregulation of mTOR. In addition to these intrinsic factors, systemic factors also 
perform a role in the hypertrophic effect. 
Systemic factors 
Hypertrophic mechanisms pertaining to factors arising from outside the muscle are 
known as systemic factors. These include testosterone, growth hormone, insulin-like 
growth factor 1 and interleukin-6 (IL-6) (Mitchell et al., 2013). IL-6 has been 
suggested as an important marker for future research as it is implicated as a regulator 
of satellite cell function (McKay et al., 2009). Furthermore, it has been shown to be 
positively correlated with mean fibre CSA after 16 weeks of resistance training 
(Mitchell et al., 2013). Other systemic factors, especially hormonal influence, was a 
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major focus of early research due to the belief that they could predict the hypertrophic 
potential of a training protocol. The relevance of systemic factors is still debated. 
However when measured as transient elevations detected in serum the evidence is 
strongly suggesting they play, more of a permissive role in hypertrophy than predictive 
of hypertrophic potential. 
Early research observed a variety of different acute testosterone responses to various 
changes in training program variables such as intensity; volume; exercise type; 
exercise order; rest period; and total time exercised (Craig et al., 1989; Cumming, 
Wall, Galbraith, & Belcastro, 1987; Gotshalk et al., 1997; Kraemer et al., 1992; 
Kraemer et al., 1990; Ostrowski, Wilson, Weatherby, Murphy, & Lyttle, 1997). This 
led early researchers to believe that the acute elevation in anabolic hormones was an 
important predictive marker of the potential for a resistance training protocol to 
provide maximum strength or hypertrophy gains. There has been some research that 
suggests that acute elevation of hormones might play a role in hypertrophic or strength 
outcomes. In 2001 Hansen and colleagues explored the effects of an arms only training 
group compared with a legs and arms group. What the authors observed was that the 
legs and arms group experienced a greater hormonal response in testosterone and 
growth hormone. This group also observed a higher percentage increase in isometric 
strength, with no significant differences in dynamic strength observed between the 
groups. However, as there was a significant difference between isometric strength at 
baseline (legs and arms were lower), which could have skewed the results as they were 
reported as a percentage change (Hansen, Kvorning, Kjær, & Sjøgaard, 2001) these 
results need to interpreted with caution. Transient increases in testosterone from an 
acute bout of resistance training has been shown to blunt androgen receptor 
catabolism. Specifically, the experimental group performed a high volume upper body 
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session before a lower body session, with the control group asked to rest before the 
lower body session. At three hours post resistance training, androgen receptor 
responses trended down in the control group. Furthermore, the experimental group was 
significantly greater in comparison to the control group at this time point (Spiering et 
al., 2009). Another paper that experimented with this design performed legs before 
arms in a within-subject study design (Rønnestad, Nygaard, & Raastad, 2011). They 
found that the experimental group experienced greater increases in hypertrophy of the 
arms (along with a greater acute response in testosterone and growth hormone) in 
comparison to the control group. As the participants of this study were untrained, it is 
possible that early adaptation to resistance training might be affected by temporary 
increases, as there is no prior exposure to these elevations in hormones. Research also 
suggests that acute elevations in hormones are not necessary to elicit hypertrophy. 
Wilkinson and colleagues demonstrated that in untrained individuals, eight weeks of 
unilateral resistance training increased whole leg CSA and muscle fibre CSA increases 
of type IIx and IIa. Despite these positive increases, no changes were observed in any 
acute hormones measured - testosterone, free testosterone, luteinizing hormone, sex 
hormone binding globulin, growth hormone, cortisol and IGF-1 (Wilkinson, 
Tarnopolsky, Grant, Correia, & Phillips, 2006). Research exploring the effect of 
transient elevations in hormones has failed to show a significant difference in MPS or 
the phosphorylation of p70S6K. West and colleagues showed similar increases in these 
markers in both a high hormonal condition and a low hormonal condition (West et al., 
2009). The authors followed this research with a training study; the demonstrated that 
the high hormonal condition was able to increase growth hormone, testosterone, and 
IGF-1, however, muscle CSA was not significantly different between groups post 
training. They further reported that muscle fibre CSA (type I and II) also increased to 
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a similar extent (West, Burd, Tang, et al., 2010). Similar null relationships have been 
observed when research explores the relationship between the area under the curve and 
various measures of strength and hypertrophy (West & Phillips, 2012) (aside from a 
weak correlation with growth hormone and type I fibre CSA). In resistance trained 
men the acute post-exercise rise in anabolic hormones showed no significant 
correlations with strength or hypertrophy (Morton et al., 2016).  
The growing body of evidence against the acute hormone hypothesis suggests that 
muscular hypertrophy is largely an intrinsic process. The combination of these studies 
suggests that normal levels of systemic hormones might play more of a permissive role 
in the overall training effects of a training stimulus and that transient increases in serum 
hormone concentrations do not appear to increase this effect. As resistance exercise-
mediated elevations in testosterone only last for approximately 30 minutes (Smilios, 
Pilianidis, Karamouzis, & Tokmakidis, 2003), it is believed these differences in short-
term elevations do not provide enough of a stimulus to improve hypertrophy over a 
training period. Increases in resting testosterone levels may, on the other hand, provide 
a more feasible mechanism for training-related gains. By elevating testosterone levels 
chronically this provides a greater chance of AR interaction and testosterone signalling 
downstream mechanism, which over the period that testosterone is increased, allows 
increased periods of positive protein balance, and hypothetically result in a larger 
hypertrophic effect.  
Testosterone and hypertrophy 
It is evident throughout the human male’s life that testosterone plays a major role in 
regulating muscle mass and growth. Puberty, a time of growth, is associated with 
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increased levels of anabolic hormones (e.g. testosterone) (Richmond & Rogol, 2007). 
In healthy young males, levels range between 4.5-10.0 ng/ml (Borst & Mulligan, 
2007). The process of ageing causes testosterone levels to decline slowly. 
Epidemiologic studies demonstrate that testosterone levels rise from the 20th decade 
where they peak and then trend down each decade at a slow constant rate. This pattern 
has been demonstrated in data from the Baltimore Longitudinal Study of Ageing 
(Harman, Metter, Tobin, Pearson, & Blackman, 2001), in community-dwelling men 
(Ferrini & Barrett-Connor, 1998) and ageing and obese men (Vermeulen, Kaufman, & 
Giagulli, 1996). It is believed that the reason for the decline in testosterone could be 
due to a decrease in Leydig cell numbers, cell secretion and increased sensitivity to the 
negative feedback loop (Borst & Mulligan, 2007). Declines in total testosterone have 
been associated with an age-dependent increase in body fat percentage, and declines 
in bioavailable and free testosterone are associated with fat-free mass and handgrip 
strength (Chin et al., 2012).  
Testosterone supplementation is associated with an increase in satellite cell number. 
This has been demonstrated in young (Sinha-Hikim et al., 2003) and old (Sinha-Hikim 
et al., 2006) people. Satellite cells (SC) as previously discussed are an important 
mechanism of continual hypertrophy by regulating the myonuclear domain (Allen et 
al., 1999). The SC proliferate and move to the damaged region, where they fuse to the 
damaged myofiber and are eventually integrated resulting in increased myofiber size 
(Hawke & Garry, 2001). Besides a permissive role in satellite cell activity, a direct 
mechanism of testosterone-imitated hypertrophy is the binding with the AR on a 
muscle cell. In the resting state, the AR exists within the cytoplasmic as a complex 
with heat shock proteins. When testosterone binds with the AR this complex 
transforms, which allows nuclear translocation of the AR along with AR homodimer 
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formation (Prescott & Coetzee, 2006). As the AR is now activated within the nucleus, 
it can bind to androgen response elements that affect target genes. Once bound to these 
elements the AR dimer can interact with the transcription pre-initiation complex to up-
regulate transcription rates which result in an increase in muscle protein synthesis 
(Heemers & Tindall, 2007). The importance of the AR-testosterone complex is 
supported by research where ARs were inhibited in rats, occurring in parallel with 
reductions in muscle hypertrophy (Inoue et al., 1994).  
The interaction of testosterone with ARs is not limited to muscle cells, as ARs can also 
be found on motor neurons. Androgen receptors found within the sciatic nerve of the 
rat, suggest that testosterone could have potential neurological effects on the peripheral 
nervous system (Jordan et al., 2002). Data on gerbil studies indicates that testosterone 
interacting with these AR may maintain the relative size of the motor neurons (Herbst 
& Bhasin, 2004) throughout normal life. One particular study showed that long-term 
castration reduced motoneuron size in the gerbils, further experiments demonstrated 
that testosterone propionate treatment prevented a reduction in motor neuron size 
(Fraley & Ulibarri, 2002). The presence of androgen receptors has also been 
determined in human fetal brain tissue, with evidence of the ability of testosterone to 
provide neuroprotection against serum deprivation (Hammond et al., 2001). With the 
addition of an aromatase inhibitor, it was also determined that the neuroprotective 
effects was likely caused by testosterone, rather than indirectly via the aromatization 
of testosterone to estradiol (Hammond et al., 2001). It is plausible that a secondary 
benefit of testosterone could also be to provide neural adaptation mechanisms, 
potentially improving transmission efficiency, which could translate into strength 
gains. 
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Neural adaptation and strength 
Although resistance training has obvious benefits on fibre hypertrophy, early literature 
suggested that not all strength observation could be as a result of muscular adaptation. 
The first indication of neural adaptation was in research where early strength gains 
were observed before any hypertrophy was identified (Akima et al., 1999; Moritani & 
DeVries, 1979), suggesting that changes in the nervous system played a role in strength 
improvements. The brain and spinal cord are known to be highly adaptable, or highly 
plastic in response to various tasks, such as skill, endurance or strength training. 
Anatomical changes within the ventral horn of the spinal cord have been observed in 
rats exposed to resistance training, with an increase in the number of excitatory 
synapses in spinal motoneurons observed (Adkins, Boychuk, Remple, & Kleim, 2006). 
Additional results demonstrated that training of a forearm grasping task led to changes 
in movement representations within the motor cortex. Two groups, skill reaching and 
load based strength reaching were tested against non-grasping controls. Similar 
changes were observed in the motor cortex, regardless of the load in the skill and 
strength reaching groups (Remple, Bruneau, VandenBerg, Goertzen, & Kleim, 2001). 
Since strength training does not favourably change representation patterns within the 
motor cortex, then other neural mechanisms must contribute to the observed strength 
change. Neural adaptation occurs within the body as a result of a training stimulus and 
is a key explanatory driver of strength development. Multiple mechanisms can adapt 
within the central and peripheral nervous systems to improve strength. These can be 
measured via electrical stimulation, which can investigate neural adaptation along 
various sections of the pathway, from the brain to muscle. The process of voluntary 
movement involves an electrical signal travelling from the motor cortex down the 
corticospinal tract, connecting with the spinal cord, where the upper motor neuron 
33 
 
synapses with interneurons and alpha motor neurons (α-MN) within the ventral horn 
at the relevant location of the spine. The action potential (AP) then travels down the 
α-MN axon which innervates muscle fibres via the motor end-plate and causes them 
to contract (Siegel, Sapru, & Siegel, 2014). Located within the muscle are muscle 
spindles which monitor the length of a muscle and how it changes. The sensory 
information of the muscle spindles is relayed via the type Ia afferent fibres to the α-
MN, mediated by an interneuron, which controls presynaptic inhibition (Zehr, 2002). 
Improvements in excitability of the Ia afferent pathway, from increased efficiency or 
reduction of presynaptic inhibition, are believed to increase the firing rate of the α-MN 
resulting in greater force production. This reflex pathway is researched in the tibial 
nerve and calf muscles and is explored by changes in the Hoffman reflex. 
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Figure 6  Overview of the neurophysiology involved with the Hoffman reflex, adapted from Aagaard et al. (2002b). 
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The Hoffman reflex (H-reflex) is electrically evoked by stimulating a peripheral nerve 
and observing changes in the recorded response (EMG) in the muscle innervated by 
that nerve.  Despite direct connection of Ia afferents to the α-MN, it is important to 
highlight that changes in the H-reflex do not necessarily reflect excitability of the 
motoneuron pool because of the effect of presynaptic inhibition (Zehr, 2002). Rather 
the size of the H-reflex reflects the efficiency of the Ia reflex pathway, including 
potential mechanisms of presynaptic or postsynaptic inhibition. At low-intensity 
electrical stimulation, where the H-reflex is observed, action potentials are 
preferentially recruited within the Ia afferents, due to the relatively larger diameter of 
this sensory axon. These signals travel up the Ia afferent to the spinal cord, via the 
dorsal root ganglion and elicits excitatory action potentials within the α-MN. The 
resultant H-wave is recorded approximately 30-40ms later (Aagaard et al., 2002b). As 
electrical stimulation is increased the thinner fibres of the α-MN are also stimulated 
causing action potentials to spread in both directions (Figure 6). The signals travelling 
down the α-MN are recorded as a direct motor response (M-wave). Signals travelling 
antidromically up the α-MN, collide with the elicited H-wave signals, which 
eventually cause the H-reflex to dissipate as the M-wave gets progressively larger up 
to the maximal motor response (Mmax) (Aagaard et al., 2002b). The change in this 
pathway, as a result of training, is influenced by the method of how it was elicited and 
the type of training that was implemented. When H-waves are explored during a 
complete rest protocol, no changes are observed during hopping training (Voigt, 
Chelli, & Frigo, 1998), electrical stimulation training (Gondin, Duclay, & Martin, 
2006), isometric training (Del Balso & Cafarelli, 2007), eccentric only training 
(Duclay, Martin, Robbe, & Pousson, 2008), and strength training (Aagaard et al., 
2002b; Holtermann et al., 2007; Lagerquist et al., 2006). With a clear lack of change 
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observed during rest it is believed that changes in H-reflex should be measured during 
muscle contraction either at MVC or a pre-determined percentage of MVC (tonic 
contraction). Aagaard and colleagues found increased normalised H-reflex amplitude 
during a ramped MVC (Aagaard et al., 2002b). Light plantar flexor training (~50% 
1RM) increased H-reflexed recruited during a 10% tonic contraction, at 5% of the 
maximum motor response (Mmax) (Lagerquist et al., 2006). Three weeks of isometric 
training resulted in increased H-reflexes at submaximal contractions of 20% and 60% 
approximately 20% Mmax (Holtermann et al., 2007). Despite a number of studies 
showing improvements in this reflex arc, some studies have found no change in H-
reflexes: 20% Mmax at 100% MVC (eccentric focused training) (Nordlund, 2010), and 
10% Mmax at 20% MVC (maximal strength training at 85-90% 1RM) (Fimland, 
Helgerud, Gruber, Leivseth, & Hoff, 2009). With such a wide variety of testing 
methods used in the literature, it can be difficult to draw solid conclusions from the 
available research. One method to help counteract these discrepancies is to map the 
entire ascending limb of the H-reflex recruitment curve. The H-reflex curve is fitted to 
a sigmoid function (Klimstra & Zehr, 2008) and a number of useful variables can be 
determined including the: maximum slope of the curve, current at the threshold of H-
reflexes, current at maximum H-reflex and the current at 50% of H-reflex max. This 
allows excitability of the H-reflex to be assessed at multiple intensities (Vila-Cha et 
al., 2012). When evaluated in this fashion it was observed that endurance training 
decreased the current required at H-reflex threshold, 50% H-reflex max and during H-
reflex max, suggesting improved excitability of the Ia reflex arc at low and high 
threshold motor units (Vila-Cha et al., 2012). The strength training group however 
only experienced a reduction in the current at H-reflex threshold, suggesting that 
improvements from strength training occurred only at the lower recruited motor units 
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(Vila-Cha et al., 2012), which is in line with the aforementioned research that observed 
increases at H-reflex intensities at or lower than 20% Mmax. These studies as a whole 
suggest that spinal plasticity of the Ia afferents can occur with various training modes 
within novices. Spinal plasticity is not the only explanatory mechanism for 
improvements in strength and power; another important mechanism is increased 
cortical drive. 
The enhancement of neural drive from the motor cortex is an acknowledged 
mechanism of strength and power improvements. Nerual drive can be investigated by 
measuring changes in volitional waves (V-Waves). Similar to the Hoffman reflex, V-
waves are elicited using a supramaximal electrical stimulation of the relevant nerve 
during maximal contraction (Aagaard et al., 2002b). The supramaximal stimulus 
(~130-150% of Mmax) ensures action potentials are travelling antidromically up the α-
MN axons. As this occurs simultaneously with an MVC, neural drive from the motor 
cortex, elicits efferent motor impulses within the α-MN, which collide with the 
antidromic action potentials, causing a cancellation effect. Usually, at Mmax or higher 
stimulus levels, the H-reflex response is nullified from signals travelling 
antidromically in the α-MN. However, this cancellation effect caused by the efferent 
motor impulses occurs before the H-reflex action potentials are elicited in the α-MN 
axon (Figure 7). This cancellation allows for some of the evoked H-reflex response to 
be recorded as a V-wave, denoted as such to indicate that it was elicited during 
voluntary contraction. Consequently, it is believed that an increase in the number of 
efferent impulses, or frequency of impulses from the motor cortex will result in 
improved chance of collision between antidromic and efferent action potentials, 
manifesting as a larger recorded V-wave (Aagaard et al., 2002b). The augmented 
neural drive is a plausible mechanism for a downstream increase in motor unit 
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discharge rate. Strength and power improvements have been observed concurrently 
with increased maximal firing frequency of single motor units in dorsiflexion ballistic 
training (Van Cutsem et al., 1998). Further research has indicated that motor unit 
discharge rate increased by ~11% in vastus medialis and vastus lateralis from 6 weeks 
of resistance training, in comparison to endurance training whereby MU discharge rate 
decreased by ~11% in these muscles. (Vila-Chã, Falla, & Farina, 2010). Early V-wave 
research compared the response between resistance trained individuals and novices 
and found that the experienced weightlifters had 70% higher V-wave response (Sale, 
Upton, McComas, & MacDougall, 1983). Increases in voluntary torque, in parallel 
with increases in the V-wave response, have been observed from various training 
modalities, including heavy periodised resistance training (Aagaard et al., 2002b), 
neuromuscular electrical stimulation training (Gondin et al., 2006), isometric training 
(Del Balso & Cafarelli, 2007), eccentric focused training (Duclay et al., 2008; 
Nordlund, 2010) and transfer from multi-joint strength training to the calf muscles 
(Fimland et al., 2009). These studies indicate that in novice populations, a significant 
mechanism of improved strength is increased neural drive to the muscles, especially 
during early stages of training. Currently, there are no training studies investigating if 
this mechanism is still apparent in a resistance trained population, or if neural 
excitability plays a larger role in this population. 
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Figure 7  Overview of the neurophysiology involved in eliciting V-waves, adapted from Aagaard et al. (2002b).
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Relationship between testosterone and corticospinal pathway 
Research has shown that a relationship exists between testosterone manipulation and 
the adaptation of the corticospinal pathway, in novice trainers (Bonifazi et al., 2004).  
Healthy males were exposed to an intramuscular injection of hCG, whereby 
testosterone increased from 4.96 to 8.73 ng/ml 48 hours post injection concurrently 
with a threefold increase in estradiol. Participant’s corticospinal pathway was tested 
with transcranial magnetic stimulation (TMS). This methodology involves stimulation 
of the motor cortex with magnetic coils to evoke motor potentials (MEP) within the 
right FDI muscles. They observed a decrease in the threshold of the cortical response, 
but no change in the slope of the MEP. A decrease in the threshold represents an 
increase in the excitability of the lowest threshold motor units (Bonifazi et al., 2004), 
or an increased output for a given input. They were also able to test soleus H-reflex in 
two subjects, who experienced no change in the threshold or slope of the ascending 
limb (Bonifazi et al., 2004). These results suggest that increasing testosterone can 
increase excitability of the corticospinal tract. The lack of change within the soleus H-
reflex parameters suggests that the observed decrease in motor threshold did not occur 
from changes within the Ia afferent reflex arc, and represented an increase in cortical 
drive. Since this methodology was only tested in two of the subjects (n=22) and the 
methods investigated two different motor neuron (MN) pathways (soleus vs. the first 
dorsal interosseous), spinal adaptation cannot be ruled out as a mechanism for the 
reduced MEP threshold stimulus. Twenty days’ later testosterone and estradiol levels 
had returned to baseline, along with the observed changes in the MEP threshold. This 
response between cortical adaptation and hormones provides a plausible mechanism 
for strength improvements observed in resistance trained populations who tend to have 
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higher basal testosterone levels. If a larger dosage of d-aspartic acid can increase 
testosterone levels with this population, then it is reasonable to believe that preferential 
strength improvements could occur via improved excitability of cortical or supraspinal 
pathways.  
D-Aspartic acid and direct neural mechanisms 
Supplementation of DAA may have a direct mechanism of action on neural adaptation 
which moderates changes in strength. Research supports the notion that DAA has a 
role as a neurotransmitter or neuromodulator (A. D'Aniello, 2007). Research on 
chickens and rats (Dunlop, Neidle, & McHale, 1986; Neidle & Dunlop, 1990) indicates 
during embryogenesis a significant increase in the concentration of DAA within the 
brain is evident, suggesting a role in central nervous system development. The research 
to date also suggests that DAA fills many of the criteria for a neurotransmitter, or act 
as a neuromodulator (Ota, Shi, & Sweedler, 2012; Spinelli et al., 2006). D-aspartic 
acid has been demonstrated to be present in high concentrations within the synaptic 
vesicles of axon terminals observed in prepared synaptosomes from the rat brain, and 
the optic lobe from European squid (S. D'Aniello et al., 2011). Further experiments 
showed that DAA significantly increased cAMP levels, in rat synaptosomes (S. 
D'Aniello et al., 2011), as well as in vivo increases in cAMP levels, when DAA was 
injected into live Aplysia limacina (Spinelli et al., 2006). Cyclic AMP is a molecule 
derived from AMP, which utilises the second messenger pathway to allow signalling 
from one neuron to another. This suggests that DAA signalling, like other 
neurotransmitters, is mediated by cAMP (S. D'Aniello et al., 2011). An important 
property of neurotransmitters is the ability to be synthesised within the neuron. The 
discovery of the existence of the enzyme DAA racemase suggests that neurons can 
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produce DAA from L-aspartic acid (S. D'Aniello et al., 2011). Additionally, literature 
has demonstrated that DAA is released from synaptosomes following artificial 
stimulation with potassium ions (S. D'Aniello et al., 2011). These experiments as a 
whole support the notion that DAA could play a role as a neurotransmitter. It is not 
clear from the research if supplementation of DAA in humans could be utilised by the 
central or peripheral nervous system. However, a plausible mechanism for the uptake 
of free DAA within the blood is via the L-glutamate transporter system. DAA has 
previously been observed to have the ability to utilise the L-glutamate transporters 
(Kanai & Hediger, 1992; Koyama et al., 2005), which provides a means for free DAA 
to enter via the glia (Spinelli et al., 2006). As the current animal literature focuses on 
the effects of DAA within brain tissue, it is not clear if the adaptation in humans can 
even occur, or if it will be exclusively supraspinal in nature, or include adaptation 
within spinal reflex pathways. The aforementioned research suggests that DAA has 
the potential to directly affect neural adaptation mechanisms, potentially resulting in 
power or strength gains. 
Resistance training and basal testosterone 
Novice populations 
The effects that resistance training has on testosterone levels in individuals new to 
resistance training is equivocal, with some research indicating increases (Izquierdo et 
al., 2006; Santtila, Kyröläinen, & Häkkinen, 2009; Staron et al., 1994) and other 
research observing no significant change (Ahtiainen, Pakarinen, Alen, Kraemer, & 
Häkkinen, 2003; Craig et al., 1989; Hansen et al., 2001; Petrella et al., 2006). The 
variability of results within the novice literature may be attributed to differences in 
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training parameters, volume, intensity and frequency of training manipulated in these 
studies. The relative importance of testosterone during early stages of training is not 
clear. Potentially in a novice population, other mechanisms such as mechanical 
deformation of muscle fibres, immune activity, or neural adaptation (Aagaard et al., 
2002b; West, Burd, Staples, et al., 2010) may be driving strength and hypertrophy over 
and above any potential benefits of increased basal testosterone levels. Additionally, 
normal levels of testosterone would be adequate to initiate downstream signalling 
events enough to observe some training gains in this population. The training literature 
in novice individuals ranges from 8 weeks to 6 months, which may not be long enough 
to initiate an adaptive increase in basal testosterone. This elevation in basal 
testosterone appears to take at least a year to manifest, as higher resting testosterone 
levels within trained populations are observed in men with one or more years training 
experience (Häkkinen, Pakarinen, & Alen, 1987; Häkkinen et al., 1988b; Häkkinen, 
Pakarinen, et al., 1985; Willoughby & Leutholtz, 2013; Willoughby et al., 2014). 
Despite this, some research in novice populations has observed increases in 
testosterone over shorter timeframes (Izquierdo et al., 2006; Santtila et al., 2009; 
Staron et al., 1994). 
In 1994 Staron and colleagues conducted a resistance training protocol in relatively 
young men and women (Staron et al., 1994). Participants (men and women) performed 
one week of familiarisation training followed by eight weeks of high-intensity training. 
Their training resembled a daily undulating periodisation model, incorporating failure 
training. One session involved an intensity at 10-12 repetitions, the other involved 
failure at 6-8 repetitions and every fortnight involved a session of one repetition 
maximum (1RM) testing. Basal testosterone was increased by the fourth week (~5.76 
to ~7.49 ng/ml) and stayed elevated throughout the remainder of the eight weeks. A 
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positive relationship was also observed between the training men’s testosterone and 
the percentage of IIa and IIb muscle fibres, (R2=0.39 and R2=0.46 respectively) 
indicating that higher basal testosterone levels are directly associated with type II 
muscle fibres in novices. Another study exploring basal testosterone in novices was 
conducted in Basque ball players over 16 weeks, investigated failure vs. non-failure 
training (Izquierdo et al., 2006). This study periodised training, decreasing volume and 
increasing intensity, at each six-week block. The intensity of the first block was 10RM, 
the second utilised 6RM and the last utilised 5RM with low-intensity ballistic training. 
The non-failure group observed an increase in testosterone at week 11, which 
regressed back to baseline by week 16. It is possible that the drop in volume, 
implemented to prevent overtraining, actually caused the increase in testosterone to 
return to baseline. Similar gains were observed between groups in 1RM strength 
(upper and lower body), upper body power, and lower body endurance test. The failure 
group experienced larger gains in an upper body endurance test, whereas the non-
failure group experienced larger gains in lower body power test. Potentially the 
increase in testosterone observed may explain the increase in squat power, with 
testosterone levels influencing neural adaptation directly via increased interaction with 
androgen receptors within neurons at the supraspinal or spinal level (Hammond et al., 
2001). Alternatively, the failure based training could have caused both the change in 
power and the fluctuations in testosterone, with the testosterone change not the true 
cause of power adaptation.  
Research in mixed mode training has also observed increased testosterone as a result 
of training (Santtila et al., 2009). Conscript soldiers were recruited into an 8-week 
study involving three experimental groups, basic training (BT) only, BT and resistance 
exercise, BT and endurance training. Maximal isometric force increased in the strength 
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and endurance groups and total testosterone increased in all groups. The BT and 
resistance exercise group experienced a reduction in body mass and fat mass, and a 
decrease in ultrasound thickness of the triceps brachii thickness, suggesting a slight 
decrease in hypertrophy. A confounding factor of this study is the basic training that 
was provided in each group, as the high volume of endurance-based military training, 
may have caused the reduced hypertrophy gains that were expected in the resistance 
training group (Santtila et al., 2009). Despite similar increases in total testosterone 
across all groups, the higher leg volume in the strength and endurance groups appeared 
to provide the greatest stimulus for increased strength of the soldiers in this study. This 
again highlights that in individuals new to training the importance of testosterone may 
be surpassed by the novel training stimulus, which is improving training gains via 
alternative mechanisms (Aagaard et al., 2002b; A. M. Gonzalez et al., 2016; West, 
Burd, Staples, et al., 2010). Not all novice research has observed increased testosterone 
from a training bout. 
Early research into basal hormonal changes from training did not find a difference in 
testosterone levels in both young and old (Craig et al., 1989). Participants trained for 
12 weeks, three days per week, using weight machines. No change in testosterone 
levels was observed in the young group, 8.46±0.58 to 8.27±0.67 ng/ml, yet the 
participants increased their lean body mass. With these values in the upper clinical 
normal range – 2.75 – 10 ng/ml (Bhasin et al., 2008) – it is possible that there was not 
much room for testosterone to increase further, already providing maximum benefits. 
Another periodised study conducted over ten weeks found in both young and old 
participants, significant improvements in 1RM squat, increased CSA of the thigh, but 
no change in total testosterone levels (Kraemer et al., 1999). A study in 2001 primarily 
explored the effect of the acute hormonal response and also observed lasting changes 
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in hormones. Researchers used arms-only training, and legs plus arms training (Hansen 
et al., 2001), with subjects acting as their own controls. Previous research had 
demonstrated that the hormonal response to a resistance training session was 
proportional to the size of the muscle volume that was activated, as well as the intensity 
of the session (Häkkinen & Pakarinen, 1993; Kraemer et al., 1990). Thus Hansen et 
al. designed this study to expose the arms to two different hormonal environments. 
The group that utilised arm and leg training observed better percent change 
improvements in isometric strength in the trained arms, as well as an increase in the 
acute hormonal response. The authors attributed the acute hormonal response to the 
significantly greater gains. However, these results have to be interpreted with caution. 
Baseline values in the combined group were significantly lower compared to the other 
group, inflating the percentage change results. With respect to the change in resting 
testosterone, the arms training group (n=8) experienced a trend for an increase, from 
6.95 to 8.27 ng/ml (p>0.05, d=0.525), whereas the legs and arms group (n=6) did not 
change, 6.37 to 6.28 (p>0.05, d=0.026) ng/ml. Potentially the study was underpowered 
to observe a change in resting testosterone. The variability between these groups 
suggests that, as a beginner, there may be a high individual adaptability to training 
stimuli, which could be related to genetic endowment. Another study that supports the 
theory that increases in testosterone levels are less important in novices was conducted 
over a longer period (21 weeks) (Ahtiainen et al., 2003). The novice group followed a 
structured and supervised protocol of whole body strength training twice per week. No 
changes in total testosterone or free testosterone were observed in this group over the 
entire study period. However, the group did experience increases in the cross-sectional 
area of the quadriceps and improvements in strength of the right leg. This study 
highlights that the apparent adaptation in basal testosterone levels, observed in 
 47 
 
resistance trained populations, may take time (longer than 21 weeks). Alternatively, 
since participants were only trained twice a week, it is possible that a greater training 
stimulus may be required to affect an increase in resting testosterone. Furthermore, it 
demonstrated that the training stimulus was enough to provide gains in hypertrophy 
and strength, absent from an increase in testosterone. Multiple studies have also 
explored the effects of resting testosterone change in the elderly. Research conducted 
within this population, appears to show no observable change in testosterone levels 
with resistance training, despite increases in training goals (Craig et al., 1989; 
Häkkinen et al., 2002; Häkkinen, Pakarinen, Kraemer, Newton, & Alen, 2000; Petrella 
et al., 2006; Reaburn et al., 1997). This is likely caused by the downregulation of 
testosterone production that occurs later in life, as well as an increased sensitivity to 
negative feedback mechanisms of the HPG axis (Figure 4) (Borst & Mulligan, 2007), 
which may overshadow any potential increases occurring from the training stimulus. 
Also as the elderly experience loss of muscle mass and strength detriments, as they 
age, it is likely that the training stimulus is enough to see measurable gains, regardless 
of the hormonal milieu. These data suggest that the testosterone adaptation to 
resistance training is variable within novices, and may play less of a role than in 
resistance trained men. 
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Table 1  Literature in novices on basal hormones during resistance training. Abbreviations: total testosterone (TT), free testosterone (FT), 
resistance training (RT), power training (PWR, men (M), women, (W), young (Y), old (O), arms only (A), legs plus arms (LA), non-significant 
change (NSΔ), ↑/↓ (significant change, increase / decrease), body mass (BM), body fat percentage (BF%), correlation (&), one repetition maximum 
(1RM), cross-sectional area (CSA), integrated electromyography (iEMG), average (AVG). 
Year 1st 
Author 
Name Population 
information 
Study Length Training Hormones Other relevant 
results 
AVG TT  
ng/ml ± SD 
1989 Craig Effects of progressive 
resistance training on 
growth hormone and 
testosterone levels in 
young and elderly subjects 
Y 
 
O 
24w 3d.w RT NSΔ TT ↓ BF% 
 
↑ BM 
8.46±0.58 
8.27±0.67 
7.26±0.44 
6.86±0.05 
1994 Staron Skeletal muscle 
adaptations during early 
phase of heavy-resistance 
training in men and 
women 
M/W 8w 
2-3d.w 
RT M: ↑ TT  
@w 5,7,9 
↑ dynamic STR 
Type II fibres & TT 
w1  5.65±0.45 
w5  7.32±1.18 
w7  7.83±1.23 
w9  7.55±0.84 
1997 Reaburn Serum testosterone 
response to high-intensity 
resistance training in male 
veteran sprint runners 
Sprinters 8w 
3d.w 
RT NSΔ TT ↑ 1RM, ↑ peak 
torque 
5.82±0.86 (SEM) 
5.53±0.81(SEM) 
1999 Kraemer Effects of heavy-resistance 
& hormonal responses 
younger vs. older men 
Y 
 
O 
10w 
 
RT 
Periodised 
NSΔ TT ↑ Squat 1RM, ↑ 
CSA thigh  
Y 5.70±0.65 
    5.78+0.49 
O 4.61±0.43 
    4.57±0.36 
2000 Häkkinen Basal concentrations and 
acute responses of serum 
hormones and strength 
development during heavy 
resistance training in 
middle-aged and elderly  
40y 
M/W 
70y 
M/W 
6m 
 
RT& 
PWR 
NSΔ TT, 
FT  
0-6m 
↑ 1RM, ↑ iEMG 4.87±1.11 
4.78±0.81 
5.27±1.59 
4.83±1.33 
2001 Hansen The effect of short-term 
strength training on human 
skeletal muscle - 
physiologically elevated 
hormone levels 
A 
 
LA 
9 w 
 
2d.w 
RT  NSΔ TT  6.95±1.84 
8.27±3.34 
6.37±3.83 
6.28±3.29 
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Table 1 (continued) Literature within novices exploring basal hormones during resistance training.  Abbreviations: total testosterone (TT), 
free testosterone (FT), resistance training (RT), power training (PWR) basic training (BT), men (M), women, (W), young (Y), old (O), physically 
active (PA), bodybuilders (BB), weightlifters (WL), non-significant change (NSΔ), ↑/↓ (significant change, increase/decrease), body mass (BM), 
body fat percentage (BF%), correlation (&), one repetition maximum (1RM), cross-sectional area (CSA), average (AVG). 
Year 1st 
Author 
Name Population 
information 
Study 
Length 
Training Hormones Other relevant 
results 
AVG TT  
ng/ml 
2002 Häkkinen Effects of heavy 
resistance/power training 
on maximal strength, 
muscle morphology, and 
hormonal response patterns 
in 60-75 y old men and 
women 
O 60-75 y 0-12w 
 
13-24w 
2d.w 
RT 
 
PWR 
NSΔ TT 
 
NSΔ TT 
↑ 1RM, ↑ FFM, 
↑I, IIa, IIb 
↓ BF% 
4.21±2.10 
3.69±1.24 
3.69±1.24 
4.21±2.74 
2003 Ahtiainen Muscle hypertrophy, 
hormonal adaptations and 
strength development 
during strength training in 
strength-trained and 
untrained men 
(PA) 
 
(BB, WL) 
21w 
2d.w 
 
 
RT 
 
RT mix 
NR 
 
↑ TT, FT 0-14 
↓ TT, FT 14-21 
↑ CSA ↑ MVC 
 
TT & MVC 
(R=0.84) 
NR 
 
NR 
2006 Izquierdo Differential effects of 
strength training leading to 
failure versus not to failure 
on hormonal responses, 
strength, and muscle power 
gains 
Basque ball 
players 
16w 
2d.w 
 
 
RT-F 
 
FT-NF 
 
Periodised 
NSΔ TT 
 
NSΔ TT 0-16 
↑ TT, 0-11 
↑ PWR, 1RM, 
 
↑ PWR, 1RM 
NF: 
w0 8.29±1.40 
w6 8.32±1.44 
w11 9.30±1.70 
w16 8.19±1.64 
 
2006 Petrella Efficacy of myonuclear 
addition may explain 
differential myofiber 
growth among resistance-
trained young and older 
men and women 
Y, 20-35y 
 
O, 60-75y 
16w 
3d.w 
Leg 
training 
 
NSΔ TT ↑ myofiber 
hypertrophy 
4.81±0.50 
4.42±0.46 
4.32±0.28 
4.52±0.30 
2009 Santtila Serum hormones in 
soldiers after basic training 
Military 
conscripts 
8w 
 
BT + RT 
periodised 
↑ TT 16.6% ↑ MVC 4.87±1.19 
5.50±1.12 
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Resistance trained populations 
In trained populations testosterone levels are higher than in novices (Häkkinen et al., 
1988b; Häkkinen, Pakarinen, et al., 1985; Willoughby & Leutholtz, 2013; Willoughby 
et al., 2014), suggesting that the increase in testosterone could be a slow adaptive 
response to the continual training stimulus. Pre to post changes in testosterone levels 
from the resistance trained literature have observed increases (Ahtiainen et al., 2003; 
Häkkinen et al., 1988b; Häkkinen, Pakarinen, et al., 1985) and other research has 
demonstrated that testosterone is not influenced (Alen, Pakarinen, Häkkinen, & Komi, 
1988; Häkkinen et al., 1987; Häkkinen, Pakarinen, et al., 1985). The lack of change in 
some of these studies may be attributed to the fact that these men could be at their 
genetic ceiling for resistance training mediated testosterone adaptation. It is evident 
however that variations appear to occur within studies which explore multiple data 
time points (Ahtiainen et al., 2003; Alen et al., 1988; Häkkinen et al., 1987; Häkkinen 
et al., 1988b; Häkkinen, Pakarinen, et al., 1985). Furthermore, these changes in 
testosterone appear to coincide with changes in training volume and give rise to 
positive relationships between testosterone and strength or power changes.  
The first long-term training study in resistance trained men was conducted in 1985, by 
Häkkinen and colleagues, over 24 weeks (Häkkinen, Pakarinen, et al., 1985). This 
study involved three groups, two training and one control. The RT group performed 
heavy resistance strength training three times per week in the barbell back squat. Loads 
and volume were progressively increased monthly, and during the third, fifth and sixth 
month, heavy eccentric training was included. The power (PWR) group also performed 
training three days in the week, which included explosive power exercises (e.g. 
explosive weighted jumping) and strength exercises at moderate intensities (60-80% 
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1RM) for the arms, legs and trunk. No changes were observed in testosterone levels in 
the RT group. However, the PWR group noted significant increases by eight weeks 
(~19%), which stayed elevated till the 16th week, decreased back down by week 20 
and returned to baseline by the 24th week. The differences observed in the experimental 
groups suggests that this style of periodisation, whereby intensity and volume are both 
increased, may not positively influence testosterone levels. The positive improvement 
in testosterone observed in PWR could be attributed to the power training element, the 
relative lighter intensities, or a combination of both. The authors also explored changes 
in the testosterone/cortisol ratio (T:C), which increased in both groups, over weeks 0-
8 and 0-16 and was significantly correlated with maximal isometric force (RT, R=0.86; 
PWR, R=0.79) during the last four weeks of training. It should be noted that in RT this 
period marked an overall plateau in isometric force improvement and a large 
variability in the group data, likely resulting in the direct relationship with T:C. In the 
PWR group the increase in T:C from weeks 20-24 was preceded by a drop in T:C from 
weeks 16-20. A possible explanation for these results is that the progressive increase 
in the volume of jumping and strength training caused a transitory drop in testosterone, 
which may have recovered as participants got used to the volume. In the men where 
this recovery was most pronounced, larger improvements in isometric force were 
observed during this phase. From this paper, it appears that levels of testosterone can 
fluctuate throughout a training program with varied intensity and volume, and in those 
individuals whose hormonal profile adapts favourably during a stressful cycle of a 
training bout, greater improvements in isometric strength may be observed.  
There is also evidence in the literature that testosterone levels do not appear to change 
over long-term training (Häkkinen et al., 1987). When weightlifters were observed in 
a 12-month follow-up study, their baseline levels (5.13±1.44 ng/ml) did not 
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significantly change (p>0.05, d=0.756) by the end of the 12 months (6.37±1.82 ng/ml). 
The observed effect size suggests that this study could have been underpowered to 
observe a significant change in testosterone. The authors noted marked decreases in 
testosterone (~23%) during the preparatory phase of the weightlifter’s main 
competition, which may have also contributed to the lack of overall change observed 
in testosterone levels. Additionally, luteinizing hormone was observed to be increased 
from baseline at 4, 8 and 12 months. This approximately occurred around the primary 
competition, coinciding with the end of the 2-week intensive preparatory phase and 
likely resulted as a protective mechanism of the HPG axis to prevent testosterone 
levels decreasing too low to be able to recover from the intensive phase. Importantly 
this data suggests that increasing volume can negatively impact resting testosterone 
levels. Serum testosterone/SHBG ratio (T:SH) also decreased during this 2-week 
intensive phase and was positively correlated (r=0.63) with changes in clean and jerk 
results. This data also suggests that during a stressful phase of a program, individuals 
whose hormonal profile is less affected by the relative demand of the training might 
gain greater improvements in strength and power, highlighting the importance of 
testosterone levels during demanding phases of training. If it is possible to artificially 
increase testosterone levels, providing a buffer during these stressful periods, the 
research suggests that this could result in larger training gains.  
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Progressive increases in total testosterone were observed with continued long duration 
training (Häkkinen et al., 1988b). This is the longest training study in resistance trained 
men (~7 years trained), conducted over a two-year period. In this study, weightlifters 
performed their regular individualised training programs developed by their coaches, 
while researchers periodically observed changes in hormones, strength and 
neuromuscular changes. They observed significant increases in testosterone levels 
from pre to post, as well as significant increases in the yearly means. Testosterone-to-
SHBG ratio increased between the annual means, with a positive correlation between 
this ratio from the second year and the percentage change in averaged concentric 
power index (r=0.84) also detected. These stronger relationships with hormones and 
strength, or hormones and power, appears to be more common in resistance trained 
populations. As training age increases, the importance of the hormonal milieu may 
increase, in comparison to the importance of intrinsic factors involved in muscular 
strength and power (A. M. Gonzalez et al., 2016). Despite no detected changes in T:C 
pre to post or between annual means, there was a significant correlation between 
percentage change in T:C and percentage change in the average level of maximal force. 
The authors theorised that this ratio is an indication of the balance of an individual’s 
anabolic and catabolic status, and may be an important indication of an elite athlete's 
potential for strength improvement (Häkkinen et al., 1988b).  
Another study in the literature explored changes in basal testosterone levels in strength 
athletes (Ahtiainen et al., 2003). This study observed two groups over a 21-week 
strength training period. These groups were strength athletes and non-strength athletes 
(novices). The novice group performed a structured controlled protocol, whereas the 
strength athletes, who were a mixture of bodybuilders and weightlifters, conducted 
their own individualised RT programs. Despite a high variability in the programs, the 
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RT group performed strength training three days per week, training different divisions 
of the body each day at a repetition range between 6-12 reps. It was found that from 
baseline testing, testosterone increased by week 7, and again at week 14 before it 
returned to the near baseline levels by week 21. This corresponded with an increase in 
total volume (calculated from training diaries), during the middle seven weeks and a 
slight decrease in the last seven weeks (Ahtiainen et al., 2003). This is in line with 
previous research discussed, whereby alterations in testosterone appear to mirror 
training volume changes (Häkkinen et al., 1987; Häkkinen et al., 1988b). This could 
be a natural adaptation within resistance trained men, to assure testosterone-mediated 
hypertrophy and recovery is maximised during high stress or high volume training 
bouts. The authors also found a positive relationship with the testosterone levels 
(overall training period average) and percentage change in isometric force (p<0.01, 
R=0.84), despite no significant change in isometric force (Ahtiainen et al., 2003). 
Some participants experienced a decrease in isometric strength, while only two 
increased by greater than 10 %. Potentially this demonstrates overtraining in some of 
the participants. It also suggests that the individuals who were able to maintain a higher 
level of testosterone throughout the study period were better able to preserve or 
increase isometric strength. The aforementioned literature suggests that our current 
understanding of the ability of resistance training to affect resting hormonal levels in 
trained men is limited. Furthermore, there are no studies that specifically explore the 
time course of the change in basal hormones that occurs from prolonged training 
(novice to advanced). More research is required in resistance trained men, to fully 
elucidate the effects of testosterone on training gains pertaining to strength, power and 
hypertrophy.
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Table 2  Literature in trained populations on basal hormones during training.  Abbreviations: total testosterone (TT), free testosterone (FT), 
luteinizing hormone (LH), sex-hormone binding globulin (SHBG), cortisol (CORT), training experience (TE), resistance training (RT), power 
training (PWR, Olympic weightlifting (OLY), non-significant change (NSΔ), ↑/↓ (significant change, increase / decrease), body mass (BM), body 
fat percentage (BF%) maximal isometric force (MIF), (SJH), correlation (&), not reported (NR), average (AVG). 
Year 1st 
Author 
Name Population 
information 
Study Length Training Hormones Other relevant results AVG TT  
ng/ml 
1985 Häkkinen Serum hormones during 
prolonged training of 
neuromuscular 
performance 
RT group 24w 3d.w RT - 
Periodised 
NSΔ TT ↑ BM, ↑ MIF, ↓ BF% 
TT/SHBG & MVC 
TT/CORT & MVC 
7.46 
7.41 
   PWR group 24w 3d.w PWR  ↑ TT 
weeks 0-8, 
0-16, NSΔ 
0-24 
↑ MIF, ↓ BF% 
TT/SHBG & MVC 
8.33 
8.5 
1987 Häkkinen Relationships between 
training volume, physical 
perf cap, serum hormone 
concentrations during 
prolonged training in elite 
weightlifters 
(~7y TE) 1 y  OLY NSΔ TT 
↑ LH at 
4,6,8,12m 
 
↓ TT during 2-week 
preparatory phase 
5.13 
6.37 
1988 Häkkinen Neuromuscular and 
hormonal adaptations in 
athletes to strength training 
in two years 
(~7y TE) 2 y OLY ↑ TT and 
LH 0-24m 
↑ TG, FFW, OLY 
results, SJH 
NSΔ MIF 0-24m 
5.37 
7.23 
2003 Ahtiainen Muscle hypertrophy, 
hormonal adaptations and 
strength development 
during strength training in 
strength-trained and 
untrained men 
(BB, WL) 21w 
2d.w 
 
 
RT mixed ↑ TT, FT 
0-14 
↓ TT, FT 
14-21 
TT & MVC (R=0.84) NR 
 
NR 
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Adaptation in testosterone from chronic resistance training 
The clinical range for normal testosterone levels is not consistent across different 
laboratories across the globe. However, traditional reference ranges for “clinically 
normal” levels are from about 2.75 – 10 ng/ml, with some laboratories reporting a 
minimum of 1.7 ng/ml and some reporting as high values as 17.27 ng/ml (Bhasin et 
al., 2008).  Clinical secondary hypogonadism is defined as <1.5 ng/ml (Bhasin et al., 
2010), at which point men are placed on replacement therapy until they reach the 3 – 
7 ng/ml range. A commonality in the resistance-trained literature is the relative basal 
testosterone levels observed in these men. The range of testosterone levels (means) 
observed in resistance trained populations ranges from 5.13 ng/ml (Häkkinen et al., 
1987) to 11.96 ng/ml (Willoughby et al., 2014). Three of these studies displayed 
testosterone values above the 70th percentile of the normal range (2.75-10 ng/ml). In 
novice individuals generally testosterone levels are much lower, 3.69 – 8.46 ng/ml, 
with all studies in the 50th percentile for the normal range (2.75-10 ng/ml) (see Table 
1). Looking at the data in this manner suggests that over time testosterone levels 
increase in men that continuously perform resistance exercise. It is reasonable to 
believe that this increase in testosterone levels is a chronic adaptation of the HPG axis, 
which occurs to maximise gains within a resistance trained population. As a person’s 
training age increases their relative gains in strength and hypertrophy progressively 
decrease, until they plateau at their genetic ceiling. It is plausible that if this adaptive 
increase in testosterone did not occur then, this plateau might be realised sooner, thus 
reducing their potential for training gains. The importance of higher resting 
testosterone levels in appears to provide improvements in strength, power and 
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hypertrophy gained from resistance training. This effect is augmented in research 
investigating increased testosterone levels beyond clinical ranges.  
Effect of supraphysiologic levels 
The relative importance of testosterone-mediated gains becomes increasingly evident 
when exogenous supplementation is used to boost levels beyond normal clinical 
ranges. Increase in testosterone from exogenous administration of 600mg testosterone 
enanthate ranges from 550%-750%, which is considered supraphysiologic levels 
(Bhasin et al., 1996). This study explored four groups: exercise and placebo; exercise 
and testosterone; no exercise and placebo; and no exercise with testosterone. The 
group with the greatest benefits was the exercise combined with testosterone 
supplementation, observing improvements in quadriceps and triceps hypertrophy and 
squat strength. The testosterone-only group also saw improvements in triceps and 
quadriceps hypertrophy as well as increases in bench and squat strength. This suggests 
that exogenous testosterone supplementation markedly enhances the chance of 
interaction with AR, either within the muscles, causing hypertrophy (Heemers & 
Tindall, 2007) or interacts with neuron AR, resulting in strength improvements (Fraley 
& Ulibarri, 2002; Hammond et al., 2001; Herbst & Bhasin, 2004). A further 
mechanism of these marked improvements is the upregulation of satellite cell activity 
(Sinha-Hikim et al., 2003). Despite these obvious improvements from anabolic 
steroids, the relative importance of testosterone in normal and resistance trained 
populations is still not clear. Moreover, the beneficial effects of testosterone boosters, 
like d-aspartic acid, (which may increase testosterone within normal clinical ranges) 
is not completely clarified. Data suggests that higher basal levels may be important in 
a trained population. If d-aspartic acid can increase testosterone within trained 
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individuals, then noticeable increases in strength and or hypertrophy might be 
experienced. 
D-Aspartic acid supplementation in humans 
Research in the supplementation of d-aspartic acid within humans is still in its infancy. 
To date, only six DAA supplement studies have been conducted within a human 
population (Table 3). The earliest study carried out in humans was in 2009 (Topo et 
al., 2009). This initial experiment involved a group of IVF patients (n=23) who 
ingested a solution of 10ml of 2.0 M sodium D-aspartate (3.12g). The placebo group 
ingested a solution of 2 M NaCl (1.12g). After 12 days of supplementation levels of 
luteinizing hormone and testosterone were significantly increased by 33.3% and 42% 
respectively. At three days’ post suspension testosterone was still significantly 
increased compared to baseline (11.5%) (Topo et al., 2009). Of note was the subject’s 
original levels of total testosterone (TT) at 4.5±0.6 ng/ml which, inclining towards 
low-normal levels of testosterone, potentially attributed to the relatively sharp increase 
in total testosterone that was observed. D-aspartic acid has been shown to improve 
sperm quality in subfertile men (IVF patients), affected by various levels of rapid 
progressive spermatozoa mortality and low total concentrations (D’Aniello et al., 
2012). In this study, a solution of 10ml of 2.0 M sodium (2.66g DAA) was 
supplemented daily for 90 days. Improvements in a total concentration of spermatozoa 
and motility were observed. The authors reported similar increases in LH and TT as 
Topo, 2009, at 1.3–1.6 fold, however as these values were not published, the baseline 
TT levels are not clear. These two studies suggest that one of DAA’s functions is to 
help regulate normal testosterone levels. 
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Table 3  D-aspartic acid research to date conducted in human males.  Abbreviations and symbols within the table: in vitro fertilization (IVF), 
no training (NA), total testosterone (TT), luteinizing hormone (LH), training age (T), non-significant change (NSΔ), fat-free mass (FFM), muscle 
strength (STR), gonadotropin releasing hormone (GnRH), estradiol (E2), body mass (BM), bench press (BP), muscle endurance (END), sleep 
(SLP), physical appearance (APP), * research conducted in products similar to DAA or containing DAA as a blend, # of note, average (AVG).
Year 1st Author Name Population 
information 
Study Length Training Hormones Other relevant results AVG TT 
ng/ml 
2009 Topo The role and molecular 
mechanism of DAA in the 
release and synthesis of 
LH and TT in humans and 
rats 
IVF patients 
 
12d NA ↑ TT, LH TT ↑ for three days’ 
post 
4.50 
6.40 
2012 D’Aniello d-Aspartate, a key element 
for the improvement of 
sperm quality 
Infertile 
men 
3m NA ↑ TT, LH  Not 
reported 
2013 Willoughby DAA combined with 28 
days RT has no effect on 
body comp, muscle 
strength, serum hormones 
associated with HPG axis 
in RT men 
T > 1y 28d 
3d.w 
RT 
periodised 
NSΔ TT ↑ FFM, ↑ STR (both 
groups) 
8.08 
8.88 
2014 Willoughby 
 
* 
RT and NMDA has no 
effect on body Comp, 
muscle performance, and 
serum hormones in 
RT males 
T > 1y 28d RT 
periodised 
NSΔ TT, 
LH, 
GnRH, E2 
↑ FFM, ↑ BM, 
↑ STR 
(both groups) 
11.96 
12.02 
2015 Bloomer  
 
* 
Influence of a DAA/Na 
NO3/Vitamin D3 
supplement on 
physiological parameters 
in middle-aged men – pilot 
study 
Overweight/ 
Obese men 
~42y 
28d NA NSΔ TT 
(↑ TT in 
some with 
low 
baseline) 
↑ vitality, libido, 
energy levels 
2.60 (3g) 
2.90 
2.90 (6g) 
3.10 
2016 Rodgers 
 
* 
Impact of a multi-
component supplement on 
testosterone, nitrate/nitrite 
and physical performance 
in RT men 
T > 0.5y 28d Normal 
RT, 
No formal 
program 
NSΔ TT 
 
# p>0.050, 
d=0.648 
↑ 5-Set BP test 
↑ perception of STR, 
END, SLP & APP 
6.2 
5.1 
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In 2013 a study combined weight training (4d.w) with supplementation (3g DAA) 
in resistance trained men (Willoughby & Leutholtz, 2013). They observed similar 
increases in hypertrophy (fat-free mass) and 1RM strength (leg press) between 
groups, yet no differences in total testosterone (8.08±0.69, 8.88±0.5 ng/ml, DAA 
from day 0-29 respectively) or free testosterone were observed. As previously 
highlighted, extended resistance training results in a gradual increase in 
testosterone, which is evident in the baseline levels of these participants. Perhaps 
with resistance training, there is a natural upregulation of DAA which is negating 
any potential benefit from exogenous supplementation. Alternatively, with 
testosterone levels near the upper limit of normal ranges, negative feedback 
mechanisms within the HPG axis might downregulate testosterone production 
regardless of any possible accumulation of DAA within tissues such as the anterior 
pituitary or testes (A. D'Aniello et al., 1996). Willoughby et al. also measured serum 
levels of DAA and DAA oxidase (DDO), which is an enzyme known to degrade 
DAA. They noted no group differences in serum DAA, but significant increases in 
serum DDO. This suggests an alternative hypothesis whereby increased DDO 
activity is degrading DAA faster than it can accumulate within target tissues 
(Willoughby & Leutholtz, 2013). In 2014 these same authors explored the effects 
of a proprietary blend product involving the methylated form of DAA (NMDA), 
DAA, trimethylglycine and S-adenosyl methionine (SAMe) (Willoughby et al., 
2014). The manufacturer’s theory (no data published) of this blend, was to 
upregulate NMDA receptors within the body to activate the HPG axis (see Figure 
4 on page 16), to increase the output of LH and TT. The results from this study also 
showed similar hypertrophy and strength gains across the study population, with no 
group interaction effects for TT (11.96±1.26 to 12.02±1.18 ng/ml, experimental 
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group means from days 0-29 respectively), FT or LH. Similar to the previous 
research, baseline levels of testosterone observed in this study are relatively high, 
and thus previously mentioned homeostasis negative feedback mechanisms could 
be preventing any further potential increase. Recently the effects of another 
proprietary blend was explored in resistance trained men (Rodgers et al., 2016). The 
supplement D-Pol™ containing 3.12g of DAA, sodium nitrate (480mg) and 
Vitamin D3 (4000IU) was given to 24 resistance trained men, subjects had a history 
of weight training, with no break from training in the last six months before the 
study. No significant changes were observed in hormones tested, including total 
testosterone (6.2±2.2, 5.1±1.2 ng/ml, d-aspartic acid means from day 0-29 
respectively). The authors observed an improvement in a five-set bench press 
challenge. However, they believed this might have been attributed to the sodium 
nitrate portion of the blend, rather than DAA. This highlights an issue that can arise 
in supplement research that involve blends, introducing confounding variables that 
make it difficult to draw solid conclusions about one ingredient over another. As 
more research is explored with pure DAA over proprietary blends, and we begin to 
understand the effects of DAA within humans better, the value of this research will 
increase. 
It is evident that d-aspartic acid research within humans is still in its infancy, and 
more research is required. Currently, the only positive effects of supplementation 
have been observed in men with infertility issues and relatively low baseline 
testosterone. Furthermore, no advantageous strength or hypertrophy adaptations 
have been found in conjunction with resistance training. To date, there is no data 
investigating dosage in a resistance trained population, where higher levels may be 
required to see an effect. As resistance trained populations adapt more slowly than 
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novice individuals, an extended training study is required to delineate if time is an 
important factor with the supplementation of d-aspartic acid in this population. 
Summing argument 
Since the mediating factors for the relationship between testosterone and strength 
are still unclear, further research into this area is needed. Past research indicates that 
d-aspartic acid can elevate basal testosterone levels in infertile men. However, the 
research in resistance trained populations is not as promising. Additional research 
is still required, as the literature has yet to explore higher dosages of the supplement, 
which may be a requirement in a resistance trained population. Furthermore, d-
aspartic acid has a plausible mechanism to directly affect the nervous system due 
to its potential role as a neurotransmitter. The proposed research will further 
elucidate the efficacy of d-aspartic acid on improving training outcomes from a 
three-month periodised training bout.  
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CHAPTER 3 – DOSING STUDY METHODS 
Subjects 
The institutional review board approved the study and participants provided written 
informed consent prior to testing and participation. A total of twenty-four 
participants from the local area completed this study. To be eligible participants had 
to be: male; aged 18–36; have no acute or chronic medical conditions; have the 
ability to bench press 100% body weight, and had been performing regular 
resistance training exercise for at least three days per week for the previous two 
years. No participants were supplementing their diet with any ergogenic or 
testosterone boosting supplements prior to testing. All participants provided written 
consent and completed a medical history check. 
Experimental approach to the problem 
This was a randomised, double-blinded, and placebo-controlled design to examine 
the effects of d-aspartic acid supplementation on basal testosterone levels following 
a two-week supplementation protocol. Participants were assigned to one of three 
experimental groups: placebo (D0), three grams of DAA (D3) and six grams of 
DAA (D6). All participants consumed ten opaque capsules each morning with 
breakfast for two weeks. They contained either: six grams of flour (D0, n=8); a 
mixture of three grams each of flour and DAA (D3, n=8); or six grams of DAA 
(D6, n=8). Participants were randomly allocated to treatment groups following a 
block randomisation procedure based on a computer-generated list of random 
numbers. Placebo (D0), mixed (D3) and pure supplement (D6) was provided in 
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identical opaque capsules to improve blinding. Group allocation was managed by a 
technical officer, while investigators were kept blind to group assignment 
throughout the intervention. All participants followed an upper/lower body split 
resistance training program for a full month, with the initial two weeks of training 
(washout period) performed without supplementation. Three time points were used 
to obtain testing data: T1, T2 and T3 (Figure 8). 
Experimental procedures 
Testing sessions consisted of a fasted blood draw, then 1RM bench press 
evaluation. Initial baseline blood measures were taken at two time points (T1 & T2) 
and averaged to ensure accuracy in baseline assessment of these markers (Figure 
8). After T1 prescribed training commenced for four weeks. After testing session 
T2 daily supplementation begun with training continuing as before. Post-measures 
were taken after these last two weeks of training and supplementation, at the end of 
week 4 (Figure 8). The supplemental period of two weeks was chosen as this has 
been previously shown to be a sufficient period to see a change in total testosterone 
levels (Topo et al., 2009). 
  
 
 
6
5
 
 
 
Figure 8  Timeline of the Study 1 design. Key: testing session 1 (T1), testing session 2 (T2), Testing session 3 (T3), training 4 d.w-1  
( ), daily supplementation ( ), blood draw  ( ).
Week 0 
PRE 
T1 
Week 2 Week 4 
T2 T3 
POST 
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1RM testing 
Bench Press dynamic strength one repetition max (1RM) was measured before the 
standardisation period (T1), beginning of the experimental period (T2) and post-
experiment period (T3) (Figure 8), as part of eligibility testing.  The correct form 
included depth to the level of the chest, with feet not leaving the floor, and the 
backside is not leaving the bench at any point during the repetition. The protocol 
for 1RM testing involved one warm up set of 10 reps at approximately 50% of their 
estimated 1RM, followed by two more warm-ups at approximately 70% and 80% 
with only 1–2 reps. After the warm-ups, participants attempted 1RMs with 
incrementally increasing weight. The weight achieved before the failed attempt was 
recorded as the 1RM. A participant’s 1RM was reached within five attempts, and 
adequate rest between attempts adhered to (3–5 mins) (Marshall, McEwen, & 
Robbins, 2011). 
Fasted blood draws 
All blood draws were obtained via venepuncture of the antecubital vein after a 12 
hour fast. Participants were also instructed to avoid strenuous exercise and alcohol 
consumption the day before the draw. Blood draws were performed by a trained 
phlebotomist (primary investigator), and subsequent draws were planned for the 
same time of morning (7:00–10:00 am) for each particular participant, to prevent 
any effect of diurnal variation. Whole blood was collected using serum separator 
tubes (SST™ II Advance, BD Vacutainer®). They were then allowed to clot for 45 
minutes and centrifuged using a fixed angle rotor centrifuge: ADAMS® Compact 
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II Centrifuge, V:227 (Becton Dickinson & Co) (828 x g, at 2700 rpm) for 15 
minutes in an air-conditioned room (19 ℃). Serum was aliquoted and stored at ‒80 
℃ until analysis (Douglas Hanly Moir Pathology, Macquarie Park, NSW, 
Australia). A single analysis of serum was conducted for total testosterone, 
estradiol, sex-hormone-binding-globulin (SHBG) and albumin. Testosterone and 
SHBG was measured via electrochemiluminescence immunoassay, on a Roche 
E170 system (Roche Diagnostics, Dee Why, NSW, Australia), with a limit of 
detection values of 0.025 ng/ml and 0.350 nmol/l respectively. Albumin was 
measured via bromocresol green succinate buffer method, on an Abbott 
ARCHITECT c16000 (Abbott Laboratories, Abbott Park, Illinois, USA). The limit 
of detection of the albumin BCG assay is 30 g/l. Estradiol was measured via 
chemiluminescent microparticle immunoassay on an Abbott i2000SR (Abbott 
Laboratories, Abbott Park, Illinois, USA), the analytical sensitivity of the estradiol 
assay is ≤ ten pg/ml. Free testosterone was calculated from total testosterone, SHBG 
and albumin (Vermeulen, Verdonck, & Kaufman, 1999). 
Training standardisation 
Participants were trained for four days per week over a one-month period. The 
prescribed training for each exercise consisted of four sets of a repetition-maximum 
range of 8-10. If the repetition range was not met, participants were asked to adjust 
the weight accordingly in the next session. Exercises during the upper body session 
were: barbell bench press; overhand pulldown; barbell overhead press and 
underhand pulldown. The lower body session consisted of back squat; good 
morning; leg extensions; and straight leg calf raises. Adherence was monitored via 
training diaries and supervised sessions (min 1x per week).  
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Dietary intake 
Participants were asked to control their diet, by avoiding any major changes in 
eating habits throughout the study. To monitor their diet, they were asked to weigh 
and recorded their food intake for three days each of the first and last week. 
Monitoring included two training days and one non-training day and these three 
days were averaged to get a daily mean for week one and week four. The food 
diaries were entered into CalorieKing (Australian Edition 4.0), then analysed for 
daily intakes (protein, carbohydrates and fats) and normalised to body weight. 
Statistical Analysis 
Analyses were conducted using IBM SPSS Statistics version 21.0 (Armonk, NY: 
IBM Corp), and the level of significance was set at p<0.05. Data are shown as 
mean±S.D. The distribution was tested for normality using the Kolmogorov-
Smirnov test. Paired sample statistics were run on total testosterone (TT), free 
testosterone (FT), estradiol (E2), sex-hormone-binding-globulin (SHBG), and 
albumin (ALB) to determine the stability of these blood measures over the 
standardisation period. As these measures were found to be unchanged, they were 
each computed (averaged) into one baseline measure. Univariate analysis of the 
absolute change scores: POST= ( 𝑇3 ‒
𝑇1+𝑇2
2
 ) was conducted, with the baseline 
scores: PRE=( 
𝑇1+𝑇2
2
 ) as covariates (Figure 8). Pairwise comparisons with 
Bonferroni correction were performed if a group effect was observed. To explore 
the responsiveness of the supplement, linear regression analysis was conducted on 
the baseline and change scores of TT and FT, of the experimental groups (n=16).  
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CHAPTER 4 – DOSING STUDY RESULTS 
Analysis of the POST values revealed no main effect for group with E2 (p=0.469), 
SHBG (p=0.070) and ALB (p=0.319). Post values of D6 TT were significantly 
reduced (~11.5±16.9 %) as compared to the pre-values (p=0.032; 5.85 to 5.12 
ng/ml). FT in group D6 was significantly decreased (429.13 to 363.38 pmol/l) as 
compared to D0 (439.62 to 480.87 pmol/l) (p=0.005) but not D3 (534.9 to 524.3 
pmol/l) (p=0.062) (Figure 9). Diet analysis revealed no significant changes in 
macronutrient (CHO: p=0.699; PRO: p=0.990; FAT: p=0.537) and caloric intakes 
(p=0.640) during the study. Regression analysis revealed no significant relationship 
between baseline total testosterone levels and total testosterone change (R=0.009, 
p=0.659), and no significant relationship between baseline free testosterone and 
free testosterone change (R=0.103, p=0.127). 
 
Table 4  Participant demographics 
 Placebo (n=8) 3 g/d (n=8) 6 g/d (n=8) 
Age (years) 24.24 ± 2.26 23.16 ± 2.16 26.06 ± 4.26 
Training age, 
(yrs) 
2.94 ± 0.78 3.25 ± 1.04 4.00 ± 1.91 
Height (m) 1.84 ± 0.03 1.74 ± 0.07 1.78 ± 0.06 
Body Mass (kg) 89.41 ± 3.59 79.50 ± 6.07 85.12 ± 7.95 
1 RM Bench (kg) 111.56 ± 15.17 97.50 ± 12.82 106.86 ± 15.74 
Data are mean±SD 
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Table 5  Hormonal markers.   PRE (Baseline), POST (T3), and Change Scores 
(Δ) of hormonal markers.  PRE values are an average of T1 and T2.
 Total Testosterone (ng/ml) 
Time Placebo 3 g/d 6 g/d 
PRE 6.03 ± 1.48 6.95 ± 1.44 5.85 ± 1.10 
POST 6.07 ± 1.35 6.91 ± 1.71 5.12 ± 1.16 
Δ 0.05 ± 0.80 -0.03 ± 0.68 -0.74 ± 0.95* 
 Free Testosterone (pmol/l) 
 Placebo 3 g/d 6 g/d 
PRE 439.62 ± 132.64 534.88 ± 127.65 429.13 ± 93.98 
POST 480.87 ± 133.48 524.25 ± 101.67 363.38 ± 78.09 
Δ 41.25 ± 52.48 -10.63 ± 66.31 -65.75 ± 79.25 * 
 Estradiol (pmol/l) 
 Placebo 3 g/d 6 g/d 
PRE 118.50 ± 20.91 117.56 ± 30.58 107.50 ± 24.22 
POST 125.12 ± 23.88 112.5 ± 34.51 104.75 ± 34.03 
Δ 6.63 ± 14.94 -5.06 ± 19.52 -2.75 ± 23.46 
 SHBG Pre (nmol/l) 
 Placebo 3 g/d 6 g/d 
PRE 34.56 ± 16.55 32.56 ± 10.72 33.56 ± 11.82 
POST 30.38 ± 12.39 32.88 ± 12.53 33.75 ± 10.98 
Δ -4.19 ± 5.90 0.31 ± 4.29 0.19 ± 1.46 
 Albumin (g/l) 
 Placebo 3 g/d 6 g/d 
PRE 
46.38 ± 2.08 45.06 ± 2.60 45.50 ± 1.49 
POST 44.75 ± 1.67 45.00 ± 2.33 45.50 ± 2.56 
Δ -1.63 ± 1.33 -0.06 ± 1.82 0.00 ± 2.35 
Data is presented as: mean±SD. * statistically significant (P<0.05) 
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Figure 9  The absolute change of free testosterone.  * statistically significant (P<0.05) 
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CHAPTER 5 – DOSING STUDY DISCUSSION 
The aim of this dosing study was to investigate the effectiveness of three grams and 
six grams on raising testosterone levels in resistance trained men.  The critical findings 
of the dosing study were, 1) resistance trained men consuming a daily dose of six 
grams of d-aspartic acid demonstrated significant reductions in total and free 
testosterone after 14 days of d-aspartic acid supplementation, and 2) the 
responsiveness to d-aspartic acid supplementation was unaffected by initial 
testosterone levels (total or free) in resistance trained men.  
The present results of Study 1 demonstrate that in resistance trained men three grams 
daily of d-aspartic acid had no significant effect on total testosterone, estradiol, sex-
hormone-binding-globulin, and albumin. This is contrary to the evidence provided by 
Topo et al. (Topo et al., 2009), where the experimental group consumed the same dose 
over 12 days and reported elevated total testosterone levels (~42 %). Baseline 
testosterone levels of the current study were higher than values found in Topo et al. 
(Topo et al., 2009) (6.3 and 4.5 ng/ml respectively), presumably because the 
population in the Topo et al. study was sedentary (Topo et al., 2009). In resistance 
training literature, total testosterone levels range from 5.8–8.6 ng/ml (Häkkinen et al., 
1988a; Häkkinen, Pakarinen, et al., 1985) for trained individuals and 4.9–6.6 ng/ml for 
untrained (McCall et al., 1999; Reaburn et al., 1997; Staron et al., 1994). The increase 
in testosterone observed in Topo et al. (Topo et al., 2009) was likely because 
testosterone levels were low enough for d-aspartic acid to have an effect. In 
comparison results in the D3 group mirror the results seen in the study by Willoughby 
& Leutholtz (Willoughby & Leutholtz, 2013), where the total testosterone levels fall 
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within levels observed in resistance trained males (Häkkinen et al., 1988a; Häkkinen, 
Pakarinen, et al., 1985). 
It was observed in the six-gram group that total testosterone was significantly reduced 
from baseline by ~12.5%, with a parallel decrease in free testosterone ~15.3% (see 
Table 5). Previous research has demonstrated that in resistance trained men, free 
testosterone can increase due to training (Ahtiainen et al., 2003). A reduction in 
calculated free testosterone in this study is due to a decrease in total testosterone, an 
increase in the binding proteins or a combination of the two occurring. Within the 
context of increasing total testosterone, a maximum effective dosage (MED) is 
observed in rat studies (A. D'Aniello et al., 1996). At the higher dosages, there was 
significantly increased accumulation of d-aspartic acid, noted in the pituitary and testes 
(A. D'Aniello et al., 1996). A dose response increase in total testosterone was observed 
until 1 µmol/g. Each increase in dose past 1 µmol/g the rise in testosterone was reduced 
(A. D'Aniello et al., 1996). It could be theorised that 6 g/d may be affecting negative 
feedback mechanisms of the HPG axis, thus reducing pituitary initiated production of 
luteinizing hormone and in turn testosterone levels. Furthermore, d-aspartic acid could 
also be over-accumulating within the testes. This over accumulation may be creating 
a disruptive effect on the mobilisation of cholesterol from the outer membrane to the 
inner (Furuchi & Homma, 2005), which would attenuate testosterone production. As 
this was the first study to administer a six-gram dosage of d-aspartic acid, these 
mechanisms can only be speculated, due to the lack of data available on the utilisation 
of this dosage of d-aspartic acid in humans. 
The reductions in testosterone observed in this study are important to consider, owing 
to the negative impact it could have on training gains within this population. Resistance 
trained men have higher levels of strength and hypertrophy compared to novice 
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trainers and also exhibit higher basal testosterone levels (Häkkinen et al., 1988a; 
Häkkinen, Pakarinen, et al., 1985; McCall et al., 1999; Reaburn et al., 1997; Staron et 
al., 1994; Willoughby & Leutholtz, 2013), which suggest a link between basal total 
testosterone levels and training-related gains. A decrease in total testosterone with a 
concurrent decrease in free testosterone could reduce the likelihood of interaction with 
androgen receptors in muscles and nerves, which would reduce the speed of 
testosterone initiated muscle protein synthesis (Heemers & Tindall, 2007). Over time 
this could translate into reduced training gains. Conversely, alterations of testosterone 
within normal physiological ranges may not be clinically significant. Research 
indicates that when total testosterone levels are observed of normal healthy ranges 
(4.9-8.6 ng/ml), it affects strength and hypertrophy. In the case of hypogonadism 
where testosterone levels are low this negatively affects strength and hypertrophy, and 
with the use of steroids, a positive effect is observed (Bhasin et al., 1996; Lunenfeld, 
Arver, Moncada, Rees, & Schulte, 2012). The changes noted in the current study 
reflect minor alterations on normal testosterone physiological ranges. It is currently 
unknown if these fluctuations are detrimental to training gains. 
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Limitations 
A potential limitation of this research may be the study length. The results from a two-
week supplementation study will only be relevant to acute usage of d-aspartic acid. 
The observed reduction in testosterone may rebound, or even decrease further and a 
longer term training study would be able to explain the effects of this supplement 
better. Moreover, it would be able to delineate changes in strength and or hypertrophy 
and observe whether d-aspartic acid affects training-related gains positively or 
negatively. 
Conclusion 
Many testosterone boosting supplements are commercially available without sufficient 
research to support their efficacy. The present study has demonstrated that 3 g/d of d-
aspartic acid was inadequate to affect any hormonal markers and that 6 g/d 
significantly reduced total testosterone and free testosterone levels, with no concurrent 
change in other hormones tested. It is currently unknown if any adverse impact of this 
reduction, on strength and hypertrophy, will occur over time. The need for longer-
duration research utilising six grams of d-aspartic acid is evident. Future research 
should explore supplementation of 6 g/d over a longer period and observe any 
correlations between basal testosterone levels and changes in hypertrophy and 
strength.  
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CHAPTER 6 – TRAINING STUDY METHODS 
Subjects 
The institutional review board approved the study and participants provided written 
informed consent prior to testing and participation. To be eligible participants had to 
be: male; aged 18–36; have no acute or chronic medical conditions; have the ability to 
bench press 100% body weight, and had been performing regular resistance training 
exercise for at least three days per week for the previous two years. None of the 
participants was supplementing their diet with any ergogenic or testosterone boosting 
supplements before testing. All participants provided written consent and completed a 
medical history check during the recruitment process. Study 1 of this thesis was used 
to determine the sample size of the training study (Melville, Siegler, & Marshall, 
2015). Free testosterone change in the six-gram group demonstrated an effect size of 
1.17, resulting in a total sample size of 12 participants. To adequately power this study 
the number was inflated to 20 participants to accommodate for a 60% adherence rate. 
Of the 22 recruited subjects, three dropped out due to personal reasons, leaving 19 that 
completed the study. Participant demographics are presented in Table 6. The study was 
conducted according to the Declaration of Helsinki and was approved by the university 
ethics committee.  
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Table 6  Participant demographics 
 Placebo (n=9) 6 g/d (n =10) 
Age (years) 25.4 ± 6.4 22.4 ± 2.6 
Training age (years) 3.3 ± 1.7 3.1 ± 1.3 
Height (m) 178.3 ± 6.2 180.4 ± 6.4 
Body Mass (kg) 82.5 ± 9.0 80.5 ± 10.2 
Data are mean±SD. No differences were observed between PLA and DAA at T1. 
Experimental approach to the problem 
Study 2 was a randomised, double-blinded, and placebo-controlled study design, with 
the objective to examine the effects of d-aspartic acid supplementation on hormonal 
levels, hypertrophy, neural and strength changes during a three-month resistance 
training program. Participants were assigned to one of two experimental groups: 
placebo (PLA, 6g rice flour, n=9) or d-aspartic acid (6g DAA, n=10). All participants 
consumed ten identical opaque capsules each morning with breakfast for 12 weeks. 
Participants were randomly allocated to treatment groups following a block 
randomisation procedure based on a computer-generated list of random numbers. 
Group allocation was managed by a technical officer, while the primary investigator 
was kept blind to group assignment throughout the experimental intervention, and data 
-analysis. All participants followed a body-split periodised training program for three 
months’ duration (4 d/w). Three time points were used to obtain all testing data, 
baseline (T1), six weeks’ post (T2) and 12 weeks’ post (T3). 
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Figure 10  Timeline of Study 2 design and testing procedures.  Baseline testing (T1), midpoint testing (T2), post testing (T3), electrical 
 stimulation protocol (  ), isometric force testing of the calf and quadriceps muscles ( ), venous blood drawn and centrifuged 
 for serum (   ), ultrasound testing of the calf and quadriceps muscle (      ), resistance training began after all testing procedures were 
 completed for T1 (        ), supplementation protocol began after all testing procedures were completed for T1 ( ). 
 
Week 0 
T1 
Week 6 Week 12 
T2 T3 
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Experimental procedures 
Testing sessions (T1-T3) involved: a fasted blood draw for hormonal and lipid 
measures; ultrasound measurements of the quadriceps and calf muscles (panorama and 
sagittal images) for hypertrophy; electrical stimulation of the calf muscles for h-curve, 
m-curve and v-wave neuromuscular parameters; and maximal voluntary contraction 
(MVC) for isometric strength of the quadriceps and calf muscles (Figure 10). 
Following T1, prescribed training and supplementation commenced for six weeks. The 
program incorporated periodisation changes, implemented from T2 (see Table 7 and 
Table 8). The purpose of the periodisation was to improve adherence, motivation and 
prevent overtraining. All participants had to follow the prescribed RT program. Post-
measures were taken after another six weeks, at the end of week 12.  
Training Program 
Participants were trained for four days per week over the three-month period, with 
supervised sessions conducted once per week. The prescribed training involved five 
exercises that included 3-5 sets of various repetition maximum (RM) prescriptions 
(2RM – 10RM). A main lift was prescribed for each day – deadlift, bench press, good 
morning/stiff-leg deadlift and squat, with accessory exercises for balance and volume. 
Briefly the program was as follows: Monday focused on the hamstrings, glutes, 
quadriceps, trapezius, latissimus dorsi and calves; Tuesday was pectoralis, deltoids, 
triceps and back extensors work; Wednesday – rest day; Thursday, hamstrings, soleus, 
trapezius, biceps and latissimus dorsi and Friday was heavily focused on quadriceps 
work with some glutes and hamstrings, see Table 7 and Table 8. These changes did 
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not affect the general layout of the program. Training diaries were given to participants 
at the end of T1 to help monitor adherence rate. All participants were asked to perform 
48 sessions in the gym in total, the average number of sessions was 47.53±0.84, or an 
adherence rate of 99.01%. Ten repetition-maximum (10RM), of the calf raise and leg 
extension, were also calculated from training diaries from the average weight of the 
sets they performed at week 1 (T1), week 7 (T2) and week 12 (T3). 
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Table 7  Program design from weeks 1-6.  Prescribed training was either repetition maximum (RM) or body weight to failure 
(BWF).  Exercise identifiers as they appear in the table: barbell (BB), conventional (C), machine (M), overhead (OH), stiff-leg (SL), 
bent-over (BO), extension (EXT), dumbbell (DB) 
Weeks 1-6             
 Set 1 Set 2 Set 3 Set 4 Set 5   Set 1 Set 2 Set 3 Set 4 Set 5 
Day 1       Day 3      
             
Deadlift (BB, C) 8RM 6RM 5RM 4RM 5RM  Deadlift (BB, SL) 10RM 10RM 10RM 8RM  
Split squats (BB) 10RM 8RM 6RM    Seated calf raise 10RM 10RM 8RM 8RM 6RM 
Seated Row (M) 8RM 6RM 4RM 4RM   Row (BO, BB) 10RM 10RM 10RM   
Stiff-Arm (M) 10RM 10RM 10RM 10RM   Biceps curl 10RM 10RM 10RM 10RM  
1-leg calf raises BWF BWF BWF    Chin-ups (N) 10RM 8RM 6RM   
             
Day 2       Day 4      
             
Bench Press (BB) 8RM 6RM 5RM 4RM 5RM  Front squat (BB) 8RM 6RM 5RM   
Press (OH, BB) 10RM 8RM 6RM 6RM 6RM  Leg press (M) 8RM 6RM 5RM   
Flys (DB) 10RM 10RM 10RM 10RM   Leg EXT (M) 10RM 10RM 10RM 10RM  
Dips 8RM 6RM 4RM 4RM   Leg curl (M) 10RM 10RM 10RM 10RM  
Back Extensions 10RM 10RM 10RM    Step-ups (DB) 10RM 10RM 10RM   
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Table 8  Program design from weeks 7-12.  Prescribed training was either repetition maximum (RM) or body weight to failure 
(BWF).  Exercise identifiers: barbell (BB), sumo (S), split-squats (SS), machine (M), dumbbell (DB), ezy-curl bar (Ez), overhand 
grip (OG), 1-arm rows were prescribed at a heavy weight (8RM-10RM), continually alternated each side, until prescribed number of 
reps were completed (*), extension (EXT). 
Weeks 7-12             
 Set 1 Set 2 Set 3 Set 4 Set 5   Set 1 Set 2 Set 3 Set 4 Set 5 
Day1       Day3      
             
Deadlift (BB, S) 4RM 4RM 3RM 3RM 2RM  Deadlift (BB, SL) 8RM 8RM 6RM 6RM  
Bulgarian SS (BB) 8RM 6RM 6RM    Pull-up (OG) 8RM 8RM 6RM   
Seated Row (M) 6RM 6RM 4RM 4RM   Seated calf raise 10RM 8RM 8RM 6RM 6RM 
Lat pulldown (M) 10RM 10RM 8RM 8RM   Biceps curl 10RM 10RM 10RM 10RM  
1-leg calf raises BWF BWF BWF    1-arm Rows (DB) 40R *    
             
Day2       Day 4      
             
Bench press (BB) 8RM 6RM 6RM 4RM 4RM  Back squat (BB) 8RM 8RM 6RM 6RM  
Seated press (DB) 6RM 6RM 6RM 6RM   Leg press (M) 10RM 6RM 8RM 6RM 6RM 
Incline press (BB) 8RM 8RM 8RM 8RM   Leg EXT (M) 10RM 10RM 10RM 8RM  
Skullcrushers (Ez) 8RM 8RM 6RM 4RM   Leg curl (M) 8RM 8RM 8RM 8RM  
Back Extensions 8RM 8RM 8RM    Step-ups (DB) 5RM 5RM 5RM 5RM  
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Fasted blood draws 
All blood draws were obtained via venepuncture of the antecubital vein after a 12 hour 
fast. Participants were also instructed to avoid strenuous exercise and alcohol 
consumption the day before the draw. Blood draws were conducted by the primary 
investigator who was trained in phlebotomy. Subsequent time point draws were 
planned for the same time of morning for each particular participant, to prevent any 
effect of diurnal variation (maximum range 7:00–10:00 am). Whole blood was 
collected using serum separator tubes (SST™ II Advance, BD Vacutainer®). They 
were then allowed to clot for 45 minutes and centrifuged using a fixed angle rotor 
centrifuge: ADAMS® Compact II Centrifuge, V:227 (Becton Dickinson & Co) (828 
x g, at 2700 rpm) for 15 minutes in an air-conditioned room (19 ℃). Serum was 
aliquoted and stored at ‒80 ℃ until analysis (Douglas Hanly Moir Pathology, 
Macquarie Park, NSW, Australia). A single analysis of serum was performed for total 
testosterone, estradiol, sex-hormone-binding-globulin (SHBG) and albumin. 
Testosterone and SHBG were measured via electrochemiluminescence immunoassay, 
on a Roche E170 system (Roche Diagnostics, Dee Why, NSW, Australia), with a limit 
of detection values of 0.025 ng/ml and 0.350 nmol/l respectively. Albumin was 
measured via bromocresol green succinate buffer method, on an Abbott ARCHITECT 
c16000 (Abbott Laboratories, Abbott Park, Illinois, USA). The limit of detection of 
the albumin BCG assay is 30 g/l. Estradiol was measured via chemiluminescent 
microparticle immunoassay, on an Abbott i2000 (Abbott Laboratories, Abbott Park, 
Illinois, USA) and the analytical sensitivity of this assay is ≤ 10pg/ml. Free 
testosterone was calculated from total testosterone, SHBG and albumin (Vermeulen et 
al., 1999). Whole blood was also collected in EDTA tubes with the order of collection 
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as EDTA then SST. After inverting the EDTA tubes, they were spun for 10 minutes 
(828 x g, at 2700 rpm), in an air-conditioned room (19 ℃). EDTA was aliquoted and 
analysed immediately for HDL levels via the dry-chemistry method on a Roche 
Reflotron machine (Roche Diagnostics, Dee Why, NSW, Australia). Previous research 
has demonstrated that the intra-assay precision of this test is below 3.2 % (Riesen, 
1990). 
Ultrasound 
Participants were asked to rest in a supine position for 20 minutes, to allow for fluid 
shift to stabilise within the muscles (Berg, Tedner, & Tesch, 1993). Extended-field-of-
view (EFOV) images were conducted at the lower third of the quadriceps muscles, 
measured as a third of the distance between the centre of the knee joint and the ASIS. 
This site was determined in pilot testing to be optimal to observe the cross-sectional 
area of the quadriceps muscles. B-mode ultrasound imaging was conducted using an 
Echo Blaster 128 family scanner, Echo Wave II v2.3.6 (Telemed, Vilnius, Lithuania) 
software. EFOV imaging is created by scanning over the muscle, with new image 
frames combining with the previous frames to form a panorama image (Noorkoiv, 
Nosaka, & Blazevich, 2010). These images were analysed for CSA of the quadriceps 
muscles; vastus lateralis (VLC), vastus intermedialis (VIC), vastus medialis (VMC) and 
rectus femoris (RFC). Incorrect estimation of the quadriceps muscle can occur if the 
image is not scanned perpendicular to the muscle. To prevent this effect, indelible ink 
was used to mark the scan line. While adhering to this scan line, the probe had to be 
moved continuously, held at a 90-degree angle to the skin using as light pressure as 
required to keep the probe in contact with the skin. These factors, along with visual 
inspection of the image were used to control the quality of the final images, with scans 
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repeated where necessary. A minimum of three images was obtained for each time 
point, with the average values from these images used for data analysis. Images were 
analysed using ImageJ 1.46 (National Institutes of Health, Bethesda, Maryland, USA) 
public domain software package. Intra-experimenter reliability (CV) of the EFOV 
method was 2.26%. 
Sagittal images were obtained again at the inferior third of the quadriceps, and at the 
midpoint of the quadriceps (50% between the centre of the knee joint and ASIS). The 
probe was manipulated at the marked site until the superficial, and deep aponeuroses 
of vastus lateralis/fat layer and vastus lateralis/vastus intermedialis layers were 
parallel, and the pennate fibres were straight as opposed to curved (Figure 11). Three 
images were obtained at these two sites for all time points. Muscle thickness was 
obtained for vastus lateralis (VLT30, VLT50) and vastus intermedialis (VIT30, VIT50) at 
the midpoint of the image, with two extra measures equal distance from the middle. 
Pennation angle was determined three times for vastus lateralis (VLA), at the midpoint 
quadriceps site (50% between the centre of the knee joint and ASIS). Final data points 
were averaged across the multiple images and measures. For the calf muscle, only 
muscle thickness of the soleus and gastrocnemius muscles was obtained. The distance 
between the lateral malleolus and the fibular head was divided into three sites: Superior 
quarter, SOLTh75 and GASTh75; superior third, SOLTh67 and GASTh67; and midpoint, 
SOLTh50 and GASTh50. The average values around the centre of the image for the three 
images were used for data analysis. Intra-experimenter reliability (CV) of the analysis 
of the sagittal images was 2.99% for the quadriceps thickness, 8.68% for calf thickness 
and 13.67 % for pennation angle. 
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Figure 11  Typical ultrasound sagittal image of the left lateral quadriceps.  
Features from top to bottom of the image are: fat layer, aponeurosis, vastus lateralis, 
aponeurosis, vastus intermedialis and femur. 
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Nerve stimulation and isometric strength 
EMG 
Surface electromyography (sEMG) was recorded from the soleus and gastrocnemius 
muscles using bipolar Ag/AgCl electrodes (Maxensor; Medimax Global, Australia).  
Electrodes (10mm contact diameter, 10mm inter-electrode distance) were placed 
parallel to the muscle fibres following careful skin preparation (removal of excess hair, 
skin abrasion, cleaning the skin with isopropyl alcohol swabs) to reduce the skin 
electrical impedance to below 5 kΩ. Soleus electrodes were placed at two-thirds of the 
distance between the medial condyle of the femur and the medial malleolus and for 
medial gastrocnemius, the two electrodes were put on the muscle belly. For each 
participant anatomical landmarks were recorded in relation to the placement of the 
electrodes to ensure consistency between testing sessions. A reference electrode was 
placed on the medial malleolus. An ML138 Octal BioAmp (common mode rejection 
ratio >85 dB @ 50 Hz, input impedance 200 MΩ) with 16-bit analog-to-digital 
conversion, sampled at 2 kHz (ADI Instruments, Sydney, NSW, Australia) was used 
to record sEMG signals into LabChart v7.3.7. Raw signals were filtered with a fourth-
order Bessel filter between 20-500 Hz. 
Posterior tibial nerve stimulation 
Transcutaneous stimulation of the tibial nerve was applied to the left knee. The 
cathode, a single Ag/AgCl electrode (Maxensor; Medimax Global, Australia), was 
located on the posterior side of the knee within the popliteal fossa. The exact location 
was identified by manipulating a rubber insulated portable cathode around the 
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popliteal fossa while stimulating at a low intensity until the largest evoked resting H-
wave was elicited from soleus. The anode was created from a sheet of aluminium foil 
(Al, 10x6 cm) and electrode paste (Ten20®, Weaver and Company, Colorado, USA). 
This was applied to the anterior aspect of the thigh just proximal to the patella. H-
reflexes, M-waves and V-waves were evoked from the soleus and gastrocnemius 
muscles using a 1-ms square wave pulse delivered by a constant current stimulator 
(DS7AH Stimulator, Welwyn Garden City, UK) applied at 400 V. 
Isometric Force 
Maximal calf muscle strength was measured as maximal isometric calf flexion torque 
exerted in an isokinetic dynamometer (KinCom 125, version 5.32, Chattanooga, TN, 
USA). The device was configured so the seat was set upright, with the participant’s 
hip and knee flexed to 90o degrees and the subject’s lateral malleolus in line with the 
centre of rotation of the lever arm. The seat angle was raised slightly so that there was 
no gap between the knee and the edge of the seat to prevent unwanted muscle activity. 
The subject was strapped in with one seatbelt running across the knees and another 
running from left shoulder to the right hip. This setup was found in pilot testing to 
reduce the contribution from the hip and thigh muscles. Subjects were warmed up with 
three submaximal contractions (~50%, ~75%, ~90% MVC) spaced one minute apart. 
After sufficient warm up, three maximal voluntary contractions (MVCs) of the calf 
muscle were recorded, with two minutes’ rest given between each MVC. Torque 
output signals were directly sampled from the dynamometer at 2 kHz (PowerLab, 
ADInstruments, Sydney, NSW, Australia). Following MVCs was the determination of 
H-reflex threshold and the maximal motor response. The participant was asked to hold 
a 10% contraction during all stimulation events. Adherence was helped by normalising 
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the level of MVC to 100% and then providing a monitor with a duplicate display of 
LabChart. This monitor displayed an enlarged mini-window, with up-to-date force 
information, and participants were asked to watch this window to maintain their goal 
of 10% tonic contraction. H-wave threshold (Hth) was approximated by increasing 
stimulation from 10 to 30 mA, by 1 mA per pass. The beginning of the H-M curve was 
defined as 3 mA lower than the stimulation intensity at which H-wave was ≥ 1 mV. 
Stimulation was then increased in multiples of 10 mA until Mmax was determined, 
which was defined as the last stimulation in a plateau spanning over three stimulation 
points. Between these two stimulation intensities (Hth – Mmax), 30 points were created 
on a logarithmic scale (Vila-Cha et al., 2012). The H-M curve was then mapped to the 
thirty points with two stimulations performed at each intensity (10s rest between each 
stimulation). M-wave and H-waves were calculated from the peak-to-peak amplitudes 
of the first and second evoked waves (~10 ms and ~35 ms respectively), following the 
stimulation artefact (Figure 12). After the H-M curve mapping, the Mmax intensity was 
used to determine the supramaximal stimulation intensity (130% Mmax). The subjects 
were then asked to perform three MVCs of approximately five seconds duration, with 
two minutes rest in between. Along the plateau of the MVCs, a supramaximal stimulus 
was applied to the tibial nerve (manually triggered) to elicit a V-wave (Figure 13) 
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Figure 12  EMG trace of soleus.  This example is at the Hmax intensity (0-50ms), with soleus on the top trace and gastrocnemius muscle 
 on the bottom trace. 
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Figure 13  Zoomed figure of V-wave data.  Force trace portrays delayed effect of stimulation.  Soleus EMG trace depicts maximum motor 
 response wave (Mmax) and the elicited volitional wave (V-wave). 
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Figure 14  H-reflex parameters displayed on a representative example  The raw data is represented as open circles, with the sigmoid 
 fit data represented along the solid line.  The short dashed line represents the slope at 50% of Hmax.  The lower filled circle represents iHth, 
 and the upper filled circle represents iHmax. 
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MVCs for the isometric knee-extension were performed after V-wave recordings.  The 
Kin Com was re-configured so that the participant’s knees and hips were at 90o 
degrees. The centre of their knee joint aligned with the centre of rotation and the ankle 
pad was fixed 2cm above the lateral malleolus. Participants were strapped in and then 
performed a series of warmups (~25, ~50, ~75% of their perceived maximal effort). 
After a short break the participants were asked to perform a maximal effort as hard 
and as fast as possible, after completely relaxing the lower body. Verbal 
encouragement was provided over the ~5s duration of the MVC. Three MVCs were 
recorded with two minutes’ rest between each. 
Force Data Processing 
MVC was defined as the peak force recorded over the entire ~5s force trace. During 
calf stimulation protocol, if MVCs were required to be calculated from V-wave traces 
then the peak force was defined as maximum level excluding any superimposed twitch 
observed on the trace. RFD was derived as the average tangential slope of the moment-
time curve (Δtorqure/Δtime), over time-windows of 0-30, 0-50, 0-100 and 0-200 ms 
in relation the onset of contraction. The onset of contraction was defined as a torque 
of 7.5 Nm above baseline levels. Maximal rate of force development (RFDmax) was 
calculated as the greatest 5-ms average slope over the entire contraction.  
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H-wave data processing 
Peak-to-peak amplitudes of the H-wave and M-wave were calculated from the sEMG 
of the soleus and medial gastrocnemius. The average of the two elicited H-waves at 
each stimulation intensity was recorded. Hmax amplitude was defined as the largest H-
wave recorded over the H-M curve. The ascending limb was defined as data from, the 
initial stimulation point, to Hmax. Before analysis, h-reflex data points were normalised 
to the Mmax of that particular time point, with stimulus intensity (current) normalised 
to the stimulus intensity at 50% Mmax.  
Data from the ascending limb was entered into a custom program coded in the 
statistical package: R (R Foundation for Statistical Computing, Vienna, Austria). This 
program incorporated a three-parameter sigmoid function (Equation 1 below) and used 
a general least squares model to find the best fit for the ascending limb H-wave data 
(Klimstra & Zehr, 2008). Recruitment curves with an R2<0.900 were omitted from 
analysis (Vila-Cha et al., 2012). The following parameters were acquired from the 
ascending limb: the slope at the midpoint (Hslp), current at H-wave threshold (iHth), 
current at H-wave maximum amplitude (iHmax) and current at 50% Hmax (iH50). These 
parameters are visually represented in Figure 14. 
 
𝐻(𝑠) =  
𝐻𝑚𝑎𝑥
1 + 𝑒𝑚(𝑖𝐻50−𝑠)
 
Equation 1 (Klimstra & Zehr, 2008) 
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Slope at 50% Hmax was estimated around H50 and iH50, using the following differential 
formula: 
𝐴𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒
𝑆𝑡𝑖𝑚𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝐶𝑢𝑟𝑟𝑒𝑛𝑡
 
𝑆𝐿𝑃50 =
(𝐻2 − 𝐻1)
(𝑖2 − 𝑖1)
 
Equation 2 
Estimation of the slope parameter (m) for Equation 1, was determined from Equation 
2 and Equation 4. 
𝐻𝑠𝑙𝑝 =
𝑚(𝐻𝑚𝑎𝑥)
4
 
Equation 3 
𝑚 =  
(𝑆𝐿𝑃50 × 4 )
𝐻𝑚𝑎𝑥
 
Equation 4 
Hmax was estimated as the largest value in the h-reflex curve, and iH50 was estimated 
as the stimulus at half Hmax. These estimations were used in Equation 1 as part of the 
nls(stat) function, which determined the parameters of the model: m, Hmax and iH50, 
where the sigmoid function best fit the data. The current intensities, iHmax and iHth, 
were calculated by entering the parameters into Equation 5.  
𝑦 = 𝑚𝑥 + 𝑏 
Equation 5 
The y-intercept (b) can be solved, as iH50 is determined from Equation 1 and Hslp is 
determined via Equation 3 (using m and Hmax). If y=50% Hmax, m=Hslp and x=iH50: 
𝑏 = ( 
1
2
× 𝐻max ) − (𝐻𝑠𝑙𝑝 × 𝑖𝐻50) 
Equation 6 
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iHmax can be determined from the x-intercept when y=Hmax: 
𝑖𝐻𝑚𝑎𝑥 =
(𝐻𝑚𝑎𝑥 − 𝑏)
𝐻𝑠𝑙𝑝
 
Equation 7 
iHth can be determined from the x-intercept when y=0: 
𝑖𝐻𝑡ℎ =  
−𝑏
𝐻𝑠𝑙𝑝
 
Equation 8 
Statistical analysis 
Analyses were conducted using IBM SPSS Statistics version 22.0 (SPSS Inc., 
Chicago, IL, USA), and statistical significance was set at p<0.05. The distribution was 
tested for normality using the Kolmogorov-Smirnov test and visual inspection of 
skewness and kurtosis. All measurements were analysed by a two-way (condition x 
time) ANOVA for repeated measures (T1, T2 and T3). In the event of a significant F 
ratio, post hoc comparisons were completed with a Bonferroni correction. One 
participant from the placebo group did not have sufficient data for calf strength and 
neural measures, thus was omitted from those analyses. Linear regression analysis was 
performed for the entire sample, to explore potential relationships between fasting 
hormones and training outcome variables. These analyses were investigated over three 
periods, T1-T2, T2-T3 and T1-T3. Unless otherwise stated, data are shown as 
mean±S.D. 
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CHAPTER 7 – TRAINING STUDY RESULTS 
Hormonal analysis 
There was no main effect of time for the blood markers, FT (p=0.661), SHBG 
(p=0.180), ALB (p=0.096), HDL (p=0.733) and a trend for a time effect for TT 
(p=0.075). No significant change was observed in TT across the study population, 
from T1-T2 (p=0.614), T2-T3 (p=0.130, d=0.317) or T1-T3 (p=0.708) (see Figure 15). 
A significant group by time effect (p=0.023) was observed in E2 (Table 9), with post 
hoc analysis showing that the DAA group experienced a 16.2±14.2% reduction in E2 
from T1 to T3 (p=0.009) which was significantly different (p=0.005) to the lack of 
change observed in the PLA group (Figure 16). All other blood markers showed no 
significant group by time effect (TT, p=0.614; FT, p=0.543; SHBG, p=0.829; ALB, 
p=0.393; HDL, p=0.301). 
Dynamic Muscle strength 
No group by time effects were observed in either 10RM leg extension or 10RM calf 
raise (p=0.540, p=0.092, respectively). A significant main effect for time was observed 
in both leg extension (p<0.001) and calf raise (p<0.001). Post hoc analysis revealed 
that dynamic leg extension strength significantly increased from T1 to T2 
(30.6±21.4%, p<0.001), T2 to T3 (14.4±14.7 %, p<0.01) and T1 to T3 (48.7±26.7%, 
p<0.001). Similarly, dynamic calf raise strength significantly increased from T1 to T2 
(53.1±54.3%, p<0.001), T2 to T3 (16.0±13.0%, p<0.001) and T1 to T3 (80.0±76.5%, 
p<0.001). 
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Figure 15  Total testosterone levels over the course of the 12 weeks.  Data are mean±SD.  
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Figure 16  Absolute change score in estradiol from T1-T3.  Data are mean±SD.  ** significantly different from placebo (p<0.01).  
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Isometric muscle strength 
No group by time effects were observed in either MVC results (calf raise, p=0.610; 
leg extension, p=0.585).  A significant main effect for time was observed for leg 
extension (p=0.001), and calf raise strength (p=0.004) (Table 11). Post hoc analysis 
revealed that isometric leg extension strength increased from T1 to T2 by 10.6±14.6% 
(p=0.020) and also from T1 to T3 by 16.9±20.5% (p=0.011) (Figure 17). Isometric 
calf strength increased at T3 by 17.2±20.1% (p=0.008) (Figure 18). 
Rate of force development 
Group by time effects was observed in QRFD25 (p=0.033) and QRFD50 (p=0.038). 
Further analysis revealed that from T1 to T3, DAA significantly increased as compared 
to PLA in QRFD25 and QRFD50 (p=0.007, p=0.010 respectively). Specifically, from 
T1-T3 the PLA group did not change (QRFD25, p=0.156; QRFD50, p=0.319), while 
the DAA group experienced a 26.7±24.8% increase in QRFD25 (p=0.024) and a 
30.3±28.2% increase in QRFD50 (p=0.025) (see Figure 19). A significant main effect 
for time was observed in Qmax (p=0.044) and Q200 (p=0.017) with a trend observed in 
Q100 (p=0.078). Post hoc analysis showed a trending increase from T1 to T3 in Q200 
(p=0.058, d=0.625), but no significant changes in Qmax (p=0.123) and Q100 (p=0.154). 
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Figure 17  Maximal voluntary contraction of the isometric seated leg extension  Values at baseline (T1), six-week mid-point (T2) and 
 12-week post testing (T3), n=19.  Data are mean±SD of the pooled study sample (PLA and DAA).  # significantly different from T1, 
 irrespective of group (p<0.05). 
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Figure 18  Maximal voluntary contraction results for isometric seated calf raise.  Values at baseline (T1), six-week mid-point (T2) and 
 12 weeks post testing (T3), n=18.  Data are mean±SD of the pooled study sample (PLA and DAA).  ## significantly different from T1, 
 irrespective of group (p<0.01). 
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Figure 19  Absolute change score in leg extension RFD.  0-25 ms, QRFD25 and 0-50 ms, QRFD50, from baseline to post testing (T1-
 T3).  Data are mean±SD.  ** significantly different from placebo (p<0.01). 
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Table 9  Fasting hormones.  Total testosterone (TT), free testosterone (FT), estradiol (E2), sex-hormone-binding-globulin (SHBG), albumin 
(ALB) levels, for placebo (PLA) and six grams per day of d-aspartic acid (DAA), at baseline (T1), six-week mid-point (T2) and 12-week post 
testing (T3).
 PLA (n=9)  DAA (n =10) 
 T1 T2 T3  T1 T2 T3 
TT (ng/ml) 6.1 ± 1.5 6.3 ± 1.5 6.0 ± 1.9  5.7 ± 1.6 5.9 ± 1.6 5.3 ± 1.4 
FT (pmol/l) 431.9 ± 113.3 443.3 ± 121.2 444.4 ± 164.2  408.3 ± 90.3 418.7 ± 108.7 387.9 ± 95.1 
E2 (pmol/l) 84.4 ± 25.0 82.8 ± 17.7 91.2 ± 26.5  92.4 ± 25.7 83.2 ± 29.5 77.1 ± 26.4
** 
SHBG (nmol/l) 36.2 ± 12.5 38.2 ± 14.5 34.6 ± 11.7  34.5 ± 15.3 34.6 ± 12.8 32.3 ± 10.2 
ALB (g/l) 45.4 ± 2.1 44.7 ± 3.1 44.6 ± 1.7  45.9 ± 2.5 46.1 ± 2.5 44.9 ± 1.9 
Data are mean±SD.  ** significant between-group difference, as compared to T1 (p<0.01). 
 
Table 10  Dynamic 10 RM strength data and body mass changes in Study 2.  Data extracted from training journals 
 PLA (n=9)  DAA (n =10) 
 T1 T2 T3  T1 T2 T3 
Leg extension 45.6 ± 19.1 58.6 ± 24.9## 62.8 ± 22.1##@@  40.3 ± 12.0 53.6 ± 17.8## 61.7 ± 19.1##@@ 
Calf raise 33.9 ± 7.0 41.1 ± 6.5## 47.8 ± 7.0##@@  31.3 ± 12.4 47.5 ± 10.5## 53.7 ± 9.8##@@ 
        
Body Mass (kg) 82.5 ± 9.0 83.2 ± 7.9 83.8 ± 8.0#  80.5 ± 10.2 81.0 ± 9.8 81.4 ± 9.9# 
Data are mean±SD.  # significantly different from T1, irrespective of group (p<0.05), ## (P<0.01). @@ significantly different from T2, irrespective 
of group (p<0.01).  
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Table 11  Maximal voluntary contractions and rate of force data.  Seated 90o isometric leg extension (Quad) and seated 90o calf raise (Calf), 
for placebo (PLA) and six grams per day of d-aspartic acid (DAA), at baseline (T1), six-week mid-point (T2) and 12-week post testing (T3). 
 PLA (n=9), PLA calf (n=8)  DAA (n =10) 
 T1 T2 T3  T1 T2 T3 
Quad        
  MVC (Nm) 236.0 ± 56.9 246.3 ± 61.2 261.1 ± 66.1#  234.6 ± 58.0 266.0 ± 50.6 278.7 ± 62.0# 
  QRFDmax(Nm/s) 1326.2 ± 527.1 1281.6 ± 497.5 1357.8 ± 483.1  1217.5 ± 444.0 1353.9 ± 355.9 1491.0 ± 281.4 
  QRFD25 (ms) 846.2 ± 310.3 820.7 ± 308.6 755.1 ± 249.7
**  749.3 ± 256.3 814.0 ± 303.4 898.6 ± 195.6** 
  QRFD50 (ms) 1028.7 ± 423.4 1005.1 ± 387.5 965.0 ± 336.2
**  922.3 ± 348.7 999.3 ± 375.2 1120.0 ± 260.2** 
  QRFD100 (ms) 999.2 ± 435.2 989.3 ± 367.2 1034.1 ± 361.5  939.5 ± 358.6 996.3 ± 334.5 1098.2 ± 266.3 
  QRFD200 (ms) 735.8 ± 272.0 740.0 ± 230.9 797.7 ± 253.2  705.8 ± 226.3 774.5 ± 218.7 836.1 ± 177.1 
Calf        
  MVC (Nm) 264.3 ± 52.0 292.8 ± 49.8 293.0 ± 40.8##  243.6 ± 61.7 268.8 ± 78.8 287.6 ± 64.8## 
  CRFDmax(Nm/s) 942.9 ± 246.7 992.4 ± 398.6 1094.1 ± 360.1  845.3 ± 212.3 1015.3 ± 315.4 1015.0 ± 413.2 
  CRFD25 (ms) 476.0 ± 144.2 517.6 ± 227.5 487.5 ± 232.9  442.8 ± 140.8 530.3 ± 172.9 460.4 ± 212.9 
  CRFD50 (ms) 588.5 ± 183.1 615.5 ± 300.1 609.1 ± 306.7  537.4 ± 172.8 663.0 ± 228.1 577.8 ± 280.3 
  CRFD100 (ms) 718.7 ± 230.6 727.0 ± 372.2 757.6 ± 380.5  641.8 ± 204.7 801.6 ± 280.9 743.4 ± 348.4 
  CRFD200 (ms) 653.6 ± 187.7 672.9 ± 246.9 721.3 ± 277.8  582.8 ± 135.9 712.2 ± 213.8 718.2 ± 290.5 
Data are mean±SD.  # significantly different from T1, irrespective of group # (p<0.05), ## (p<0.01).  * significant between group difference, as 
compared to T1 (p<0.05), ** (p<0.01). 
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α-motor neuron excitability 
H-wave, M-wave and V-wave parameters are presented in Table 12 and Table 13.  A 
trend for a time effect was observed in gastrocnemius Hmax (p=0.091), with no other 
time effects observed in the other gastrocnemius h-reflex variables (p>0.140). No 
significant differences for Hmax were observed from T1 to T3 (p=0.246). A significant 
group by time effect was observed in gastrocnemius iHmax (p=0.026), and in iH50 
(p=0.048). Post hoc analysis revealed that iHmax PLA was reduced 27.0±27.1% 
(p=0.048) from T1 to T3 and 25.3±20.6% (p=0.049) from T2 to T3 in PLA compared 
to DAA (Figure 20). Post hoc analysis for iH50 showed a between-group trend, T1 to 
T3 (p=0.070, d=0.996), and between-group significance observed from the T2 to T3 
change (p=0.032) (Figure 21). PLA tended to decrease from T1 to T3 (22.6±25.6%, 
p=0.062 d=1.156) and from T2 to T3 (21.9±20.8%, p=0.081, d=0.836). No within-
group change was observed in DAA iH50 from T1 to T3, or from T2 to T3. No time 
effects (p>0.200) or group by time effects (p>0.100) were observed in any soleus h-
reflex measure.  
Efferent drive and M-wave data 
The V/Mmax ratio had no main effect for time (V/Mmax, p=0.417; V/Mmax, p=0.587, 
soleus and gastrocnemius respectively) or group by time effect (V/Mmax, p=0.568; 
V/Mmax, p=0.496, respectively). A trend for a group by time effect was observed for 
soleus Mmax (p=0.055). No significant differences were observed in soleus Mmax (T1-
T2, p=0.128; T1-T3, p=0.420; T2-T3, p=0.110). No time effect (p=0.173) or group by 
time effect (p=0.867) was observed for gastrocnemius Mmax. 
  
 
 
1
0
7
 
T
1
-T
3
T
2
-T
3
-6 0
-4 0
-2 0
0
2 0
4 0
N
o
r
m
a
li
s
e
d
 C
u
r
r
e
n
t
 (
i)
P L A
D A A
* *
 
Figure 20  Absolute change score in normalised iHmax.  (Normalised to current at 50% Mmax), from baseline to post testing (T1-T3) and 
 midpoint to post testing (T2-T3).  Data are mean±SD.  * significantly different from placebo (p<0.05). 
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Figure 21  Absolute change score in normalised iH50.  (Normalised to current at 50% Mmax), from baseline to post testing (T1-T3) and 
 midpoint to post testing (T2-T3).  Data are mean±SD.  * significantly different from placebo (p<0.05).
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Table 12  Soleus neural variables.  Maximal M-wave (Mmax), V-wave to maximal M-wave ratio (V/Mmax), maximal H-wave (Hmax), slope at 50% 
Hmax (Hslp), current (i), current at H-wave threshold (iHth), current at 50% Hmax (iH50), current at Hmax (iHmax), for placebo (PLA) and six grams per 
day of d-aspartic acid (DAA), at baseline (T1), six-week mid-point (T2) and 12-week post testing (T3). 
 Placebo (n=9)  6 g/d (n =10) 
Soleus T1 T2 T3  T1 T2 T3 
Mmax, mV 9.5 ± 3.5 8.0 ± 2.3 9.8 ± 4.4  9.8 ± 2.6 11.3 ± 5.4 8.9 ± 4.0 
V/Mmax, % 30.46 ± 27.75 34.08 ± 29.28 26.49 ± 18.60  24.89 ± 9.33 30.37 ± 17.62 28.92 ± 20.29 
Hmax, % Mmax 44.1 ± 18.3 47.4 ± 18.2 47.6 ± 15.4  45.3 ± 12.4 46.3 ± 17.4 39.8 ± 12.5 
Hslp, mV/mA 2.1 ± 1.4 2.6 ± 2.3 2.8 ± 1.7  2.1 ± 1.3 2.9 ± 2.3 2.3 ± 1.7 
iHth, % i at 50% Mmax 59.0 ± 27.0 50.8 ± 23.0 40.3 ± 8.8  47.8 ± 19.1 44.5 ± 17.1 49.8 ± 21.0 
iH50, % i at 50% Mmax 70.8 ± 29.5 62.4 ± 25.6 51.0 ± 9.5  60.8 ± 23.5 54.8 ± 20.1 62.5 ± 20.6 
iHmax, % i at 50% Mmax 82.7 ± 32.3 74.1 ± 29.4 61.8 ± 12.5  73.8 ± 28.3 65.0 ± 23.7 75.2 ± 22.2 
Data are mean ± SD.   
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Table 13  Gastrocnemius neural variables.  Maximal M-wave (Mmax), V-wave to maximal M-wave ratio (V/Mmax), maximal H-wave (Hmax), 
slope at 50% Hmax (Hslp), current (i), current at H-wave threshold (iHth), current at 50% Hmax (iH50), current at Hmax (iHmax), for placebo (PLA) and 
six grams per day of d-aspartic acid (DAA), at baseline (T1), six-week mid-point (T2) and 12-week post testing (T3). 
 Placebo (n=9)  6 g/d (n =10) 
Gastrocnemius T1 T2 T3  T1 T2 T3 
Mmax, mV 7.7 ± 3.0 9.0 ± 3.1 8.9 ± 3.5  9.7 ± 2.8 10.1 ± 3.5 10.7 ± 2.9 
V/Mmax, % 26.50 ± 28.41 30.87 ± 28.76 24.50 ± 18.54  22.20 ± 9.91 25.30 ± 10.41 27.40 ± 30.24 
Hmax, % Mmax 44.0 ± 26.5 35.4 ± 17.4 34.6 ± 18.9  40.7 ± 21.7 37.7 ± 17.3 29.3 ± 12.2 
Hslp, mV/mA 1.8 ± 1.2 2.3 ± 1.6 2.9 ± 2.4  2.3 ± 1.6 2.8 ± 1.8 1.7 ± 1.2 
iHth, %i at 50% Mmax  52.1 ± 18.6 55.3 ± 31.6 40.0 ± 7.6  48.9 ± 18.4 45.2 ± 17.0 47.8 ± 20.6 
iH50, %i at 50% Mmax 68.2 ± 23.9 68.6 ± 34.6 47.7 ± 7.7  60.3 ± 22.6 53.7 ± 20.0 60.1 ± 22.5ϕ 
iHmax, %i at 50% Mmax 84.3 ± 30.9 82.0 ± 38.8 54.6 ± 8.2  71.7 ± 27.5 62.2 ± 23.3 72.8 ± 26.3*ϕ 
Data are mean±SD.  * significant between-group differences, as compared to T1 (p<0.05).  ϕ significant between-group differences, as compared 
to T2. 
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Muscle hypertrophy and architecture 
Quadriceps cross-sectional area (CSA), muscle thickness and pennation angle are 
presented in Table 14, and calf muscle thickness is presented in Table 15.  No group 
by time effects were observed for any of the body composition measures: body mass 
(p=0.759); quadriceps CSA (p>0.400); quadriceps thickness (p>0.300); calf thickness 
(p>0.100); quadriceps pennation angle (p>0.300). A significant main effect for time 
was observed in body mass (p=0.005, Table 10), with post hoc analysis revealing that 
the study population had increased by 1.5±2.3 % from T1 to T3 (p=0.045). 
Results in the EFOV images demonstrated significant main effects for time in all CSA 
quadriceps measures: VLC (p<0.001), VIC (p=0.002), RFC (p=0.034) and VMC 
(p<0.001). Post hoc analysis revealed that VLC was significantly increased from T1 at 
T2 (6.5±8.5%, p=0.020) and T3 (10.1±9.4%, p<0.001) and VMC was significantly 
increased from T1 at T2 (7.8±7.1%, p<0.001) and T3 (11.4±10.0%, p<0.001). VIC was 
significantly increased from T1 to T3 (6.6±8.7%, p=0.008), with a trend observed 
between T1 and T3 in RFC (p=0.091, d=0.573). See Figure 22 for a representative 
example of the quadriceps hypertrophy that occurred. 
A significant main effect for time was observed in VIT33 (p=0.047), and in pennation 
angle, VLA (p=0.040). Other thickness variables for the quadriceps muscles did not 
reach significance (VLT50, p=0.059, d=0.198; VLT33, p=0.055; VIT50, p=0.676). Post 
hoc analysis revealed a trend for an increase from T1 to T3, in VIT33 (p=0.135, 
d=0.511), VLT33 (p=0.150, d=0.515) and VLA (p=0.106, d=0.476). 
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Results for sagittal calf thickness showed no significant main effects for time in soleus 
at SOLTh75 (p=0.217), SOLTh67 (p=0.141) and a trend in SOLTh50 (p=0.063, d=0.49). 
Significant effects for time were observed in gastrocnemius muscle at GASTh75 
(p<0.001) and GASTh67 (p=0.004) but not GASTh50 (p=0.468). Post hoc analysis 
revealed that for GASTh75, T2 and T3 were significantly increased from T1 by 
9.7±10.7% (p=0.002) and 18.6±27.7% (p=0.011) respectively. GASTh67 was 
significantly increased by 20.6±34.7% (p=0.012), T1 to T3. 
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Figure 22  Representative example of quadriceps hypertrophy.  Vastus lateralis, VL; vastus intermedialis, VI; rectus femoris, RF; vastus 
 medialis, VM). 
VL 
VI 
RF 
VL 
VL 
VI RF
 
T1 
VL 
25.7cm2 
20.4cm2 
5.2cm2 
16.5cm2 
28.9cm2 
T3 
25.3cm2 
5.5cm2 
17.4cm2 
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Table 14  Quadriceps muscles hypertrophy and morphological changes.  Vastus lateralis (VL), vastus intermedialis (VI), rectus femoris (RF), 
vastus medialis (VM).  Ultrasound parameters: CSA slice at 33% distance from centre knee joint to the ASIS (C); sagittal thickness at 33% distance 
from centre knee joint to the ASIS (Th33), sagittal thickness at 50% distance from centre knee joint to the ASIS (Th50), angle of pennation at 50% 
distance from centre knee joint to the ASIS (A). 
 Placebo (n=9)  6 g/d (n =10) 
 T1 T2 T3  T1 T2 T3 
CSA        
 VLC (cm
2) 22.4 ± 5.3 24.1 ± 4.9# 24.8 ± 4.7###  21.1 ± 4.4 21.9 ± 3.6# 22.7 ± 4.1### 
 VIC (cm
2) 23.7 ± 4.1 24.4 ± 3.9 25.3 ± 3.6###  26.6 ± 3.7 27.3 ± 3.9 27.9 ± 3.8### 
 RFC (cm
2) 4.1 ± 1.4 4.3 ± 0.8 4.6 ± 1.0  4.7 ± 1.2 5.1 ± 1.1 5.2 ± 1.2 
 VMC (cm
2) 18.7 ± 4.1 19.6 ± 4.3### 20.4 ± 4.1###  18.3 ± 4.6 20.1 ± 4.8### 20.5 ± 4.7### 
Thickness        
 VLTh33 (mm) 27.5 ± 3.7 28.5 ± 3.1 28.3 ± 4.0  26.4 ± 4.1 27.1 ± 4.9 27.7 ± 4.8 
 VITh33 (mm) 17.2 ± 3.4 18.9 ± 2.7 18.4 ± 3.3  19.1 ± 4.0 19.5 ± 4.2 19.8 ± 3.4 
 VLTh50 (mm) 25.8 ± 3.6 26.6 ± 3.5 26.6 ± 4.6  26.0 ± 4.7 27.1 ± 5.5 27.1 ± 4.7 
 VITh50 (mm) 17.2 ± 3.4 18.9 ± 2.7 18.4 ± 3.3  20.1 ± 4.6 20.6 ± 4.7 20.5 ± 4.6 
Angle        
 VLA (degrees) 14.4 ± 2.6 15.6 ± 3.0 16.4 ± 3.7  15.9 ± 3.4 17.5 ± 4.6 16.6 ± 3.2 
Data are mean±SD.  # significantly different from T1, irrespective of group (p<0.05), ### (p<0.001) 
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Table 15  Calf muscles hypertrophy.  Soleus (SOL), gastrocnemius (GAS).  Ultrasound parameters: sagittal thickness at 75% distance from the 
lateral malleolus to the fibular head (Th75), sagittal thickness at 67% distance from the lateral malleolus to the fibular head (Th67), sagittal thickness 
at 50% distance from fibular head to the lateral malleolus (Th50). 
 Placebo (n=9)  6 g/d (n =10) 
 T1 T2 T3  T1 T2 T3 
Soleus        
 SOLTh75 (mm) 14.0 ± 2.5 13.3 ± 2.6 14.0 ± 2.3  14.1 ± 2.1 13.6 ± 1.5 14.2 ± 1.4 
 SOLTh67 (mm) 14.3 ± 2.3 14.7 ± 2.2 14.9 ± 2.2  14.1 ± 2.2 14.3 ± 2.2 14.9 ± 2.3 
 SOLTh50 (mm) 14.8 ± 2.2 17.4 ± 5.7 16.2 ± 3.0  14.2 ± 3.5 15.5 ± 2.6 16.1 ± 2.2 
Gastrocnemius        
 GASTh75 (mm) 8.6 ± 3.0 9.4 ± 3.2
## 10.4 ± 2.4#  9.4 ± 1.6 10.1 ± 1.5## 10.1 ± 1.5# 
 GASTh67 (mm) 8.5 ± 3.0 9.8 ± 3.0 10.6 ± 2.9
#  9.4 ± 2.5 9.7 ± 3.0 10.1 ± 2.5# 
 GASTh50 (mm) 3.8 ± 2.0 4.2 ± 1.8 4.4 ± 1.3  4.5 ± 3.0 3.2 ± 1.0 3.8 ± 0.9 
Data are mean±SD.  # significantly different from T1, irrespective of group (p<0.05), ## (p<0.01)
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Hormonal relationships with training variables 
Testosterone 
No relationships were observed between change in total testosterone and change of the 
sum of quadriceps CSA, at any time point (p>0.05). No relationships were found 
between change in testosterone and change in the isometric strength of the leg 
extension or calf raise, at any time point (p>0.05). 
Estradiol 
No relationships were observed between change in estradiol and change of the sum of 
quadriceps CSA, at any time point (p>0.05). No relationships were observed between 
estradiol change and change in the isometric strength of the leg extension, or calf raise 
at any time point (p>0.05). Change scores from T1 to T3 revealed a negative 
relationship observed between estradiol and soleus iHmax p=0.023, R
2=0.269 (Figure 
23) 
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Figure 23  Relationship between estradiol change and change in Hmax current of 
the soleus muscle, from T1 to T3.  Trend line displays data for both groups (n=18), 
with a significant association between E2 and soleus iHmax (adjusted R
2=0.186, 
standardised β coefficient=−0.484, p=0.042).  Dashed lines represent 95% CI.  
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From T2 to T3 a positive relationship was observed between estradiol and both soleus 
and gastrocnemius Hslp variables, p=0.032, R
2=0.257 (Figure 24, soleus); p=0.005, 
R2=0.393 (Figure 25, gastrocnemius). 
 
Figure 24  Relationship between change in estradiol and the change in H-
reflex slope variable of the soleus muscle, from T2 to T3.  Trend line 
displays data for both groups (n=18), with a significant association between E2 
and soleus Hslp (adjusted R
2=0.211, standardised β coefficient=0.507, 
p=0.032).  Dashed lines represent 95% CI. 
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Figure 25  Relationship between estradiol and the H-reflex slope variable 
of the gastrocnemius muscle.  Trend line displays data for both groups 
(n=18), with a significant association between E2 and gastrocnemius Hslp 
(adjusted R2=0.355, standardised β coefficient=0.627, p=0.005).  Dashed lines 
represent 95% CI.  
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CHAPTER 8 – TRAINING STUDY DISCUSSION 
The primary aim of the training study was to investigate the long-term training 
outcomes, with the supplementation of d-aspartic acid in resistance trained men.  The 
main objectives were to evaluate the effectiveness of six grams of d-aspartic acid on 
hormonal, strength, hypertrophy and neural change. The principal findings of the 
present study were, 1) 12 weeks of resistance training resulted in equivalent strength 
and hypertrophy gains across both the placebo and d-aspartic acid groups, 2) 12 weeks 
of daily d-aspartic acid supplementation was ineffective at altering total testosterone 
levels, but reduced levels of estradiol, 3) 12 weeks of daily d-aspartic acid 
supplementation resulted in an increase in the early rate of force development of the 
isometric leg extension and 4) the placebo group experienced a reduction in all 
gastrocnemius h-reflex parameters pertaining to current intensity. 
Effects of d-aspartic acid on hormones, strength and hypertrophy 
Supplement companies are purporting d-aspartic acid as a viable supplement to be 
utilised for improving strength and hypertrophy, via a proposed increase in total 
testosterone. As such the results of the present study refute these claims, and are in 
accordance with research on d-aspartic acid (3 g/d, 4 weeks) in a resistance trained 
population (Willoughby & Leutholtz, 2013). Willoughby & Leutholtz observed 
equivocal gains in strength and hypertrophy in both placebo and d-aspartic acid 
groups, as well as no change in total testosterone levels or other hormones tested. 
Recent research has indicated that utilising a daily dose of six grams of d-aspartic acid, 
decreased levels of total testosterone (Melville et al., 2015), over a two-week 
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supplementation period (study 1). The lack of change observed in the present study 
suggests that this reduction of basal testosterone is transitory. 
A plausible mechanism for lack of testosterone change in Study 2 of this thesis, could 
be the upregulation of d-aspartate oxidase production which degrades d-aspartic acid. 
Previous research in resistance trained men has observed marked increases in d-
aspartate oxidase (Willoughby & Leutholtz) with no change in total testosterone levels. 
Potentially DDO could be acting as a negative feedback mechanism for d-aspartic that 
regulates levels within the body. Alternatively, negative feedback mechanisms of the 
hypothalamic–pituitary–gonadal axis could be regulating testosterone synthesis 
(Figure 4). A decrease in testosterone will cause the hypothalamus to produce more 
gonadotropin-releasing hormone, stimulating luteinizing hormone production in the 
pituitary gland, which in turn would travel to the gonads to produce more testosterone 
(Molina, 2013; Sower, Freamat, & Kavanaugh, 2009). Tying in with this theory could 
be the effect that estradiol has on feedback mechanisms. Estradiol appears to play a 
role in the downregulation of the pulse frequency of luteinizing hormone from the 
anterior pituitary (Hayes, Seminara, Decruz, Boepple, & Crowley Jr, 2000; Rochira et 
al., 2006). Luteinizing hormone is secreted in a pulsatile manner, that is, it is secreted 
in short bursts from the hypothalamus rather than as a constant flow. Changes in the 
pulse frequency of a hormone, therefore, affects the influence that particular hormone 
imparts on target tissues and negative feedback mechanisms. A decrease in estradiol 
may cause the pulse frequency of luteinizing hormone to increase (Hayes, Seminara, 
Decruz, Boepple, & Crowley Jr, 2000; Rochira et al., 2006), which in turn would 
increase testosterone. Therefore the transitory reduction in total testosterone observed 
in study 1 (Melville et al., 2015) could have reversed this effect from estradiol or other 
negative feedback loops (hypothalamus, anterior pituitary gland) over the longer 
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timeframe of the current study. A potential reason why total testosterone did not 
continue to increase, is likely because once levels normalised, negative feedback 
signals to the hypothalamus and anterior pituitary would downregulate production of 
testosterone (refer to Figure 4), effectively reducing secretion rate to maintenance 
levels. The combination of these two feedback mechanisms would also likely 
counteract the effect of the estradiol feedback loop, as estradiol had decreased by the 
end of the study.  
The reduction in estradiol in the current study might be explained by the relative 
dosage and length of the protocol, as this is the first long-term study with a dosage of 
six grams of d-aspartic acid, in healthy resistance-trained men. 17β-estradiol is 
biosynthesized from testosterone in a number of tissues that express the enzyme 
aromatase. Aromatase is produced from the CYP 19 gene and is part of the cytochrome 
P450 superfamily (Simpson et al., 2002). In men, approximately 15% of estradiol is 
synthesised in the testes (Simpson et al., 2002), with the remaining produced at tissues 
that express aromatase including Leydig cells (testes), adipose tissue, hypothalamus, 
bone tissue and vascular smooth muscle (Simpson et al., 2002). A potential mechanism 
of this reduction could have occurred via disruption of the testosterone-estradiol 
aromatase pathway. D-aspartic acid in relation to estradiol regulation has not been 
clarified in humans. Furthermore, it is not clear if d-aspartic acid functions differently, 
depending on the target tissue where the aromatase enzyme is expressed. In vitro 
research on boar testes demonstrate that d-aspartic acid induced a significant increase 
in aromatase activity (defined as the rate of in vitro conversion of testosterone to 
estradiol) (Lamanna, Assisi, Botte, & Di Fiore, 2007). Direct relationships between d-
aspartic acid and estradiol have also been observed in the reproductive cycle of the 
female lizard (Podarcis s. silica) (Assisi, Botte, D'Aniello, & Di Fiore, 2001). 
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Moreover, the addition of d-aspartic acid into incubation wells containing lizard 
ovarian tissue results in an increase in the rate of conversion of testosterone to 
estradiol. Of note, is that the synthesis of new aromatase is not possible within an in 
vitro model, and while the authors did not ascertain the mechanism of the upregulation 
of aromatase activity, it was proposed that there were inactive pools of aromatase that 
was stimulated by the introduced d-aspartic acid (Assisi et al., 2001). Conversely, in 
the testes of the lizard, a negative correlation is observed between endogenous levels 
of d-aspartic acid and estradiol levels. Furthermore, injection of d-aspartic acid 
temporarily reduces estradiol (baseline levels within 24 hours) (Raucci, D'Aniello, & 
Di Fiore, 2005). These studies suggest that it is possible that the action of d-aspartic 
acid is dependent on the tissue where it is produced, (or the tissue where it accumulates, 
in the case of supplementation) which would explain intersex and interspecies 
differences. In rat’s concentrations of estradiol do not change after one or five hours 
in serum (A. D'Aniello et al., 2000; Santillo et al., 2014). In humans (resistance trained 
men) estradiol remains unchanged over two (Melville et al., 2015), and four weeks 
(Willoughby & Leutholtz, 2013) (combined supplementation and resistance training 
protocols). If the standard function of d-aspartic acid in humans is to upregulate 
aromatase activity – similar to the changes observed in boar and the female lizard 
(Assisi et al., 2001; Lamanna et al., 2007) – then it is likely that the higher dose utilised 
in the present study, had a negative impact on normal functioning of d-aspartic acid on 
aromatase activity via oversaturation of the tissues with d-aspartic acid. Conversely, if 
the standard function of d-aspartic acid is to downregulate aromatase activity in 
humans, which occurs in the male lizard (Raucci et al., 2005), then the accumulation 
of d-aspartic acid may have caused a gradual reduction in estradiol over time, via 
reduced aromatase activity. Despite this decrease in estradiol, results of the present 
 124 
 
study clearly demonstrate no concurrent differences in hypertrophy or strength gains. 
This data indicates that the relative effect of this reduction, with respect to gaining 
muscle or improving strength is inconsequential in comparison to the intrinsic 
mechanisms driving hypertrophy (A. M. Gonzalez et al., 2016; West, Burd, Staples, et 
al., 2010) and neural change (Aagaard, 2003; Aagaard et al., 2002b; Van Cutsem et 
al., 1998). Within the context of neural adaptation, the placebo group experienced 
increased excitability of the calf H-reflex pathway, which was absent in the d-aspartic 
acid group. In addition, a positive relationship was observed between estradiol and the 
recruitment gain of both soleus and gastrocnemius muscles, suggesting the reduction 
in estradiol might have played a role in the lack of neural change observed in the 
experimental group. 
Effects of d-aspartic acid on the H-reflex pathway 
In gastrocnemius, the normalised current intensity for iHmax decreased within the 
placebo group from T2 to T3 (~25%) while there was no change observed in the d-
aspartic group. Furthermore, iH50 in the placebo group was also was significantly 
different to d-aspartic acid from T2 to T3. It was hypothesised that d-aspartic acid may 
improve excitability and neural adaptation via testosterone interaction with androgen 
receptors within the neurons (Fraley & Ulibarri, 2002; Hammond et al., 2001; Herbst 
& Bhasin, 2004) or directly via d-aspartic acid’s proposed role as a neurotransmitter 
(A. D'Aniello, 2007; S. D'Aniello et al., 2011; Ota et al., 2012). Contrary to this, results 
within the gastrocnemius muscle indicated that the placebo group experienced 
improved excitability of the Ia reflex arc. Improvements of this reflex arc can be 
represented by an increased amplitude of the H-wave response at a given stimulus, or 
a reduction of current required to recruit a known H-wave amplitude (for example Hmax 
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intensity-). These improvements signify increased excitability at the level of the 
motoneuron. Previous research in novice individuals has shown that the stimulus 
intensity required to evoke H-reflex threshold was reduced post training of the 
dorsiflexors (Dragert & Zehr, 2011) and reduced after plantar flexion strength training 
(Vila-Cha et al., 2012). Increases have also been observed in H-reflex amplitudes 
elicited at an equivalent M wave of 5% Mmax (Lagerquist et al., 2006) and 20% 
(Holtermann et al., 2007) of Mmax Conversely some studies have demonstrated no 
change in various H-reflex variables. Eccentric training of the trapezius muscle in 
healthy subjects failed to induce any changes in normalised current intensities 
(Vangsgaard, Taylor, Hansen, & Madeleine, 2014). Eccentric focused training did not 
change H-reflex elicited at 20% Mmax during a maximal contraction protocol 
(Nordlund, 2010) and likewise, maximal strength training at 85-90% 1RM had no 
effect on the excitability of H-waves recruited at 20% MVC at a current inducing an 
M-wave 10% of the maximum response. The aforementioned studies suggest that the 
adaptability of the spinal reflex is quite variable in novices, and when it is observed to 
change, it tends to improve excitability of the low-threshold motor units. As the results 
of the current study showed a decrease in the current required to elicit Hmax and H50, 
and as motor units are recruited in sequence according to the size principle, regardless 
of training (Van Cutsem et al., 1998), this suggests that the moderate to high threshold 
motor units were recruited at a lower stimulus. This is the first study in a resistance 
trained population, which has observed improvements in spinal responsiveness at the 
level of the motoneuron similar to previous observations in novice populations 
(Dragert & Zehr, 2011; Lagerquist et al., 2006; Vila-Cha et al., 2012). With H-reflex 
methodology it difficult to know where along the spinal pathway this adaptation is 
occurring. Mechanistically this could be caused by improved excitability of the alpha 
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motor neuron, improved excitability of the Ia afferent loop, or a decrease in 
presynaptic inhibition at the level of the interneuron (Zehr, 2002). These 
improvements of excitability experienced by the placebo group were absent in the d-
aspartic acid group.  
The lack of change in gastrocnemius h-reflex parameters within the d-aspartic acid 
group suggests that supplementation is inhibiting adaptation of the excitability of the 
spinal pathway in the calves. One potential explanation for this could be related to the 
possible role of d-aspartic acid as a neurotransmitter. Free d-aspartic acid has been 
demonstrated to have the ability to enter neurons via L-glutamate transporters (Kanai 
& Hediger, 1992; Koyama et al., 2005). While this could be beneficial in small 
amounts by providing an additional neurotransmitter to upregulate neural 
transmission, a large concentration of DAA entering the neuron could be detrimental. 
If d-aspartic acid is saturating the L-glutamate transporters, then it may be stalling the 
release and transport of a more potent neurotransmitter, such as glutamate (Engelsen, 
1986). While this could be a minor effect, over the course of a training period it may 
have resulted in the blunted neural adaptation that was observed in the d-aspartic 
group. Although there was an observed inhibition of adaptation of the spinal pathway 
in the d-aspartic acid group, both groups equally improved calf isometric and dynamic 
strength with no change in power within the calf muscles. This suggests that the 
between-group differences observed in excitability of the spinal pathway to the calf 
muscles were negligible, with respect to altering strength or power in the calf raise.  
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Effects of d-aspartic acid on rate of force development 
A novel finding of the current study was that early RFD in the leg extension increased 
in the d-aspartic acid group by ~26.7±26.1% (0-25 ms) and ~30.3±29.7% (0-50 ms), 
with no change observed in the placebo. These results suggest that the supplementation 
of six grams of d-aspartic acid improved the participant’s ability to rapidly generate 
force, providing preliminary evidence that suggests that d-aspartic acid could be 
beneficial for sporting applications which require explosive movement. 
Previous research on early RFD change from resistance training conflicts with 
evidence demonstrating increases in early RFD (Aagaard et al., 2002b; Blazevich, 
Cannavan, Horne, Coleman, & Aagaard, 2009; de Oliveira, Rizatto, & Denadai, 2013), 
no change (Häkkinen, Alen, & Komi, 1985) and also decreases (Marshall et al., 2011). 
Of the aforementioned studies only a few have been conducted in resistance trained 
populations (Häkkinen, Alen, et al., 1985; Marshall et al., 2011), so the standard 
response within trained populations has not been clarified. Potential mechanisms that 
are associated with changes in power include, changes to the intrinsic muscle 
contractile properties, like twitch RFD (Andersen & Aagaard, 2006), and neural 
adaptation. Neural adaptation can include: earlier recruitment of type II motor units, 
as demonstrated by a reduction in recruitment threshold distributions (Van Cutsem et 
al., 1998); increased observation of ‘true’ doublet spikes; or increased maximal firing 
frequency of motor units during voluntary ballistic contractions shown by a reduction 
of inter-spike intervals (Van Cutsem et al., 1998). Improvements in power have also 
been observed in traditional periodised training, increases in the mean average EMG 
(MAV) and the rate of EMG rise (RER), signified an increase in efferent neural drive 
to the muscle (Aagaard, Simonsen, Andersen, Magnusson, & Dyhre-Poulsen, 2002a). 
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Furthermore, since they were observed during the early phase of muscle contraction 
(0-50ms), this suggested changes in motoneuron discharge rate. Authors also reported 
an increased V-wave response, reflecting an increase in spinal motoneuronal output, 
which could result in an increase in the firing frequency of the motor units (Aagaard 
et al., 2002a). The supplementation of d-aspartic acid could also be affecting neural 
adaptation directly. 
D-aspartic acid has been recently suggested to have various properties that are similar 
to neurotransmitters (A. D'Aniello, 2007). It has been found in high concentrations in 
various nervous tissues of a marine mollusc and is observed to be released from the 
synaptic vesicles along with other excitatory amino acids (Spinelli et al., 2006). 
Additional experiments revealed that injection of d-aspartic acid into these animals 
increased cAMP content, analysed within the cerebral ganglia. Live cultured neurons, 
extracted from the cerebral ganglia, also resulted in an increase in cAMP content 
(Spinelli et al., 2006). The importance of this finding, is further evidence of d-aspartic 
acid’s role as a neurotransmitter, as various cellular responses to neurotransmitters rely 
on the cAMP molecule via the second messenger pathway (Spinelli et al., 2006). 
Research has also suggested that d-aspartic acid may be able to use L-glutamate 
transporters (Koyama et al., 2005), which could be a potential mechanism for how free 
d-aspartic acid in the blood, could enter the neuroglia and the neurons (Spinelli et al., 
2006). It is not clear from the research if d-aspartic acid’s role within the brain would 
differ to its potential role within the periphery. It is hard to speculate the specific 
mechanisms which are attributing to the change in leg extension RFD of the current 
study, due to the lack of neural testing within the quadriceps.  
Hypothetically as d-aspartic acid appears to have various properties akin to 
neurotransmitters, supplementation may have increased the availability of d-aspartic 
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acid within the brain or neurons, which improved cortical or spinal excitability and 
resulted in an improvement in RFD. As the change in RFD was exclusive to the 
quadriceps and not the calf muscles, it is likely that this adaptation occurred as a 
combination of specific programming and interaction with d-aspartic acid 
supplementation. The lack of change in RFD within the calf muscles may be explained 
by the amount of volume prescribed, which was lower than the quadriceps 
prescription. Training volume for the calf muscles encompassed 36 reps in the 10RM 
– 8RM range and 6 reps at 6RM during the first 6-week block. In weeks 7 – 12, there 
was 26 reps at 10RM – 8RM and 12 reps at 6RM. Additional volume for the calf 
included 30 reps at approximately 20RM – 30RM (sets to failure). Conversely, 
quadriceps volume during weeks 1 – 6 was comprised of 114 reps per week in the 
10RM – 8RM range and 28 reps within the 6RM – 8RM. Volume during weeks 7 – 12 
included 82 reps at the 10RM – 8RM range and 48 reps at 6RM. Thus for the 
quadriceps, the initial six weeks utilised high volume in the moderate intensity range, 
with less volume at the high-intensity range. The second periodisation block, traded 
volume in the moderate intensity range, for increased volume at the high-intensity 
range. Similar periodisation changes have previously resulted in improvements in 
early and peak RFD in novices (Aagaard et al., 2002a).  Aagaard and colleagues 
implemented a training protocol which required 3RM – 10RM training for 10 weeks 
and then implemented a 4RM – 6RM heavy loading cycle for the final month. In 
novices, it is possible that a periodisation change to greater training volume at higher 
intensities is driving RFD improvements from resistance training. The placebo results 
of the current study revealed that the training alone did not elicit an RFD change in 
resistance trained men, despite similar volume and intensity changes as the study 
conducted by Aagaard and colleagues. Even though power improvements have been 
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observed with resistance training in novices (Aagaard et al., 2002a), specific power 
training may be required to see continual RFD improvements in a resistance trained 
population, as research has shown that in these populations resistance training either, 
does not change RFD, or can even decrease RFD (Häkkinen, Alen, et al., 1985; 
Marshall et al., 2011). Despite this, d-aspartic acid supplementation resulted in 
increased early RFD within the quadriceps, albeit not until post testing. It is reasonable 
to believe that the periodisation change at the midpoint of this study, to more volume 
at the higher intensity range (4RM – 6RM), in combination with supplementation, 
triggered the positive adaptation in power. As this is the first study to observe d-
aspartic acid mediated improvements in RFD, further research is required to 
investigate these preliminary results and delineate the mechanisms that are causing the 
enhancement of early RFD within the quadriceps. 
Effects of d-aspartic acid on supraspinal drive 
The present study showed that V/Mmax ratio in the calf muscles was not significantly 
different between groups, neither did V/Mmax improve over the course of the training 
study. These results suggest that neither d-aspartic acid nor the stimulus of resistance 
training was able to change supraspinal drive to the calf muscles in this population. 
Research in novice populations has demonstrated increases in V/Mmax ratio with 
resistance training (Aagaard et al., 2002b; Del Balso & Cafarelli, 2007; Nordlund, 
2010; Vila-Cha et al., 2012), additionally when RT individuals are compared with 
novices, significantly larger V-wave responses are observed in the trained individuals 
(Sale et al., 1983). Data on endurance training has failed to show any improvements 
in V-wave measures, suggesting that the enhancement of neural drive is an adaptation 
exclusive to resistance training (Vila-Cha et al., 2012). The results from the present 
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study exhibited high variability between subject’s V-waves, which might suggest an 
issue with the sensitivity of the method that was used in this study. Alternatively, given 
the nature that calves are not a high priority muscle to train, it could suggest that data 
obtained from the participants represents a population with a mixture of trained and 
untrained calves. Regardless, the variability in the data suggests that the study could 
have been underpowered to observe a significant change in V-waves. Furthermore, 
alterations in supraspinal drive cannot be entirely eliminated with the methodology 
used in the current study. This is due to the fact that changes in V-waves are an indirect 
measure of supraspinal drive. V-waves can be affected by spinal mechanisms, such as 
alterations within the Ia afferent pathway or changes at the level of the motoneuron. 
With the absence of a direct measure of supraspinal drive, such as transcranial 
magnetic stimulation, it is possible that a change may have occurred in neural drive 
that was not detected with the current methodology. This is the first study to investigate 
changes in V-waves, in a resistance trained population over a long-term training study. 
The lack of change within the placebo group could suggest that improvements in 
supraspinal drive do not influence strength changes in resistance trained populations. 
Alternatively, it is plausible that the V-wave methodology of the current study was not 
sensitive enough to observe a change in a resistance trained population.  
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Importance of sex hormones in trained populations 
A secondary objective of this thesis was to investigate if any relationships between 
hormones and improvements in strength, hypertrophy or neural adaptation, exist 
within a resistance trained population. 
Total testosterone 
It was hypothesised that testosterone would have a positive relationship with 
hypertrophy and isometric strength. No relationships were observed between resting 
total testosterone change and change in the sum of quadriceps CSA, nor with a change 
in leg extension MVC or change in calf raise MVC. Previous research has found 
positive relationships between maximal isometric force and the hormonal milieu in 
both resistance trained (Häkkinen, Pakarinen, et al., 1985) and novices (Ahtiainen et 
al., 2003). One study has explored the relationship between testosterone and 
hypertrophy, which investigated the effects of various dosages of testosterone 
enanthate (Sinha-Hikim et al., 2002). Change in type I and II muscle fibre area were 
observed to be positively related to the change in testosterone, irrespective of any 
training stimulus. The difference between this study and the present study, however, 
is the relative shift in testosterone levels. In the present study, no significant changes 
were observed in testosterone levels over the course of the study, despite observed 
changes in hypertrophy. Conversely, testosterone enanthate doubled (300mg) and 
tripled (600mg) serum testosterone, bringing levels well above clinical ranges. With 
this amount of testosterone in the blood the likelihood of interaction with androgen 
receptors is markedly increased, resulting in the relationship with fibre area 
hypertrophy that was observed (Sinha-Hikim et al., 2002). The results of the present 
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study suggest that in a resistance trained population, resting testosterone levels do not 
significantly change over 12 weeks of periodised training. There were also no drastic 
changes to volume or intensity which could have triggered an overtraining effect that 
has been observed previously, nor did d-aspartic acid appear to have any long-term 
effect on testosterone. Resistance trained populations tend to exhibit higher levels of 
testosterone (Häkkinen et al., 1988a; Häkkinen, Pakarinen, et al., 1985; McCall et al., 
1999; Reaburn et al., 1997; Staron et al., 1994; Willoughby & Leutholtz, 2013), which 
appears to be a chronic adaptation, as a result of a year or more continuous training. 
After this adaptation is realised, provided there is no obvious change in volume or 
intensity (Häkkinen et al., 1987), resting testosterone levels may be relatively stable in 
resistance trained populations. These results suggest that the importance of basal 
testosterone change, within clinical ranges, are negligible in resistance trained 
populations, with respect to strength or hypertrophy improvements. The data presented 
in this study is further evidence that serum levels of hormones play a more of a 
permissive role in hypertrophy. These results also highlight that it is likely that intrinsic 
factors such as activation of various signalling pathways, phosphorylation of 
intramuscular signalling proteins, regulation of messenger RNA (translation 
initiation), increases in AR content and satellite cell activity that play a larger role in 
the hypertrophic response to resistance training (A. M. Gonzalez et al., 2016; West, 
Burd, Staples, et al., 2010). 
Estradiol 
A positive relationship was observed between the change in estradiol and the change 
in the H-reflex slope parameters of soleus and gastrocnemius from, T2 to T3. The slope 
of the ascending limb of the H-reflex curve represents a reduction in the degree of 
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threshold differences within the motoneuron pool, or an improvement in the ease of 
recruitment gradation (Kernell & Hultborn, 1990; Vila-Cha et al., 2012). Estradiol is 
understood to play a role in the functioning of the central nervous system. In vitro 
hippocampal slices from the rat brain have demonstrated that estradiol enhances 
synaptic transmission and the degree of long-term potentiation (Foy, 2011). In women, 
stages of the menstrual cycle with high estradiol levels (late follicular to mid luteal 
phase), were associated with less inhibition and more facilitation activity when probed 
with a weak magnetic stimulus (TMS). Conversely, there was a tendency for higher 
inhibition, when circulation estradiol was low during the early follicular phase (Smith 
et al., 1999). Whilst there is less data on the effects of estradiol in men, the regression 
results suggest that reduced levels of estradiol may decrease the excitability of the 
spinal Ia afferent pathway. A negative relationship was also observed between the 
change in estradiol and the change in the current for Hmax within the soleus muscle, 
from T1 to T3. This relationship is indicating that a reduction in estradiol tended to 
increase the stimulus required to elicit Hmax, suggesting that those individuals with 
lower estradiol at post-testing negatively impacted excitability, at the level of the 
motoneuron. 
Limitations 
This study has a few limitations pertaining to methodological design. One potential 
issue with this research is the reliance on participants taking their supplement dosage 
each day. Participants were given their allocated supply for six weeks at a time, to help 
keep track of adherence. With this design, it is possible that some participants might 
have forgotten to take their daily dose on occasion, despite this being controlled for, 
via weekly checks and prompts, there can be issues with compliance when participants 
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are instructed to take supplements on their own time. In hindsight, an ideal system 
would have participants consuming their pills in front of the primary investigator 
during all face-to-face interactions, with an online/mobile check-in program to account 
for all the other days. Another limitation of this study is the lack of neural testing for 
the quadriceps muscles. Quadriceps data on H-reflex and V-wave changes would 
provide better insight, as to the mechanism behind the improvement in quadriceps 
RFD experienced in the DAA group. Neural adaptation measures were piloted in the 
quadriceps, however, unfortunately, the regular appearance of both H-waves and V-
waves could not be replicated. After multiple attempts at different protocols, it was 
decided in the interest of time management, to omit the neural measures in the 
quadriceps. This design choice ties in with another limitation in relation to the 
omission of a clinical marker of dynamic strength. Ideally, a 1RM protocol for the 
squat could have been included. With the original study design that included 
quadriceps neural testing, isometric leg extension was chosen to mirror this 
methodology as 1RM testing of the squat closely represents gross strength across 
multiple joints, which was believed would not be an ideal comparison with the neural 
markers. Another reason 1RM testing was omitted due was due to the time constraints 
of the participants. An extra day of 1RM testing would have been required, so as not 
to interfere with neural methods and vice versa. Furthermore, we believed that the 
superior control that isometric testing provides would result in a better indicator of 
strength change over a 1RM protocol, especially for calf strength which could be more 
accurately compared to the neural change. In relation to this issue is the choice of 10-
RM calf raise and 10-RM leg extension to indicate strength changes. It could be argued 
that the utilisation of log diary to indicate changes in repetition maximum strength has 
some shortfalls. However, it is believed that this accurately depicts strength changes 
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throughout the study intervention as participants were encouraged to undertake 
progressive loading. Furthermore, we believe despite leg extension and calf raise - 
while traditionally utilised as an accessory exercise - are an ideal match to our testing 
protocols of neural and isometric testing, over and above a more traditional testing 
measure such as the squat (which crosses multiple joints). Another limitation of this 
research is the reliance on V-waves to measure the change in supraspinal drive. The 
inclusion of a direct measure of supraspinal drive, such as transcranial magnetic 
stimulation may have provided clearer insight into potential cortical changes. With 
respect to hypertrophy, a stronger and more reliable measure for muscular change 
would have been to use magnetic resonance imagery (MRI). The ease of use and access 
of ultrasound equipment outweighed the accessibility, cost and organisation required 
to utilise MRI technology for hypertrophy testing. An additional limitation of this 
study is the likelihood of being underpowered for some measures, with the potential 
for type II errors. A number of measures presented trends, with moderate to small 
effect sizes, suggesting that significant results may have been observed if more 
participants were recruited. 
Conclusion 
The results of the present study demonstrate that the supplementation of d-aspartic 
acid daily for 12 weeks, with resistance training, has no additive benefit on strength, 
or hypertrophy in the calf or quadriceps muscles over just resistance training alone. D-
aspartic acid did not have any long-term positive or negative effects on basal 
testosterone levels, which could be explained by negative-feedback mechanisms of the 
body attempting to keep the hormonal state of the body in homoeostasis. 
Supplementation of d-aspartic acid caused a decrease in resting estradiol levels, which 
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theoretically could be as a result of disruption of the testosterone-estradiol aromatase 
pathway. This reduction in estradiol did not appear to influence strength or 
hypertrophy negatively. However, results from regression analysis suggest that 
reductions in estradiol could be negatively impacting mechanisms of spinal 
excitability. The present study demonstrated that supplementation of d-aspartic acid 
preferentially improved explosive power, in the early phase of the rate of force 
development. This adaptation was only observed within the quadriceps muscle, which 
might be explained by a difference in prescribed volume. Moreover, contradictory 
results were observed in spinal excitability of the calf muscles, whereby preferential 
adaptation of the H-reflex pathway occurred in the placebo group. If d-aspartic acid is 
able to improve early rate of force development, then it could be beneficial to sports 
which require explosive power development. However, more research is needed to 
confirm these findings and explain the mechanism of d-aspartic acid mediated 
improvement in power.  
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CHAPTER 9 – THESIS CONCLUSION 
Summary 
The aim of this thesis was to undertake a systematic investigation of the effectiveness 
of the proposed testosterone boosting supplement, d-aspartic acid, in resistance trained 
men. Chapters 3-5 presented the initial study of this thesis, whereby after a 
familiarisation period, three doses of d-aspartic acid (0g, 3g and 6g), were given daily 
to resistance trained men for 14 days to observe changes in basal hormones. This study 
identified that three grams of d-aspartic acid did not significantly affect hormonal 
levels within this population. The six-gram dose reduced total testosterone levels by 
12.5% and free testosterone by 15.3%. Study 2, was presented in chapters 6-8 and 
explored the six-gram dosage over a periodised 12-week resistance training program. 
The experimental group experienced a reduction in estradiol, by the end of the 12 
weeks, which is believed to be as a result of disruption of the testosterone-estradiol 
aromatase pathway. D-aspartic acid also resulted in an increase in early RFD in leg 
extension, which is likely as a consequence of a combination of the programming 
prescribed in the second six-week block, and d-aspartic acids proposed role as a 
neurotransmitter. The placebo group exclusively experienced an improvement of 
spinal excitability, of the moderate to high threshold motor units within the 
gastrocnemius muscle. Isometric strength and hypertrophy of the calf and quadriceps 
muscles increased in both groups.  
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Originality of work 
Study 1 of this thesis was the first study to explore multiple dosages of d-aspartic acid 
in humans (Melville et al., 2015). Previous research in resistance trained men had 
failed to show any improvement in testosterone levels with short-term d-aspartic acid 
supplementation. It was hypothesised that a larger dosage might be required to increase 
levels within a resistance trained population. A novel finding of study 1, was that the 
six-gram d-aspartic acid group actually decreased testosterone levels, over a two-week 
supplementation period. Study 2 is the first long-term training study to explore d-
aspartic acid supplementation in resistance-trained men. Additionally, study 2 is the 
first study to explore spinal plasticity, as measured by H-reflexes, within a resistance 
trained population. Original findings of study 2 include the reduction in estradiol in 
the d-aspartic acid group; increase in early rate of force development of the quadriceps 
(d-aspartic acid group); and blunting of spinal plasticity to the calves, which was only 
observed in the placebo group. Furthermore, this is one of the first studies to find no 
relationship between change in testosterone levels and change in hypertrophy or 
strength.  
Practical Implications 
For the sole purpose of strength or hypertrophy gains, the results of this thesis suggest 
no added benefit from taking d-aspartic acid while training if the individual is 
resistance trained. Thus recommendations are to avoid this supplement if the goal is to 
train for pure strength or hypertrophy, due to its potential to negatively disrupt 
hormonal homoeostasis, and no added benefit while training for these goals. Within 
the context of power development, preliminary data suggests that supplementation of 
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d-aspartic acid (6 grams per day) improves early rate of force development, within the 
quadriceps muscles, in resistance trained men. It is possible that supplementation could 
be applicable to athletes seeking improvement in quadriceps power. In order to take 
advantage of this potential improvement in power, a periodised program should be 
implemented, with similar volume and intensity distributions. Furthermore, it should 
be expected that this power improvement, might be exclusive to the quadriceps until 
further research is conducted. Since a specific power program was not implemented in 
this study, the results of this research cannot be extended to this type of programming. 
Future directions 
Future research should aim to further elucidate a potential mechanism for the 
improvement in early RFD, within the quadriceps muscle following, d-aspartic acid 
supplementation and resistance training. Ideally, this research would explore neural 
adaptation within the quadriceps muscle, and utilise a protocol that could also delineate 
if adaptation is occurring from presynaptic or postsynaptic inhibition mechanisms. 
Additionally, a combination of resistance and power training could be explored to 
provide the greatest stimulus, to observe a different between d-aspartic acid and 
placebo. The effects of d-aspartic acid on the rate of force development could also be 
explored within the context of an acute setting. If d-aspartic acid is able to improve 
early rate of force development from a single dose, or from a loading strategy, there 
could be a useful application to temporary explosive power improvement, without the 
added issues of hormonal disruption. Additionally, power adaptations could be 
explored in other muscles, to delineate if this adaptation is exclusive to the quadriceps.  
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Conclusion 
The results of this thesis support and expand upon the current literature on the 
supplementation of d-aspartic acid in resistance trained men. D-aspartic acid appears 
to be negatively disrupting hormonal homoeostasis, which temporarily manifests as a 
reduction in testosterone. Long term, the decrease in testosterone seems to be corrected 
by the body, at the expense of a reduction in estradiol. Supplementation has no 
beneficial effect on strength and hypertrophy. Conversely, d-aspartic acid appears to 
have some interesting, conflicting effects on neural adaptation and rate of force 
development; that warrant further investigation to determine if this supplement could 
still be useful within the correct context.  
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APPENDICES 
Appendix 1 – Background Questionnaire 
Name: ______________________________________ Study ID#:______________ 
DOB:  _____/_____/_____   
Age: _____ 
Date _____/_____/_____ 
How long have you been doing consistent, structured resistant training?  
 ________Years ________ Months 
Have you taken any testosterone boosting supplements before (including anabolic 
steroids), and if so which ones? 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
How long has it been since you have taken these supplements? ___Y____ M 
Have you ever had a heart attack, or had heart issues? Yes   No 
Are you a diabetic?       Yes   No 
Have you ever had any recent major surgeries?  Yes   No 
Had any recent injuries?     Yes   No 
Have you ever had spells of dizziness from exercise?  Yes   No 
Have you ever been diagnosed with hypertension?   Yes   No 
Have you ever been diagnosed with abnormal cholesterol levels?  
Yes   No 
Are you allergic to whey protein or dairy?    Yes   No 
Are you allergic to amino acids?      Yes   No 
Do you have any other know allergies? 
____________________________________________________________________
____________________________________________________________________ 
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PLEASE TURN OVER FOR MORE QUESTIONS  
Medications: 
Prescription Drug Name Dosage 
  
  
  
  
  
  
  
  
  
  
  
Non-Prescription/Supplement 
 Drug Name 
Dosage 
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Appendix 2 - Data Sheet – study 1 
Name: ______________________________________   
ID:_____________________ 
 
Height: ________________ 
Sleep time:  ___________hrs (B1)  Weight: _____.____kg 
Bench Press 1RM: ___________kg  (B1) 
Testosterone:  ___________  (B1)  Date: ____/____/____ 
Estradiol:  ___________  (B1) 
 
Sleep time:  ___________hrs (B2) Weight: _____.____kg 
Bench Press 1RM: ___________kg  (B2) 
Testosterone:  ___________  (B2)  Date: ____/____/____ 
Estradiol:  ___________  (B2) 
 
Sleep time:  ___________hrs (B3)  Date: ____/____/____ 
Testosterone:  ___________  (B3) 
Estradiol:  ___________  (B3) 
 
Sleep time:  ___________hrs (B4)  Weight: _____.____kg 
Bench Press 1RM: ___________kg  (B4) 
Testosterone:  ___________  (B4)  Date: ____/____/____ 
Estradiol:  ___________  (B4) 
 
Sleep time:  ___________hrs (B5)  Weight: _____.____kg 
Testosterone:  ___________  (B5) 
Estradiol:  ___________  (B5)  Date: ____/____/____ 
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Appendix 3 – Participant information sheet, study 1 
Project Title: Exploring the short term effectiveness of D-Aspartic Acid in resistance 
trained men undergoing standardised training.  
(Phase 1) 
Who is carrying out the study? 
PhD student in the School of Science and Health at UWS. 
You are invited to participate in a study conducted by PhD candidate Geoffrey 
Melville (School of Science and Health) under the supervision of Dr Paul Marshall 
and Dr Jason Siegler. 
What is the study about? 
The purpose of this study is to investigate the effect of the supplement d-aspartic acid 
on changes in fasted basal testosterone levels during standardised training. D-aspartic 
acid is a naturally occurring, endogenous amino acid that is found in nervous and 
endocrine tissues of the human body. Previous research has suggested that d-aspartic 
acid has the potential to increase levels of testosterone. The supplement d-aspartic acid 
will be sourced from supplier Bulk Nutrients and is fit for human consumption.  The 
proposed research will help the investigators better understand the effectiveness of the 
supplement. 
Is there an eligibility criteria? 
Two or more years resistance training experience (consistent training excluding de-
loading phases); male; 18 – 36 years old; healthy; have the ability to squat at least 
130% of their bodyweight; have the ability to bench 100% of their bodyweight; ability 
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to communicate in English; no acute or chronic medical conditions which would make 
resistance training hazardous or primary outcome measures impossible to assess; 
willingness and cognitive ability to provide written informed consent to participate in 
the trial. 
As with any product consumed or brought into contact with humans, there is a risk of 
developing an allergic reaction. During the study participants assigned to the 
experimental groups will be consuming the supplement d-aspartic acid. If you have a 
known allergy to this product or other amino acids, you will also be excluded from the 
study. 
What does the study involve? 
The study will require you to attend the research laboratory at UWS Campbelltown 
campus building 20 on 6-8 occasions. The first session will include a blood draw, one 
repetition maximum (1RM) bench press, along with familiarisation of the exercise 
program. In this session you will be given training and nutritional diaries, to be filled 
out to the best of your ability throughout the study. You will be required to come into 
the lab in the morning after a 12 hour fast (B1/1RM). After a 5-10 minute resting 
period, the investigators will take a venous blood sample from the forearm. Once per 
week for the duration of the study, you can attend the university gym for a supervised 
training session (if required or need some technique questions answered). You will be 
expected to train four times per week starting the day of the initial testing session. At 
the beginning of the experimental period (B2/1RM), you will be randomly assigned a 
particular dose of the supplement (d-aspartic acid) or a placebo, and you will consume 
a daily dose your allocated pills for the duration of the experimental period (14 days). 
You will continue training the same way as during the first 2 weeks. Throughout the 
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experimental period, further blood draw testing will be conducted, following the same 
procedures as initial testing and collection (O1-3 & B3-5). The following figure will 
help illustrate the timeline. 
 
 
0-7 days 7-14 days 14-21 days 21-26 days 
Standardisation training period (14 
days) 
Supplementation period (12 days) 
 
How much time will the study take? 
The study will be conducted over 6 weeks. Your involvement will require you to attend 
the research laboratory on 6-8 occasions and research gym on 4 occasions. The first 
session will take approximately 60 minutes; gym sessions should take between 60-90 
minutes, and blood work collection should be completed within 30 minutes. 
Will the study benefit me? 
At the end of the study, you will be given access to the results of the study. This will 
provide you with information about the effectiveness of this particular supplement. 
Will the study involve any discomfort for me? 
Yes. First, the 1RM testing sessions are designed to find how much weight you are 
able to move for one repetition, which can be uncomfortable. Second, the sampling of 
venous blood involves inserting a needle into one of your forearm veins (like a 
standard blood test). Most people experience this as a brief, transient sharp pain. Third, 
Baseline Time point 1 Time point 2 
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the amount of training volume required for the study is designed to match as close as 
possible the average volume for an advanced trained population. Therefore you may 
experience some discomfort from Delayed Onset of Muscle Soreness (DOMS). 
Are there any risks? 
Human research into the product d-aspartic acid is still in early stages, and thus all of 
the potential risks associated with consumption are unknown.  Known side-effects of 
testosterone supplementation (e.g. anabolic steroids) include increased estradiol, 
reduced HDL cholesterol (good cholesterol) acne, hair loss, gynecomastia, liver 
damage, mood changes and atrophy of the testicles. While it is thought that d-aspartic 
acid is likely to raise basal testosterone, current evidence from humans does not 
suggest the elevation will be to a level associated with reported side-effects of anabolic 
steroid use.  Anecdotal reports of side-effects associated with d-aspartic acid use must 
be weighed against the likelihood people are also using a variety of other substances 
that may induce these side-effects.  We do not expect any side-effects to be 
experienced (e.g. reduced HDL cholesterol, increased acne or increased 
estradiol).  However, we will be monitoring levels of estradiol and unwanted physical 
changes. Furthermore, if you notice or experience any physical changes that you are 
not used to, or do not expect, please contact Geoffrey Melville or any of the research 
team as soon as possible.  
How is this study being paid for? 
The study is being sponsored by Higher Research Degree funds available to PhD 
candidates, for the School of Science and Health at the University of Western Sydney. 
Supplement sponsorship is provided by Bulk Nutrients, TAS, Australia. 
Will anyone else know the results? How will the results be disseminated? 
 163 
 
All aspects of the study, including results, will be confidential, and only researchers 
will have access to information on participants. Data collected from you will be 
presented in undergraduate classes, research seminars, conference presentations, 
postgraduate theses and/or research publications; under none of these circumstances 
will your identity be revealed to the audience or the readership. Information collected 
for this project, or generated by this project may be used for another purpose by the 
researcher, for which ethical approval will be sought. It may be possible for 
participants to identify each other. Potentially there may be multiple participants 
training in the gym at the same time. This, however, will not expose any participant to 
any greater risk. At no point will personal information or results be disclosed to anyone 
other the specific participant the results relate to. 
Can I withdraw from the study? 
Participation is entirely voluntary. You are not obliged to be involved and, if you do 
participate, you can withdraw at any time without giving any reason and without any 
consequences. 
Can I tell other people about the study? 
Yes, you can tell other people about the study by providing them with the chief 
investigator’s contact details. They can contact the chief investigator to discuss their 
participation in the research project and obtain an information sheet. 
What if I require further information? 
When you have read this information sheet, PhD candidate Geoff Melville will discuss 
it with you and answer any questions you might have. If you would like to know more 
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at any stage, please feel free to contact Geoff Melville g.melville@uws.edu.au, 
0426263496, 46203917 
If you would like to see the current human research on d-aspartic acid, please refer to 
the following article: 
Topo E, Soricelli A, D'Aniello A, Ronsini S, D'Aniello G. The role and molecular 
mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in 
humans and rats. Reproductive Biology and Endocrinology. 2009;7. 
What if I have a complaint? 
This study has been approved by the University of Western Sydney Human Research 
Ethics Committee (HREC). The approval number is H10087 
If you have any complaints or reservations about the ethical conduct of this research, 
you may contact the Ethics Committee through the Office of Research Services on Tel 
+61 2 4736 0229 Fax +61 2 4736 0013 or email humanethics@uws.edu.au.   
Any issues you raise will be treated in confidence and investigated fully, and you will 
be informed of the outcome.  If you agree to participate in this study, you may be asked 
to sign the Participant Consent Form. 
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Appendix 4 – Participant consent form, study 1 
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Appendix 5 - Participant information sheet – study 2 
Project Title:  Exploring the effectiveness of D-Aspartic Acid on training adaptation 
during a 12-week training program 
Who is carrying out the study? 
You are invited to participate in a study conducted by PhD candidate Geoffrey 
Melville (School of Science and Health), under the supervision of Dr Paul Marshall 
and Dr Jason Siegler. 
What is the study about? 
The purpose of this study is to investigate the effect of d-aspartic acid has on changes 
in fasted basal testosterone levels from 3 months of training. D-aspartic acid is a 
naturally occurring, endogenous amino acid that is found in nervous and endocrine 
tissues of the human body. Previous research has suggested that d-aspartic acid has the 
potential to increase levels of testosterone. The supplement d-aspartic acid will be 
sourced from supplier Bulk Nutrients and is fit for human consumption. This study 
will investigate the effects that elevation of testosterone has on training outcomes 
following a resistance exercise program. Training outcomes measured will be changes 
in strength, hypertrophy and adaptation of the peripheral somatic nervous system. 
Is there an eligibility criteria? 
Two or more years resistance training experience (consistent training excluding de-
loading phases); male; 18 – 36 years old; healthy; have the ability to squat at least 
130% of their bodyweight; have the ability to bench 100% of their bodyweight; ability 
to communicate in English; no acute or chronic medical conditions which would make 
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resistance training hazardous or primary outcome measures impossible to assess; 
willingness and cognitive ability to provide written informed consent to participate in 
the trial. 
As with any product consumed or brought into contact with humans, there is a risk of 
developing an allergic reaction. During the study, all participants will be asked to 
consume a drink of maltodextrin (sugar) and whey protein isolate (dairy protein) for 
post workout nutrition. Therefore anyone with a known allergy to these products is 
instantly excluded from the study. During the study participants assigned to the 
experimental groups will be consuming the supplement d-aspartic acid. If you have a 
known allergy to this product or other amino acids, you will also be excluded from the 
study. 
What does the study involve? 
The study will require you to attend the research laboratory at UWS Campbelltown 
campus building 20 for three testing time points (which may be 1-2 sessions long 
depending on time available), and conduct training at the university research gym on 
multiple occasions over a 3 month period. The first session will involve testing 1 
repetition maximum (1RM) for the back squat and the bench press. Initial testing will 
also involve measurement of the thigh muscle using ultrasound technology and 
measurement of the peripheral somatic nervous system using electrical nerve 
stimulation. Blood draws will be taken at 0 weeks, 6 weeks and 3 months. During 
blood draws participants will be required to come into the lab in the morning (7-10 
am) after a 12 hour fast (food, coffee). After a 5-10 minute resting period, the 
investigator will take a venous blood sample (3-4 tubes) from the forearm (similar to 
a normal blood test). This will be analysed for hormonal levels (TT, FT, E2, SHBG, 
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ALB) and HDL cholesterol. For the three days surrounding the blood draw testing day 
(i.e. day before/day of/day after) participants are required to fill out a 24h food diary 
(9 total). 
For the duration of the study participants will come in for supervised training sessions. 
The first week participants are expected to come in for the four days to become familiar 
with each of the training days. From then on participants will continue to training four 
times per week, and are only required to come in for one supervised session, the other 
three conducted at their normal gym. At the supervised sessions, participants will be 
asked to bring in the provided training diary for photocopying (to allow for ongoing 
data entry). 
During the experimental period, participants will consume a dose of pills (11 capsules) 
containing the supplement (DAA) or a placebo each morning. They will train for 12 
weeks, with small changes in the program at the 6-week mark. Participants will also 
be expected to consume the provided post workout nutrition within 30 minutes of 
finishing their workout. 
How much time will the study take? 
The study will be conducted over approximately 3 months. Your involvement will 
require you to attend the research laboratory or research gym on the previously 
mentioned occasions. The first session for each time point will involve 1RM testing of 
the bench press and squat, and provided criteria is met this will be followed by neural 
testing of the calf muscle. This will take approximately 30-45 minutes for 1RM testing 
and 90 minutes for the calf protocol. The second session at each time point will involve 
venous blood draws followed by an ultrasound of the quad and calf. Blood draw takes 
approximately 20 minutes (allowing for relaxation period), and the ultrasound will 
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take 30-75 minutes, varying from person to person. There is the option if the participate 
prefers to complete testing in one day. If this was the case, the order of testing would 
be blood, ultrasound, 1RMs, and neural stimulation. Furthermore, they would be asked 
to bring in something they could consume for breakfast to have after the blood and 
ultrasound been completed. Bear in mind this could take 3-4.5 hours. 
Will the study benefit me? 
At the end of the study, you will be given access to the results of the study. This will 
provide you with information about the effectiveness of this particular supplement for 
you as an individual. Throughout the study post-workout nutrition in the form of 
powder will be provided free of charge. You’re weekly allocation of post workout 
nutrition will be provided to you when you come to your weekly supervised session. 
Over 3 months of professional, motivated training, participants should expect to see 
gains in strength and/or hypertrophy. 
Will the study involve any discomfort for me? 
Yes. First, the 1RM testing sessions are designed to find how much weight you are 
able to move for one repetition, which can be uncomfortable. Second, the sampling of 
venous blood involves inserting a sharp needle into one of your forearm veins (like a 
standard blood test). Most people experience this as a brief, transient sharp pain. Third, 
nerve stimulation involves a short electrical stimulus applied to a nerve in your leg. 
Some experience this as a sharp, but transient pain. Fourth, the amount of training 
volume required for the study is designed to match as close as possible the average 
volume for an advanced trained population. Therefore you may experience some 
discomfort from Delayed Onset of Muscle Soreness (DOMS).  
Are there any risks? 
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Human research into the product d-aspartic acid is still in early stages, and thus all of 
the potential risks associated with consumption are unknown.  Known side-effects of 
testosterone supplementation (e.g. anabolic steroids) include increased estradiol, 
reduced HDL cholesterol (good cholesterol) acne, hair loss, gynecomastia, liver 
damage, mood changes and atrophy of the testicles. While there is evidence to suggest 
that d-aspartic acid can raise basal testosterone, current evidence from humans does 
not suggest the elevation will be to a level associated with reported side-effects of 
anabolic steroid use. Anecdotal reports of side-effects associated with d-aspartic acid 
use must be weighed against the likelihood people are also using a variety of other 
substances that may induce these side-effects.  We do not expect any side-effects to be 
experienced (e.g. reduced HDL cholesterol, increased acne or increased 
estradiol).  However, we will be monitoring levels of estradiol, HDL cholesterol and 
unwanted physical changes. Furthermore, if you notice or experience any physical 
changes that you are not used to, or do not expect, please contact Geoffrey Melville or 
any of the research team as soon as possible.  
How is this study being paid for? 
The study is being sponsored by Higher Research Degree funds available to PhD 
candidates, for the School of Science and Health at the University of Western Sydney. 
Supplement sponsorship is provided by Bulk Nutrients, TAS, Australia. 
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Will anyone else know the results? How will the results be disseminated? 
All aspects of the study, including results, will be confidential, and only researchers 
will have access to information on participants. Data collected from you will be 
presented in undergraduate classes, research seminars, conference presentations, 
postgraduate theses and/or research publications; under none of these circumstances 
will your identity be revealed to the audience or the readership. Information collected 
for this project, or generated by this project may be used for another purpose by the 
researcher, for which ethical approval will be sought. It may be possible for 
participants to identify each other. Potentially there may be multiple participants 
training in the gym at the same time. This, however, will not expose any participant to 
any greater risk. At no point will personal information or results be disclosed to anyone 
other the specific participant the results relate to. 
Can I withdraw from the study? 
Participation is entirely voluntary. You are not obliged to be involved and, if you do 
participate, you can withdraw at any time without giving any reason and without any 
consequences.  
Can I tell other people about the study? 
Yes, you can tell other people about the study by providing them with the chief 
investigator’s contact details. They can contact the chief investigator to discuss their 
participation in the research project and obtain an information sheet. 
What if I require further information? 
When you have read this information sheet, PhD candidate Geoff Melville will discuss 
it with you and answer any questions you might have. If you would like to know more 
 172 
 
at any stage, please feel free to contact Geoff Melville g.melville@uws.edu.au, 
0426263496, 46203917 
What if I have a complaint? 
This study has been approved by the University of Western Sydney Human Research 
Ethics Committee (HREC). The approval number is H10087. 
If you have any complaints or reservations about the ethical conduct of this research, 
you may contact the Ethics Committee through the Office of Research Services on Tel 
+61 2 4736 0229 Fax +61 2 4736 0013 or email humanethics@uws.edu.au.   
Any issues you raise will be treated in confidence and investigated fully, and you will 
be informed of the outcome.  If you agree to participate in this study, you may be asked 
to sign the Participant Consent Form. 
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Appendix 6 – Participant consent form, study 2 
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Appendix 7 – Venepuncture log book 
 
 
